百张假照换来十年禁，师生同陷撤稿泥潭 诸平 据《撤稿观察》（ Retraction Watch ）2020年8月7日报道—— Cancer researcher hit with 10-year ban on federal US funding for nearly 100 faked images ，美国底特律韦恩州立大学（ Wayne State University in Detroit , WSU ）一名失去博士学位的前科学家在被发现有不轨行为后，同意 10 年内 禁止从事任何由美国联邦政府资助的研究 。 美国研究诚信办公室（ U.S. Office of Research Integrity , ORI）说，王志伟（ Zhiwei Wang 音译）在美国国立卫生研究院（National Institutes of Health简称NIH）资助的9项拨款、3项拨款申请以及他2006年的博士学位申请中伪造数据。 据ORI报道，王志伟的15篇论文中有伪造数据不轨行为，其中14篇论文已被撤回。第15篇文章也是自身难保，要求王志伟撤回或修正，这是2008年发表在《分子癌症治疗学》（Molecular Cancer Therapeutics）上的一篇论文，其篇名为——3,3-二吲哚甲烷诱导人类乳腺癌细胞生长阻滞和凋亡与p27 kip 的诱导和核定位有关（ Induction of growth arrest and apoptosis in human breast cancer cells by 3,3-diindolylmethane is associated with induction and nuclear localization of p27 kip ）。 王志伟曾经是韦恩州立大学病理学系（ the department of pathology , WSU）的博士后，另一位前WSU研究员 法兹卢尔·萨卡尔（ Fazlul Sarkar ， Fazlul H Sarkar ） 也曾在病理学系工作过。但是，法兹卢尔·萨卡尔已经有40篇论文被撤回，其中包括至少有35篇论文也有王志伟的署名（ at least 35 with Wang ）。 WSU调查委员会在2015年8月底结束的一项单独不当行为调查（ Final Report of the Investigation Committee of Wayne State University ）显示， 法兹卢尔·萨卡尔是王志伟的论文指导老师。这份431页的最终调查报告的结论是: 因为PubPeer对 法兹卢尔·萨卡尔的研究结果的真实性提出质疑之后，法兹卢尔·萨卡尔不服而且起诉了PubPeer，但没有成功（ unsuccessfully sued PubPeer ），败诉也使法兹卢尔·萨卡尔失去在另一所大学的一个新职位。 根据ORI的调查发现了一个优势证据可以证明，王（志伟）从事研究过程中有故意的不当行为。详见ORI的评述原文： ORI found by a preponderance of evidence that engaged in research misconduct by intentionally, knowingly, and/or recklessly falsifying and/or fabricating images representing protein expression, invasion and migration assays, and electrophoretic mobility shift assays (EMSA) in experiments designed to identify underlying mechanisms controlling cell proliferation, differentiation, and apoptosis in cancer so that novel targeted therapeutic agents could be identified. 《 撤稿观察 》指出，这是他们所见过的最长的发现之一，不守信用令人震惊，每一段捏造都接近三位数。但在2008年庆祝王志伟获得美国国防部（Department of Defense）大笔资助的新闻发布会上，WSU对这位博士后大加赞扬（Wayne State praised the postdoc ）： WSU 负责研究的副校长乔·邓巴博士 (Dr. Joe Dunbar) 说，王博士的研究反映了对抗美国最常见的癌症和第二大癌症死亡原因所需要的智慧和活力。目前，无论是激素难治性前列腺癌 (Hormone Refractory Prostate Cancer) 还是转移性前列腺癌 (Metastatic Prostate Cancer) ，都没有实际的治疗方法，王博士的工作给那些与这种毁灭性疾病作斗争的人们带来了新的希望，也证明了 WSU 在致力于改变人们生活的尖端研究。下面是 副校长乔·邓巴博士的讲话原文： “Dr. Wang’s research reflects the type of ingenuity and vigor needed for fighting the most commonly diagnosed cancer and second leading cause of cancer death in the United States,” said Dr. Joe Dunbar, associate vice president for Research at Wayne State. “With no practical methods for treating either Hormone Refractory Prostate Cancer or Metastatic Prostate Cancer currently in existence, Dr. Wang’s work gives new hope to those battling this devastating disease, and exemplifies Wayne State’s dedication to cutting edge research that will change people’s lives.” 王志伟在我国的苏州大学（Wang appears to be at Soochow University in China）任职，此前他离开了WSU后，在美国波士顿的贝斯以色列女执事医疗中心（Beth Israel Deaconess Medical Center in Boston）工作了一段时间。《 撤稿观察 》无法立即联系到王博士对此发表评论。 王志伟博士简介 据 生物通 （ Ebiotrade ）对 王志伟 的介绍： 王志伟 教授，博士生导师 教育背景 ： 1989~1994年 蚌埠医学院 临床医学专业 学士 1998~2001年 上海交通大学医学院 细胞生物学专业 硕士 2002~2006年 美国韦恩州立大学医学院 病理学专业 博士 2007~2011年 美国韦恩州立大学医学院 博士后、Research Associate 工作经历 ： 1994~1998年 蚌埠医学院 助教 2001~2002年 上海交通大学医学院 助教 2011~2013年 美国哈佛大学医学院 讲师 2013~至今 苏州大学唐仲英血液学研究中心 教授 研究领域：细胞信号传导和肿瘤发生机制,自然化合物抗癌的机制。 另据世界上领先的开放图书出版商—— IntechOpen 网站对王志伟（ Wang Zhiwei ）博士的介绍，他是我国苏州大学唐氏血液学中心（Cyrus Tang Hematology Center, Soochow University, China.）教授。在中国安徽蚌埠医学院（Anhui Bengbu Medical College）获得医学学士学位，在美国密歇根州韦恩州立大学（Wayne State University, Michigan, USA）获得博士学位（Ph. D）。他在美国密歇根州韦恩州立大学的Karmanos癌症研究所（ Karmanos Cancer Institute, Wayne State University , Michigan, USA）完成博士后研究。后来，他在美国哈佛医学院贝斯以色列女执事医学中心（ Beth Israel Deaconess Medical Center , Harvard medical School, USA）担任讲师。他在同行评审期刊上发表了140多篇论文，其H指数为31，被引用了3000多次。他曾担任资助基金的临时评审员，并担任40多家期刊论文的临时审稿人。王博士的研究兴趣集中在Notch、FoxM1和E3泛素连接酶等细胞信号通路在衰老和致瘤中的作用。此外，他还对微小核糖核酸（microRNA）和干细胞在耐药性中的作用感兴趣。更多信息请注意浏览原文或者相关报道。
奇谈怪论——” 5G 技术导致新冠病毒传播”已经撤稿 诸平 据《撤稿观察》（ Retraction Watch ）2020年7月26日提供的消息，将COVID-19归咎于5G技术的论文已经被撤回（ Paper blaming COVID-19 on 5G technology withdrawn ）。 一篇声称5G手机技术可能导致新型冠状病毒（COVID-19）感染的论文已被撤回，但在此之前，科学侦探伊丽莎白·比克(Elisabeth Bik)就曾经怀疑这是不是2020年最差的论文（“ worst paper of 2020 .”）。它是由来自意大利、美国和俄罗斯的一个研究小组合作完成的拙作，在《生物调节和稳态制剂杂志》 网站2020年7月16日在线发表——Fioranelli M, Sepehri A, Roccia MG, et al. 5G Technology and induction of coronavirus in skin cells. .J Biol Regul Homeost Agents,2020, 34(4): 10.23812/20-269-E-4. doi: 10.23812/20-269-E-4.该杂志是由Biolife出版的，该杂志声称已经进行了同行评议，但未对《撤稿观察》的置评请求作出回应。现在，该论文的摘要在PubMed数据库中被标记为撤回（WITHDRAWN），该论文也从其杂志的网站上消失了。其摘要摘引于下，仅供参考。 Abstract “In this research, we show that 5G millimeter waves could be absorbed by dermatologic cells acting like antennas, transferred to other cells and play the main role in producing Coronaviruses in biological cells. DNA is built from charged electrons and atoms and has an inductor-like structure. This structure could be divided into linear, toroid and round inductors. Inductors interact with external electromagnetic waves, move and produce some extra waves within the cells. The shapes of these waves are similar to shapes of hexagonal and pentagonal bases of their DNA source. These waves produce some holes in liquids within the nucleus. To fill these holes, some extra hexagonal and pentagonal bases are produced. These bases could join to each other and form virus-like structures such as Coronavirus. To produce these viruses within a cell, it is necessary that the wavelength of external waves be shorter than the size of the cell. Thus 5G millimeter waves could be good candidates for applying in constructing virus-like structures such as Coronaviruses (COVID-19) within cells.” Keywords: 5G technology; COVID-19; DNA; dermatologic antenna; inductor; millimeter wave. 根据作者的说法：在这项研究中，我们发现5G毫米波可以像天线一样被皮肤细胞吸收，并转移到其他细胞，在生物细胞中产生冠状病毒的过程中起重要作用。 这篇论文的作者显然不仅对5G有疑虑，而且对数学也有问题。他们在文章中写道:在另一项研究中，有人认为5G技术对人类健康造成了巨大危害，它会对人类引起720阶乘（720！）种不同类型的疾病，癌症只是众多疾病中的一种。 但正如詹姆斯·海瑟斯（ James Heathers ）在推特上指出的，720的阶乘（720！）是一个相当大的数字。它到底有多大?记住，5G会导致720！种不同的疾病。我想在ICD-10中大概有13000种疾病。这比720！少了很多! 迄今为止，有关新冠病毒（COVID-19）的论文撤稿数量已经到达26篇详见That makes 26 papers about COVID-19 that have been retracted .更多关于5G与新冠病毒的报道，可以注意浏览“ 5G传播新冠病毒？无厘头谣言出炉记 ”等相关报道。
撤稿与学术诚信度及大学排名的影响 诸平 之前写过“ 撤稿：一个常被忽视的关键指标 ”，今天对此再进行一些补充，顺便谈谈诚信度，特别是指学术诚信度（Scholarly Integrity简称 I S ）与撤稿的关系，以及撤稿对《泰晤士报高等教育2020年世界大学排名》( 2020 Times Higher Education World University Rankings ) 位次的影响。 1.世界顶级大学的撤稿现象 前文已经指出， 令人担忧的是被广泛接受的大学排名系统并没有把撤回的出版物作为排名过程影响因素的一部分加以考虑。《泰晤士报高等教育2020年世界大学排名》( 2020 Times Higher Education World University Rankings )中的许多顶尖大学都出现在《撤稿观察》数据库( Retraction Watch database 简称RWDB )中。我们对其排名中的前50名大学举行检测，结果显示没有一家高校能够幸免。具体详见图1所示。51所大学平均撤稿35.7篇，最少3篇，最多92篇。由于2020年大学排行榜中涉及到科研成 果的引用（ Citations ）权重占30%，主要是考虑科研的影响( research influence )，而且是以2014-2019年的数据最为基础进行计算，因此图1中的2014-2019就是在2014年元月1日到2019年12月31日之间的撤稿数量。红色线条则表示的是RWDB中撤稿总数。 图1 2020大学排行榜中Top50的撤稿数量统计结果 2. 撤稿数量对大学排行榜中位次的影响 假设 泰晤士报高等教育2020年世界大学排名为 R 1 ;考虑撤稿因素之后的校正排名为 R 2 ; x 表示撤稿数量； I S 表示学术诚信度， I S =100 e -bx ； b 为一常数，此处 b =0.046。 R 2 = R 1 +0.01 R 1 （100- I S ）= R 1 +0.01 R 1 (100-100e -bx )= R 1 + R 1 (1-e -bx )= R 1 (2+e -bx ) 图2 Top50撤稿数量（A）、校正排序 R 3 与原排序 R 1 的关系（B）、 排序变化△ R (C)以及 R 1 与 I S 关系(D) 图3 图2 （B）的放大图即校正排序 R 2 与原排序 R 1 的关系 结果显示，经过考虑撤稿因素影响，使51所世界顶级大学的排名均有所变化，影响最小的是排序后退一个位次，最多后退37个位次，平均后退13个位次。 3.几名重要撤稿人的学术诚信度计算结果 根据 I S =100e - 0.046 x 对于15位作者的学术诚信度计算结果如下表： 佐藤嘉洋 他本人很多年来一直在日本九州岛Tagawa小镇的 见立医院（Mitate Hospital） 工作，该医院“并不以科研水平著称”、“病人也不多”，佐藤嘉洋却为其贡献了99%以上的“科研”产出。 佐藤嘉洋的研究的关注点在于“如何降低骨折风险”，其中数十项临床试验涉嫌欺诈。 其捏造的报告产生的影响——很多关于如何降低骨折风险——波及面甚广。其试验采用的元分析得出了错误结论，同时专业学会、 机构 以其论文为基础制定了各种医学指南。为追踪那些不知道是否被伪造过的研究，科研人员招募了上千名真实患者并开展了新试验。 佐藤嘉洋2000～2003年间在弘前大学（ Hirosaki University ）医学院担任教授 。可能是因为迫于调查的压力，他与2017年元月自杀， 但弘前大学的调查并没有因为他的自杀谢罪而终止，还是在继续进行 。而Yoshitaka Fujii（藤井善隆）是日本的麻醉学研究者，他从2012年到现在，被发现至少编撰了183篇科学论文的数据 （这些论文有些已经被撤回），被认为是单个作者被撤的最高纪录。 约阿希姆·博尔特（Joachim Boldt）曾担任德国路德维希港医院（Klinikum Ludwigshafen）麻醉科主管，主要从事关于羟乙基淀粉的应用研究，是一种作为手术期预防和治疗循环血量不足或休克的胶体。在被揭发（2010年）之前，他在液体治疗领域尤其是胶体治疗领域是超级大腕。曾经发表过300多篇文章，由于90余篇论文造假，他于2010年11月被院方开除，传说开除之后去了捷克继续行医。四大名刊之一的 The BMJ 刊登了一篇有关约阿希姆·博尔特的文章，可不是什么名垂青史的事，而是把他牢牢的钉在耻辱柱上，文章的标题是：《Blodt，伟大的造假者》（ Boldt: the great pretender | The BMJ ）。90余篇撤稿论文都是闭门造车的产物，完全集中在羟乙基淀粉临床研究方面。 4. 不同 b 值与撤稿数量 x 对于 I S 的影响 不同 b 值与撤稿数量 x 对于 I S 的影响见图4所示。 b 值分别取0.046, 0.04, 0.03和0.02时， I S 随 撤稿数量 x 的变化如图4所示。 图4 不同 b 值与撤稿数量 x 对于 I S 的影响
已发表 77 年的论文引起人们关注 诸平 据《撤稿观察》（ Retraction Watch ）2020年7月8日的报道，有争议的心理学家、 人格研究先驱 汉斯·艾森克 ( Hans Eysenck ，1916-1997 ) 发表了77年的论文，引起了人们的关注。 一些期刊对汉斯•艾森克的另外7篇论文也表示关注，其中一篇是这位现已去世的心理学家在“二战”中期发表的论文。 对1997年去世的汉斯·艾森克的怀疑早在20世纪90年代初就已经出现 （ surfaced in the early 1990s ） ，甚至会更早一些。迄今为止，汉斯·艾森克的论文至少有14篇（ 14 of his papers ）被撤回，他的传记作者罗德·布坎南（ Rod Buchanan ， biographer has said ）说，这一总数可能远远超过60篇。现在有71篇论文（ 71 have now been hit ）令人担忧。 最新的此类举措来自《皇家医学学会杂志》（ Journal of the Royal Society of Medicine，JRSM ），该杂志发布了如下通知： JRSM和SAGE出版公司发布了对下列文章的关注 1. Eysenck H J. Suggestibility and Hypnosis—an Experimental Analysis.Proceedings of the Royal Society of Medicine1943; 36(7): 349–354. https://doi.org/10.1177/003591574303600713 . 2. Eysenck H J. The Measurement of Personality. .Proceedings of the Royal Society of Medicine1946; 40(2): 75–80. https://doi.org/10.1177/003591574604000209 . 3. Eysenck H J. Personality and Behaviour Therapy.Proceedings of the Royal Society of Medicine1960; 53(7): 504–508. https://doi.org/10.1177/003591576005300705 . JRSM和SAGE发表了上述表达关注的文章，以提醒读者注意上面所列的与伦敦国王学院（King’s College London）的一篇评论有关的文章。 该综述审查了汉斯·艾森克(Hans J. Eysenck)和罗纳德·格洛萨特-马迪克(Ronald Grossarth-Maticek)合著的有关人格和某些健康结果的论文。基于以下发现，国王学院建议撤回一些文章。 其一是关注数据集的有效性，包括参与者的招募、措施的管理、结果确定的可靠性、数据收集中的偏差、相关协变量的缺失以及每篇文章中分析的案例的选择等。 其二是 汉斯·艾森克(Hans J. Eysenck)和罗纳德·格洛萨特-马迪克(Ronald Grossarth-Maticek) 报告的结果，与现代临床科学和对疾病过程的理解是不可信和不相容的。 虽然国王学院的评论（ King’s College review ）没有考虑上述JRSM的文章，但 JRSM和SAGE 认为，提醒读者注意国王学院的评论以及关于 汉斯·艾森克(Hans J. Eysenck)和罗纳德·格洛萨特-马迪克(Ronald Grossarth-Maticek) 工作的问题是很重要的。 其余的来自SAGE旗下的《国际社会精神病学杂志》（ International Journal of Social Psychiatry ）对下面的这些文章也有类似的关注。 1）Eysenck, H. J. (1985). Behaviourism and Clinical Psychiatry. International Journal of Social Psychiatry, 31(3), 163–169. https://doi.org/10.1177/002076408503100301 2）Eysenck, H. J. (1960). Objective Approaches to Personality Assessment. Edited by B. M. Bass and I. A. Berg. Princeton, New Jersey: D. van Nostrand Company Inc., 1959. Pp. 233. Price, 37s. 6d. International Journal of Social Psychiatry, 5(4), 320–320. https://doi.org/10.1177/002076406000500424 3）Eysenck, H. J. (1960). Levels of Personality, Constitutional Factors, and Social Influences: An Experimental Approach. International Journal of Social Psychiatry, 6(1–2), 12–24. https://doi.org/10.1177/002076406000600104 4）Eysenck, S. B. G., Eysenck, H. J. (1962). Rigidity as a Function of Introversion and Neuroticism: a Study of Unmarried Mothers. International Journal of Social Psychiatry, 8(3), 180–184. https://doi.org/10.1177/002076406200800302 关于国王学院关于汉斯·艾森克的报告原文可以点击（ here ）浏览。关于1943年发表的论文，虽然它发表至今已经有77年的历史了，但是，它并非是撤稿论文中发表时间最长的。迄今为止，《撤稿观察》（ Retraction Watch ）看到的最古老的撤回声明是涉及到1923年发表的一份病例报告，该报告在其发表80年后的2003年被撤回。关于汉斯·艾森克也可以参看： 学术地震！知名心理学家13篇论文撤稿，61篇存疑，被指陷入“科学丑闻” 的相关报道，为了便于阅读，特转载于下，仅供参考。 近日（ 2020年02月下旬 ），两份期刊宣布撤稿英国著名心理学家汉斯·艾森克（Hans Eysenck，1916-1997）的 12 篇论文，还提出他有 61 篇论文存在疑问。其中，《感知与运动技能》（Perceptual and Motor Skills）已经撤稿 3 篇，并提出 36 篇存在疑问；而《心理报告》（Psychological Reports）已经撤稿 9 篇，提出 25 篇存在疑问，部分论文发表于 60 年前。加上2020年 1 月的另一次撤稿，汉斯·艾森克被撤稿的论文总计达到了 13 篇，有人估计这个数字最终可能超过 60 篇。 1 汉斯·艾森克简介 汉斯·艾森克曾在 1955～1983 年任伦敦大学国王学院（King's College London）精神病研究所心理学教授，并兼任莫兹利和贝斯莱姆皇家医院的心理学专家。他是当时被引数最高的学者之一，至今仍然常常作为人格研究的先驱之一登上各个版本的心理学教材。 艾森克最知名的贡献之一就是提出了人格的“三因素模型”，他率先提出了基于生物学的人格理论，即从大脑构造和神经系统运作机制的角度理解人格。他主张人格的不同是写在每个人的基因里的。他提出了三个基本的人格维度，即外倾性（extraversion）、神经质（neuroticism）、精神质（psychoticism），并以此为基础建立了三因素模型。其中，外倾性指人的外向程度，由脑部网状结构调节；神经质指情绪稳定的程度，与大脑的边缘系统相关；精神质指侵略性和对他人的敌对性的程度，与睾酮有关。 汉斯·艾森克(Hans J. Eysenck) 这次被撤稿的论文主要与德国社会学家、心身医学研究者 罗纳德·格洛萨特-马迪克(Ronald Grossarth-Maticek) 合作完成。他们在 1990 年前后提出一套理论，将人格与疾病相关联，对易患某种疾病的人格给出清晰明确的定义，并认为有这样人格的人会比其他人更易患某种疾病，在患病后也会比别人更快死亡。例如，“易患癌症人格”（cancer-prone personality）被描述为情感压抑，在面对外界压力时通常更加消极；“易患心脏病人格”（ heart disease-prone personality）无法容忍令人不满的状况，因而变得有攻击性、脾气暴躁。在此基础上，他们还提出了一些尝试改变易患疾病人格的心理治疗方法。 这一理论现在看来实在是有违常识。2019 年 2 月，格拉斯哥大学（University of Glasgow）的安东尼·J·佩洛西（Anthony J. Pelosi）在《健康心理学杂志》（Journal of Health Psychology）发文，对研究数据提出质疑，并称之为“科学丑闻”（scientific scandal）。接下来，艾森克曾经任教的伦敦大学国王学院对他和格洛萨特-马蒂塞克合著的所有论文进行了仔细审查。 2 伦敦大学国王学院的调查报告 2019 年 5 月，伦敦大学国王学院发表了调查报告，回顾了艾森克和格洛萨特-马蒂塞克合著的以人格与身体健康为主题的论文。他们考量了这些论文数据库的有效性，包括“招募参与者、措施管理、确认结果的可靠性、数据收集中的偏见、缺乏相关的协变量、对分析案例的选择”等等。经过调查，他们认为这些论文并不可靠，建议刊载这 26 份稿件的 11 份期刊撤稿。 该报告评述道：“艾森克和格洛萨特-马蒂塞克所著的这些论文中的结果是不可信的，也与现代临床医学和对疾病过程的理解不相符，其中很多展现了实际上在医学上未知的效果”。例如，这些论文声称对于有“易患癌症”的人格的人来说，其癌症致死的相对风险达到人格健康人群的 100 倍以上，而阅读疗法可以减少 80% 的癌症致死风险。 伦敦国王学院提议撤稿的论文主要分为两类，其中一类是观察性队列研究（observational cohort studies）报告。这些报告基于一个庞大的数据组，数据于 1960 年代至 1970 年代早期采集于南斯拉夫茨尔文卡镇（Crvenka），以及于 1970 ~ 1980 年代采集于德国海德堡（Heidelberg）。这两个项目的追踪观察都持续了 15～20 年，最初的目标是评估经特殊设计的人格量表能否预测癌症、冠心病、以及全因死亡率的发展。数据还用于调查生存率与其他因素（诸如酒精、咖啡和软饮的摄入量、体能锻炼、吸烟等）的关系。 另一类论文属于干预性治疗报告，主要评估格洛萨特-马蒂塞克开发的一个心理治疗项目对身体健康的影响。该治疗项目被称作“创新创造行为疗法”（Creative Novation Behaviour Therapy，又名 Maudsley Intervention），以个人或小组的形式实施，以阅读疗法的形式进行。艾森克与格洛萨特-马蒂塞克合著的这些论文评估了创造力治疗、阅读疗法等心理治疗方式在预防癌症和冠心病以及降低死亡率上的作用。 调查委员会表示无法获取这类研究的任何数据，但他们根据现有的同行评审论文、评论文章以及重复实验进行了评估。基于调查结果，委员会建议伦敦大学校长联系这 11 家期刊的编辑，告知这些论文存在缺陷。2020年 1 月《国际运动心理学杂志》（International Journal of Sport Psychology）率先撤稿，到 2 月 10 日，SAGE 旗下期刊《感知与运动技能》、《心理报告》发布了撤稿声明。艾森克的传记作者罗德·布坎南（Rod Buchanan）估计，撤稿数量最终可能超过 60 篇。 3 多项结果遭受质疑 艾森克的大量撤稿为近年来的心理学可重复危机添上了新的注脚。2018 年 5 月，《心理科学》（Psychological Science）上的一篇论文指出，著名的“棉花糖实验”，实际上不能预测儿童未来学业与发展状况。2018 年 6 月，一名记者在 Medium 发文质疑著名的“斯坦福监狱实验”，在社交媒体引起轰动。到 2018 年 11 月，开放科学中心（Center for Open Science）心理学家布莱恩·诺赛克（Brian Nosek）主持的Many Labs 2发表项目结果，项目尝试重复了 28 项心理学研究，其中只有 14 个被成功重复。 经典心理学实验被推翻有很多因素，比如最初的数据采集存在缺陷、样本量过小、对于影响试验结果因素考虑不够周全等等。备受关注、引用数量较高的研究不能被重复，并非说明社会科学研究无效或不可信，也不是在否定该领域的先驱和他们的成果，而是对过去的研究工作进行严格的验证、做出必要的修正，使该领域更加严谨规范。 事实上，心理学相对来说是一个非常年轻的学科，它诞生于 1879 年威廉·冯特（Wilhelm Wundt）创立第一个心理学实验室的时刻，到今天也不过 140 多年的历史。给它一点时间吧，艾森克不是第一个被撤稿的“大牛”，显然也不会是最后一个。
上嶋 浩順(Hironobu UESHIMA)卷入撤稿风波 诸平 一家杂志撤回了一名多产的日本麻醉师—— 上嶋 浩順( Hironobu UESHIMA ) 的两份病例报告，此人似乎卷入了一场不当行为调查。 《JA临床报告》（ JA Clinical Reports ）中的两个案例研究，是由东京昭和大学病院 （ Showa University Hospital ） 的 上嶋 浩順( Hironobu UESHIMA ) 和Hiroshi Otake撰写。 根据谷歌学学术研究， 上嶋 浩順(Hironobu UESHIMA) 大约有170篇以他的名字命名的论文，所以《撤稿观察》（ Retraction Watch ）对其十分重视，将密切关注此事的进展。 两篇被撤回的文章分别是2016年和2018年的 发表在 《JA临床报告》上。《JA临床报告》是施普林格公司出版的一份期刊，不过它隶属于日本麻醉学家协会主办的一种期刊。 通过Scopus数据库检索，昭和大学病院 （ Showa University Hospital ） 麻酔科的 上嶋 浩順 ( Hironobu UESHIMA )有162篇论文署有其名,详见截图。 关于其人撤稿信息请注意浏览《撤稿观察》（ Retraction Watch ）网站的最新报道。 近2020年以来已经发表论文10余篇。摘引于下，仅供参考。 文献标题 作者 年份 来源出版物 施引文献 Transnasal humidified rapid-insufflation ventilatory exchange can be utilized in tracheal stenosis caused by thyroid tumor Ueshima, H. , Goda, T. , Otake, H. 2020 Journal of Clinical Anesthesia 0 Clavipectoral fascial plane block in a patient with dual antiplatelet therapy undergoing emergent clavicular surgery Ueshima, H. , Ishihara, T. , Hosokawa, M. , Otake, H. 2020 Journal of Clinical Anesthesia 0 Cadaveric study of the spread of injectate in thoracoabdominal nerve block through perichondral approach Ueshima, H. , Takeda, Y. , Ohtsuka, A. 2020 Journal of Clinical Anesthesia 0 Below-knee amputation following the pectineus muscle plane block and sciatic nerve block Ueshima, H. , Otake, H. 2020 Journal of Clinical Anesthesia 0 Thoraco lumbar interfascial plane (TLIP) block: A systematic review of the literature Ince, I. , Shimada, T. , Ueshima, H. , Hassan, M. , Turan, A. 2020 Journal of Clinical Anesthesia 0 Cadaveric study of the spread of injectate for several types of spinal canal block Ueshima, H. , Takeda, Y. , Ohtsuka, A. 2020 Journal of Clinical Anesthesia 0 Use of a cardiopulmonary resuscitation simulator for objective evaluation of the quality of cardiopulmonary resuscitation objectively Ishikawa, Y. , Ueshima, H. 2020 Journal of Clinical Anesthesia 1 Blocking of the saphenous and obturator nerves using a pectineus muscle plane block Ueshima, H. , Sawada, A. , Yamakage, M. , Fujimiya, M. 2020 Journal of Clinical Anesthesia 1 Hematoma after the thoracoabdominal nerves block through perichondrial approach (TAPAblock) Ueshima, H. , Otake, H. 2020 Journal of Clinical Anesthesia 0 Thoracoabdominal nerves block through the perichondral approach for effective perioperative analgesia during upper abdominal surgery Ueshima, H. , Hiroshi, O. 2020 Journal of Clinical Anesthesia 0
部分已撤稿的新冠病毒（ Covid-19 ）研究论文 诸平 自新冠疫情爆发以来，已经蔓延至世界210多个国家和地区，截止2020年6月4日15点（ Last updated: 2020-06-04 15:05:04 ）全球新冠肺炎确诊病例已经超过658.6万例（ Coronavirus Cases: 6586010 ），死亡病例已经达到388250人。对于新冠病毒 （ COVID-19 ）的研究，据 PubMed 数据库的统计结果，与 COVID-19 有关的论文共有 18702篇（截止2020年6月4日 ）。 但是，有些论文可能已经撤稿，据《撤稿观察》 （ Retraction Watch ）网站报道，该网站 一直在追踪关于COVID-19研究论文的撤稿之事—— database ，对其数据库（ database ）的一部分内容，在此摘引于下，仅供参考。至于最新撤稿情况请关注《撤稿观察》网站相关新近更新结果。 Retracted（已经撤稿的论文） “ Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag ,” bioRxiv preprint published January 31, 2020 and withdrawn February 2, 2020. More context here . “ Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China ,” medRxiv preprint published February 11, 2020 and withdrawn February 21, 2020. More context here . “ Chinese medical staff request international medical assistance in fighting against COVID-19 ,” letter in The Lancet published February 24, 2020 and retracted February 26, 2020. More context here . “ Potential False-Positive Rate Among the ‘Asymptomatic Infected Individuals’ in Close Contacts of COVID-19 Patients ,” paper in the Chinese Journal of Epidemiology published March 5, 2020 and retracted a few days later. More context here . “An epidemiological investigation of 2019 novel coronavirus diseases through aerosol－borne transmission by public transport,” published in early March in Practical Preventive Medicine and retracted sometime in mid-April. More context here . “ First viral replication of Covid-19 identified in the peritoneal dialysis fluid ,” published in Bulletin de la Dialyse à Domicile on April 13, 2020, retracted on April 20, 2020. Our coverage here . “ Hydroxychloroquine plus azithromycin: a potential interest in reducing in-hospital morbidity due to COVID-19 pneumonia (HI-ZY-COVID) ?” preprint published on medRxiv, May 11, 2020, withdrawn on May 20, 2020. Our coverage here . “ From SARS-CoV to Wuhan 2019-nCoV Outbreak: Similarity of Early Epidemic and Prediction of Future Trends ,” preprint posted on bioRxiv, January 25, 2020, withdrawn January 28, 2020. “ Analysis of Ten Microsecond simulation data of SARS-CoV-2 dimeric main protease ,” preprint posted on bioRxiv, April 12, 2020, withdrawn April 16, 2020. “ Computational analysis suggests putative intermediate animal hosts of the SARS-CoV-2 ,” preprint posted on bioRxiv, April 5, 2020, withdrawn April 20, 2020. “ Mental health status and coping strategy of medical workers in China during The COVID-19 outbreak ,” preprint posted on medRxiv, February 25, 2020, withdrawn March 7, 2020. “Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings,” published in Travel Medicine and Infectious Disease on April 11, 2020, retracted on May 2, 2020 . Our coverage here . “ Effectiveness of Surgical and Cotton Masks in Blocking SARS–CoV-2: A Controlled Comparison in 4 Patients ,” published on April 6, 2020 in the Annals of Internal Medicine, retracted on June 1, 2020 . Temporarily retracted （暂时撤稿论文） “ Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study ,” published in Engineering on March 18, 2020 and temporarily retracted, now back online, all without explanation. “ Should sexual practices be discouraged during the pandemic ?” Journal of the American Academy of Dermatology, published unknown (accepted April 16), retracted on or around May 11. Our coverage here . Expressions of concern （关注论文） “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial,” published in International Journal of Microbial Agents on March 20, 2020. More context here and here . “ Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 ,” published in the New England Journal of Medicine on May 1, 2020. Our coverage here . “ Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis ,” published in The Lancet on May 22, 2020. Our coverage here .
印麻醉学研究者 一次撤稿10篇 诸平 印度的一组麻醉学研究人员已经从一份期刊 （ Saudi Journal of Anaesthesia ，Saudi J Anaesth ） 上，一次性撤回了10篇论文，是因为这10篇论文与其他各种论文有很高的相似度，而且有大量数据造假的证据。 《 沙特麻醉杂志》（ Saudi Journal of Anaesthesia ，Saudi J Anaesth ）已经撤回了印度加尔各答（ Kolkata ）的 Anjan Das （5篇是第一作者，3篇是第二作者，2篇是第三作者）及其同事的10篇文章，详见下面 , , , , , , , , , 。这些论文分别是在2014-2018年之间在 《 沙特麻醉杂志》（Saudi J Anaesth）上 发表的 。 1. Das A, Chhaule S, Bhattacharya S, Basunia SR, Mitra T, Halder PS, Chattopadhyay S, Mandal SK. Controlled hypotension in day care functional endoscopic sinus surgery: A comparison between esmolol and dexmedetomidine: A prospective, double-blind, and randomized study. Saudi J Anaesth. 2016 Jul-Sep;10(3):276-82. 2. Das A , Mukherje A, Chhaule S, Chattopadhyay S, Halder PS, Mitra T, Basunia SR, Mandal SK. Induced hypotension in ambulatory functional endoscopic sinus surgery: A comparison between dexmedetomidine and clonidine as premedication. A prospective, double-blind, and randomized study. Saudi J Anaesth. 2016 Jan-Mar;10(1):74-80. 3. Banerjee D, Das A , Majumdar S, Mandal RD, Dutta S, Mukherjee A, Chakraborty A, Chattopadhyay S. PONV in Ambulatory surgery: A comparison between Ramosetron and Ondansetron: a prospective, double-blinded, and randomized controlled study. Saudi J Anaesth 2014;8:25-9. 4. Mukherjee A, Das A , Mayur N, Bhattacharyya C, Biswas H, Mitra T, Roybasunia S, Mandal SK. Comparative evaluation of analgesic sparing efficacy between dexmedetomidine and clonidine used as adjuvant to ropivacaine in thoracic paravertebral block for patients undergoing breast cancer surgery: A prospective, randomized, double-blind study. Saudi J Anaesth. 2018 Oct-Dec;12(4):548-554. 5. Bhar D, RoyBasunia S, Das A , Kundu SB, Mondal RC, Halder PS, Mandal SK, Chattopadhyay S. A comparison between intrathecal clonidine and neostigmine as an adjuvant to bupivacaine in the subarachnoid block for elective abdominal hysterectomy operations: A prospective, double-blind and randomized controlled study. Saudi J Anaesth. 2016 Apr-Jun;10(2):121-6. 6. Das A, Dutta S, Chattopadhyay S, Chhaule S, Mitra T, Banu R, Mandal P, Chandra M. Pain relief after ambulatory hand surgery: A comparison between dexmedetomidine and clonidine as adjuvant in axillary brachial plexus block: A prospective, double-blinded, randomized controlled study. Saudi J Anaesth. 2016 Jan-Mar;10(1):6-12. 7. Das A, Majumdar S, Halder S, Chattopadhyay S, Pal S, Kundu R, Mandal SK, Chattopadhyay S. Effect of dexmedetomidine as adjuvant in ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded and randomized controlled study. Saudi J Anaesth. 2014 Nov;8(Suppl 1):S72-7. 8. Mitra T, Das A , Majumdar S, Bhattacharyya T, Mandal RD, Hajra BK. Prevention of altered hemodynamics after spinal anesthesia: A comparison of volume preloading with tetrastarch, succinylated gelatin and ringer lactate solution for the patients undergoing lower segment caesarean section. Saudi J Anaesth. 2014 Oct;8(4):456-62. 9. Das A , Majumdar S, Kundu R, Mitra T, Mukherjee A, Hajra BK, Dutta S, Chattopadhyay S. Pain relief in day care arthroscopic knee surgery: A comparison between intra-articular ropivacaine and levobupivacaine: A prospective, double-blinded, randomized controlled study. Saudi J Anaesth. 2014 Jul;8(3):368-73. 10. Manuar MB, Majumdar S, Das A, Hajra BK, Dutta S, Mukherjee D, Mitra T, Kundu R. Pain relief after Arthroscopic Knee Surgery: A comparison of intra-articular ropivacaine, fentanyl, and dexmedetomidine: A prospective, double-blinded, randomized controlled study. Saudi J Anaesth. 2014 Apr;8(2):233-7. 更多信息请浏览《 撤稿观察 》（ Retraction Watch ）的相关报道。
分子与转化医学研究者邹明辉撤稿已达 9 篇 诸平 邹明辉 据《 撤稿观察 》（ Retraction Watch ） 2020 年 1 月 13 日报道，美国佐治亚州立大学（ Georgia State University ）分子和转化医学研究科学中心的邹明辉教授撤稿数量已有 9 篇，而且是同一种杂志发表的论文。《 撤稿观察 》报道指出，佐治亚州立大学的一位著名研究人员 2019 年 撤回 了 两篇论文，其中 8 篇对有问题的图像表示关注， 现在已经多达九篇。 邹明辉 教授是全部九篇已撤回论文的共同作者，这些论文已于 2003 年和 2010 年发表在《生物化学杂志》（ Journal of Biological Chemistry ）上。在最初受到关注的 8 篇论文中，有 7 篇已撤回，其中一篇已更新为更正。 有一个典型的 撤回通知 （ retraction notice ）可以作证，点击可以浏览详细内容。其中涉及 “ 尼古丁诱导的 AMP 激活的蛋白激酶激活抑制 3T3L1 脂肪细胞中的脂肪酸合成酶：氧化应激的作用（ Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 adipocytes: A role for oxidant stress ） ” ，指的是图像复制，作者提议 “ 发表修订版图或重复实验 ”, 但是被该杂志拒绝了。原因如下： This article has been withdrawn by Ming-Hui Zou, Hong Wang, Ping Song, and Miao Zhang. Zhibo An and Xuemei Geng could not be reached. The Journal raised questions regarding the following. Lanes 1 and 2 of the FAS immunoblot in Fig. 6 B were reused in lanes 4 and 5. Lanes 2 and 3 of the actin immunoblot in Fig. 6 B were reused in lanes 4 and 5. Lanes 1–3 of the FAS immunoblot in Fig. 6 B were reused as AMPK-α in Fig. 6 C . The withdrawing authors were able to locate data for a repeated experiment conducted at the time of the original work for the FAS immunoblot in Fig. 6 B . In addition, the authors also found the original Fig. 6 C , although the original immunoblots were not available for evaluation, 12 years after its publication. The withdrawing authors offered to publish an amended figure or to repeat the experiments. The Journal declined both offers, a decision with which the authors respectfully disagree. Furthermore, the withdrawing authors state that the results of this paper have been confirmed by the results of complementary experiments presented in the article and that the principal observations of this article were further confirmed in publications (Cheng, P. Y., et al. (2007) Biochem. Pharmacol. 74, 1758–1765; Tang, G. J., et al. (2011) Free Radic. Biol. Med. 50, 1492–1502; Alnakshbandi, A. A., et al. (2012) Saudi J. Health Sci. 1, 139–142; Perng, D. W., et al. (2013) Crit. Care Med. 41, 120–132; Ko, H. K., et al. (2015) J. Cell Physiol. 230, 1781–1793; Huang, M., et al. (2016) Oncogenesis 5, e195; Brynildsen, J. K., et al. (2018) Proc. Natl. Acad. Sci. U.S.A. 115, 4282–4287; Yuk, T., et al. (2018) 2018, 10.1155/2018/7420265; Hasan, M. K., et al. (2018) Endocrinology 159, 931–944). The withdrawing authors stand by the experimental data and the conclusions of the paper. The article, with confirmatory data supporting the results, can be obtained by contacting the withdrawing authors. 根据 Clarivate Analytics 的 Web of Science 数据库统计结果，这 9 篇已撤回的论文被引用近 1100 次。 根据佐治亚州 立大学网站提供的信息，邹明辉是分子和转化医学领域的国际公认的研究者， 佐治亚州 分子医学 研究联盟 杰出学者，佐治亚州立大学研究副校长，是佐治亚州分子与转化医学中心的创始主任。 他拥有医学博士学位，并获得了国际少年糖尿病基金会（ Juvenile Diabetes Foundation International ）和美国心脏协会（ American Heart Association ）的著名奖项，包括职业发展奖（ Career Development Award ），欧文 ·H· 佩奇动脉粥样硬化研究奖（ Irvin H. Page Atherosclerosis Research Award ）和国家知名研究者奖 (National Established Investigator Award) 。 邹明辉研究氧化应激在心血管生物学和疾病中的作用。他因在心血管研究中的重要发现而获得公认，其中包括确定与导致血管疾病的血管病理相关的两种关键蛋白的作用，并鉴定 AMP 激活激酶（ AMPK ）（一种调节能量代谢的关键酶）的特性，肥胖，糖尿病和心血管疾病，作为心脏代谢综合症中氧化应激的传感器和调节剂。 美国国家卫生研究院，国际青少年糖尿病研究基金会（ JDRF ）和美国糖尿病协会的独立研究人员，以及美国心脏协会的国家科学家发展（ SDG ）和国家知名研究人员（ EIA ）获奖者，邹利用这些（以及许多其他奖项）在具有直接临床相关性的巨大潜力的领域中进行科学观察。在过去的几年中，他已经在包括 Nature Medicine,J. Clin. Invest.,Circulation., Circulation Research, ATVB,Diabetes,J. Biol. Chem., Hypertension 在内的高影响力期刊上发表了 135 篇同行评审论文。 2008 年，他当选为美国临床研究学会（ American Society for Clinical Investigation ）成员，这是美国最古老的医师科学家荣誉学会之一，其成员身份反映了其成员在早期（年龄未满 45 岁）的成就。 邹明辉告诉 《 撤稿观察 》 （ Retraction Watch ），他的团队不同意该期刊撤回论文的决定，并指出：所有这些已发表的文本均由该杂志进行审查，并由我们与 JBC 的编辑共同同意。显然，这些论文中存在错误，但主要结论是正确的。因此，这些文件不应撤回。期刊应该给予我们纠正的机会。更多信息请注意浏览相关报道。
哈佛大学肿瘤实验室的撤稿信息 诸平 詹姆斯 · 米尔 （ James W. Mier ） 哈佛大学对贝丝 · 伊斯雷尔女执事医学中心（ Beth Israel Deaconess Medical Center ）癌症研究人员实验室的工作展开调查，该实验室一直受到学界匿名审议平台（ PubPeer ）的关注有五年多了。 关于 詹姆斯 · 米尔 管理的该实验室的产出成果质疑，是 2014 年就在 PubPeer 开始出现 （ began appearing ），主要涉及的问题看起来是对图片的操纵。匿名举报人克莱尔 · 弗朗西斯（ Clare Francis ）于 2014 年 9 月 27 日向哈佛医学院院长和研究诚信院长格蕾琴 · 布罗德尼基（ Gretchen Brodnicki ）发送了一封有关这方面评论的电子邮件， 2019 年 7 月 24 日，格蕾琴 · 布罗德尼基要求克莱尔 · 弗朗西斯重新发送该电子邮件。 同样是在 2019 年 7 月，《癌症研究》（ Cancer Research ）杂志对 詹姆斯 · 米尔 及其同事在 2006 年发表的论文 表示关注 ，在该杂志网站发布了提醒读者的关注（ expression of concern ）公告，其中明确指出： 编辑者发布此提示，以提醒读 者对本文的关注：图 4A 中存在蛋白质印迹（ Western blot ）相似之处（ C-Myc 和 Vinculin ）。原始凝胶不适用。原论文详见： ChoD C,CohenM B,PankaD J,CollinsM,GhebremichaelM,AtkinsM B,et al. The efficacy of the novel dual PI3-kinase/mTOR inhibitor NVP-BEZ235 compared with rapamycin in renal cell carcinoma.Clin Cancer Res,2010, 16: 3628–3638. Abstract/FREEFull Text 2019 年 10 月初，该杂志编辑部根据作者的要求，因为图像的人为操作而收回了该论文。关于撤稿公告详见： David J.Panka,WeiWang,Michael B.AtkinsandJames W.Mier. Retraction: The Raf Inhibitor BAY 43-9006 (Sorafenib) Induces Caspase-Independent Apoptosis in Melanoma Cells . Cancer Res, 2019, 79(20): DOI: 10.1158/0008-5472 . CAN-19-2621.PublishedOctober 2019. https://cancerres.aacrjournals.org/content/79/20/5459 D. J. Panka, W. Wang, M. B. Atkins 和 J. W. Mier 同意撤回这篇文章的决定。但是，根据科睿唯安（ Clarivate Analytics ）的 Web of Science 统计结果，该论文已被引用了 134 次。 哈佛大学没有直接回答《撤稿观察》对有关调查结果以及是否有其他论文准备撤稿的问题。相反，向《撤稿观察》发送了以下声明： 我们完全致力于维护最高的道德标准，并严格保持我们研究的完整性。我们会根据机构政策和适用法规对所有引起我们注意的问题进行彻底审查。 詹姆斯 · 米尔 对此没有任何回应。不过 詹姆斯 · 米尔 由于在肾脏癌方面的工作，于 2013 年曾经 获得了 美国癌症研究协会的 25 万美元奖金 （ In 2013 received a $250,000 award from the American Association for Cancer Research ）。他还是 美国国家卫生研究院（ NIH ）多项资助的 （ several NIH grants ）首席研究员或共同首席研究员。有关后续结果有待关注。
SAGE 出版公司收回了 22 篇文章,实际远不止这些 诸平 据《撤稿观察》（ Retraction Watch ）网站2019年9月13日报道， SAGE出版公司在13日当天撤回了一位材料科学研究人员在他们的 两份期刊上发表的22篇文章 ，但是引起他们注意的一位匿名读者说，作者的重复影响到100多篇文章。 2019年早些时候，澳大利亚斯文本理工大学（ Swinburne University of Technology in Australia ）的艾利·纳扎里（ Ali Nazari ）从爱思维尔的一份杂志上撤回了5篇论文。他现在共有27篇论文被撤销,其他22篇撤稿论文来自《国际损伤力学杂志》（ International Journal of Damage Mechanics ）和《复合材料力学杂志》（ Journal of Composite Mechanics ）。2019 年1月末，来自一个匿名读者的邮件让一些出版商担忧,艾利·纳扎里 在自己超过100篇论文中 复制了他的工作。 以下是 SAGE撤回的22篇文章的撤回通知 : 在2019年，SAGE意识到作者涉嫌在《国际损伤力学杂志》和《复合材料杂志》上重复发表22篇文章的不当行为。SAGE和这些期刊的编辑立即展开了一项调查，发现下面的文章与之前发表的文章有明显的重叠，其中至少有一名作者的文章列在下面的每篇文章中。因此，SAGE和该期刊的编辑决定撤回以下文章，原因是重复发表。 根据科睿唯安（Clarivate Analytics）的 Web of Knowledge 的统计结果显示，这些论文被引用的次数从零到32次不等。 艾利·纳扎里（ Ali Nazari ）在论文发表时在伊斯兰阿扎德大学（ Islamic Azad University ），他并没有回应SAGE的处理，但是，他所在的大学Swinburne告诉《撤稿观察》: Swinburne可以确认，一项涉及Swinburne研究人员的调查正在按照大学负责任的研究政策和程序进行。在调查结束和结果确定之前，我们不能对这些指控发表进一步评论。Swinburne致力于维护研究的完整性，并严肃对待自我剽窃的指控。更多关于研究完整性和我们的行为准则的信息可以在此找到 （ availablehere ） 。 《撤稿观察》询问SAGE，在 2011年至2013年之间，纳扎里发表现已被撤回的文章时，是否使用了剽窃检测软件。 SAGE 告诉我们，事实并 非如此，但现在情况已经发生了变化: 当时两家期刊的投稿系统都没有使用抄袭/复制检查软件(与业内大多数期刊一样)，所以在我们进行调查之前，并没有发现高水平的逐字匹配。 我们在期刊的工作流程中增加了剽窃/复制检查步骤，所有的新提交的论文都将自动生成一个相似度报告，以检测其相似度。虽然不是绝对正确的，但我们相信，该系统将获得在这些论文中发现的非常高水平的逐字匹配，并且不会将高度重复的投稿转入到同行评审阶段。 告密者“松了一口气” 引起出版商注意的匿名读者告诉《撤稿观察》，“撤回通知是准确的，但不完整。这名读者说，他/她还指出了数据中可能存在的不一致，不一致的作者名单，以及他所说的“明显伪造数据”。 撤回通知只捕捉了重复，没有解决其他问题。 读者说会出现这种情况 SAGE撤销了纳扎里和那个出版商合作发表的所有论文。就我所知，清单上有几项我从未明确建议过。 看到有出版商认真对待这件事，我松了一口气。 读者说，除了 爱思唯尔已经撤回的五篇文章 ( five papers retracted ) 外 ，该出版商还在调查其他文章。施普林格自然杂志在2012年调查过这个问题，并决定不撤回纳扎里的任何文章，现在又在调查了。写这篇文章时，泰勒和弗朗西斯还没有回复读者上周的来信。 那么为什么读者会对这个案例感兴趣呢? 在建筑材料领域，重复和低质量的研究已经变得如此普遍，以至于研究人员不得不花费大量的精力来弄清楚一篇论文是否可靠。我读纳扎里博士的论文是为了我自己的工作，我读了他的几十篇论文才意识到他的工作完全不可靠，而且是重复的。这些论文是我在这个领域的某些研究的基础。只有时间才能揭示所造成的损害的全部程度。 更多信息请注意关注相关后续报道。 SAGE撤稿通知： In 2019 SAGE became aware of author misconduct concerning suspected redundant publication of 22 articles published in International Journal of Damage Mechanics and Journal of Composite Materials . SAGE and the journals’ Editors immediately launched an investigation and found that the following articles contain significant overlap with previously published articles by at least one of the authors listed on each of the articles below. Therefore, SAGE and the journals’ Editors have decided to retract the following articles for reasons of redundant publication. International Journal of Damage Mechanics Nazari, A, Aghazadeh Mohandesi, J, Riahi, S, (2011) Modified Modeling Fracture Toughness of Functionally Graded Steels in Crack Divider Configuration. International Journal of Damage Mechanics 20(6): 811–830, DOI: 10.1177/1056789510382851 Nazari A, Riahi, S, (2011) The Effects of TiO2 Nanoparticles on Flexural Damage of Self-compacting Concrete. International Journal of Damage Mechanics 20(7): 1049–1072, DOI: 10.1177/1056789510385262 Nazari A, Aghazadeh Mohandesi, J, Riahi, S, (2012) Modeling Impact Energy of Functionally Graded Steels in Crack Divider Configuration Using Modified Stress–Strain Curve Data . International Journal of Damage Mechanics 21(1): 27–50, DOI: 10.1177/1056789510397073 Nazari A, Riahi, S, (2012) Optimizing Mechanical Properties of Binary Blended Concrete Utilizing CuO Nanoparticles. International Journal of Damage Mechanics 21(1): 81–96, DOI: 10.1177/1056789510397074 Aghazadeh Mohandesi, J, Sangghaleh, A, Nazari A, (2012) Strength Assessment and Bonding Study of Aluminum Short Fiber-Reinforced Gypsum Composites. International Journal of Damage Mechanics 21(1): 129–149, DOI: 10.1177/1056789510397075 Nazari A, Ali Milani, A, (2012) Ductile to Brittle Transition Temperature of Functionally Graded Steels. International Journal of Damage Mechanics 21(2): 191–205, DOI: 10.1177/1056789511398270 Nazari A, Riahi, S, (2012) Prediction of Physical and Mechanical Properties of High Strength Concrete Containing CuO Nanoparticles by Artificial Neural Network and Genetic Programming. International Journal of Damage Mechanics 21(2): 207–236, DOI: 10.1177/1056789510397079 Ali Milani, A, Nazari A, (2012) Modeling Ductile-to-Brittle Transition Temperature of Functionally Graded Steels by Gene Expression Programming. International Journal of Damage Mechanics 21(4): 465–492, DOI: 10.1177/1056789511406561 Nazari A, Khalaj, G, Didehvar, N (2012) Computational Investigations of the Impact Resistance of Aluminum–Epoxy–Laminated Composites. International Journal of Damage Mechanics 21(5): 623–646, DOI: 10.1177/1056789511411739 Riahi S, Nazari, A, Ghasemi, D, (2012) Prediction of Resistance to Water Damage of Geopolymers with Seeded Fly Ash and Rice Husk Bark Ash by Fuzzy Logic. International Journal of Damage Mechanics 21(6): 822–842, DOI: 10.1177/1056789511419984 Bohlooli, H, Nazari A, Mehdi Kaykha, M, (2012) Analytical Modeling of Charpy Impact Energy of Functionally Graded Steels by ANFIS. International Journal of Damage Mechanics 21(6): 913–939, DOI: 10.1177/1056789511431269 Nazari A, Riahi, S, Khalaj, G, Bohlooli H, Mehdi Kaykha, M, (2012) Prediction of Compressive Strength of Geopolymers with Seeded Fly Ash and Rice Husk–Bark Ash by Gene Expression Programming. International Journal of Damage Mechanics 21(8): 1202–1226, DOI: 10.1177/1056789511431991 Bohlooli, H, Nazari A, Mehdi Kaykha, M, (2013) Microhardness profile prediction of functionally graded steels by artificial neural networks. International Journal of Damage Mechanics 22(1): 17–36, DOI: 10.1177/1056789511432653 Nazari A, Riahi, S, (2013) Prediction of the effects of nanoparticles on early-age compressive strength of ash-based geopolymers by fuzzy logic. International Journal of Damage Mechanics 22(2): 247–267, DOI: 10.1177/1056789512442519 Journal of Composite Materials Nazari, A, Riahi, S, Limewater effects on properties of ZrO 2 nanoparticle blended cementitious composite J Compos Mater 2011 45: 639–644, DOI: 10.1177/0021998310376118 Nazari, A, Riahi, S, Assessment of the effects of Fe 2 O 3 nanoparticles on water permeability, workability, and setting time of concrete J Compos Mater 2011 45: 923–930, DOI: 10.1177/0021998310377945 Nazari, A, Riahi, S, Optimization mechanical properties of Cr 2 O 3 nanoparticle binary blended cementitious composite J Compos Mater 2011 45: 943–948, DOI: 10.1177/0021998310377944 Nazari, A, Riahi, S, The effects of limewater on split tensile strength and workability of Al 2 O 3 nanoparticles binary blended concrete J Compos Mater 2011 45: 1059–1064, DOI: 10.1177/0021998310378909 Nazari, A, Riahi, S, The effects of limewater on flexural strength and water permeability of Al 2 O 3 nanoparticles binary blended concrete J Compos Mater 2011 45: 1165–1172, DOI: 10.1177/0021998310378907 Nazari, A, Riahi, S, The effects of TiO 2 nanoparticles on properties of binary blended concrete J Compos Mater 2011 45: 1181–1188, DOI: 10.1177/0021998310378910 Nazari, A, Riahi, S, The effects of ZrO 2 nanoparticles on properties of concrete using ground granulated blast furnace slag as binder J Compos Mater 2012 46: 1079–1090, DOI: 10.1177/0021998311414944 Nazari, A, Sedghi, A, Didehvar, N, Modeling impact resistance of aluminum–epoxy-laminated composites by artificial neural networks J Compos Mater 2012 46: 1593–1605, DOI: 10.1177/0021998311421222 View Abstract
哈佛癌症实验室接受联邦不当行为调查 諸平 据《撤稿觀察》（ Retraction Watch ）2019年4月19日報道，李山姆 (Sam W. Lee)已經撤稿3篇，李究竟是哈佛大学的一名研究人员還是以前是哈佛大学的一名研究人员目前還並不清楚，因爲郵件聯係或者電話聯係都沒有明確結果。不管怎樣，他的撤稿論文署名單位為哈佛大學（見上面截圖），由于撤回了包括《自然》（Nature）杂志發表的一篇在内的3篇论文。而且，還有一篇曾經在《分子與細胞生物學》（Molecular and Cellular Biology）雜志發表的論文也引起關注（who has lost three papers to retraction , including one from Nature , now has an expression of concern for another article, this one in Molecular and Cellular Biology. ）。對於2000年的“Overexpression of Kinase-Associated Phosphatase (KAP) in Breast and Prostate Cancer and Inhibition of the Transformed Phenotype by Antisense KAP Expression”疑問中写道: 美国微生物学会(ASM)和《分子与细胞生物学》(MCB)編輯部发表了對其关注的提示（ expression of concern ），以提醒读者注意关于本文中数据完整性的问题。哈佛医学院已经通知MCB編輯部可能影响图5A的图像复制。ASM已经進行了审核，并确认了可疑的重复，这是由第一作者（Sam W. Lee）的实验室得出的。對此等待研究誠\性办公室(Office of Research Integrity, 簡稱ORI)給出審定結果， ORI已經給出了一个发现，不過有人正在对这个发现提出上诉。然而，ORI通常不会确认存在调查的，除非他们发现不当行为。当被问及对此有何评论时，哈佛医学院仅表示: 我们致力恪守最高的道德标准，并严格维持研究的诚信。任何引起我们注意的问题都将按照机构政策，并在适用的情况下，以公平和保密的方式，彻底审查。 根据SCI網絡版Web of Science的Clarivate Analytics网站的統計結果，这篇现已被撤回的论文已經被引用了64次。關於 李山姆 (Sam W. Lee) 的撤稿等更多信息請注意瀏覽原文或者相關報道（也可以點擊上述鏈接直接瀏覽）。
高引撤稿论文 Top10 及撤稿排行榜 诸平 2018年已经结束，2019年已经开始，在过去被撤稿的论文中有些论文可能根本无人问津，但是也有些论文则频频被引，下面就列举出被引频次最高的前10篇撤稿论文 （被引频次超过620次，最高达到1900余次；而且有些论文撤稿后还继续被引40次到977次不等） ，同时附上撤稿数量最多的前32名，仅供参考。 Top 10 most highly cited retracted papers Ever curious which retracted papers have been most cited by other scientists? Below, we present the list of the 10 most highly cited retractions as of October 2018. Readers will see some familiar entries, such as the infamous Lancet paper by Andrew Wakefield that originally suggested a link between autism and childhood vaccines . You’ll note that many papers — including the #2 most cited paper — received more citations after they were retracted, which research has shown is an ongoing problem . Although just missing out on the top ten and coming in at number 11 – with 605 citing articles – this article is also designated as a “Highly Cited Paper” by Clarivate Analytics’ Web of Science, meaning it was ranked in the top one percent of all papers in its subject field in the last 10 years: Selective killing of cancer cells by a small molecule targeting the stress response to ROS . NATURE July 14, 2011. (by: Lakshmi Raj, Takao Ide, Aditi U. Gurkar, Michael Foley, Monica Schenone, Xiaoyu Li, Nicola J. Tolliday, Todd R. Golub, Steven A. Carr, Alykhan F. Shamji, Andrew M. Stern, Anna Mandinova, Stuart L. Schreiber, Sam W. Lee). Article Year of retraction Citing Articles before retraction Citing Articles after retraction Total cites (journals indexed by Web of Science) Primary Prevention of Cardiovascular Disease with a Mediterranean Diet . N Engl J Med April 4, 2013 Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella, D, Aros F, Gomez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pinto X, Basora J, Munoz MA, Sorli JV, Martinez JA, Martinez-Gonzalez MA, et al., for the PREDIMED Study Investigators 2018 1792 79 1917 2. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin .SCIENCE, JAN 21 2005 Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I. 2007 224 977 1255 3. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children .LANCET, FEB 28 1998 Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA 2010 647 512 1206 4. An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus .PLANT JOURNAL, MAR 2003 Voinnet O, Rivas S, Mestre P, Baulcombe D. 2015 900 201 1103 5. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells .BLOOD, NOV 1 2001 Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. 2009 578 289 887 6. TREEFINDER: a powerful graphical analysis environment for molecular phylogenetics .BMC EVOLUTIONARY BIOLOGY, JUN 28 2004 Jobb G, von Haeseler A, Strimmer K. 2015 748 114 862 7. Viral pathogenicity determinants are suppressors of transgene silencing in Nicotiana benthamiana .EMBO JOURNAL, NOV 16 1998 Brigneti G, Voinnet O, Li WX, Ji LH, Ding SW, Baulcombe DC 2015 769 40 811 8. Spontaneous human adult stem cell transformation .CANCER RESEARCH, APR 15 2005 Rubio D, Garcia-Castro J, Martín MC, de la Fuente R, Cigudosa JC, Lloyd AC, Bernad A. 2010 318 383 725 9. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial .LANCET, JAN 11 2003 Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. 2009 547 127 722 10. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis .CELL, JUN 12 2009 Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA. 2015 494 121 622 撤稿排行榜 （ Top32 ） Who has the most retractions? Here’s our unofficial list (see notes on methodology), which we’ll update as more information comes to light: Yoshitaka Fujii (total retractions: 183) See also: Final report of investigating committee , our reporting, additional coverage Joachim Boldt (96) See also: Editors-in-chief statement , our coverage Diederik Stapel (58) See also: our coverage Adrian Maxim (48) See also: our coverage Yuhji Saitoh (48) See also: our coverage Yoshihiro Sato (48) See also: our coverage Jun Iwamoto (44) See also: our coverage Chen-Yuan (Peter) Chen (43) See also: SAGE , our coverage Fazlul Sarkar (41) See also: our coverage Hua Zhong (41) See also: journal notice Shigeaki Kato (40) See also: our coverage James Hunton (37) See also: our coverage Hyung-In Moon (35) See also: our coverage Naoki Mori (32) See also: our coverage Jan Hendrik Schön (32) See also: our coverage Soon-Gi Shin (30) See also: our coverage Tao Liu (29) See also: our coverage Bharat Aggarwal (28) See also: our coverage Cheng-Wu Chen (28) See also: our coverage A Salar Elahi (27) See also: our coverage Richard L E Barnett (26) See also: our coverage Antonio Orlandi (26) See also: our coverage Prashant K Sharma (26) See also: our coverage Rashmi Madhuri (24) See also: our coverage Scott Reuben (24) See also: our coverage M Ghoranneviss (22) See also: our coverage Anil K Jaiswal (22) See also: our coverage Gilson Khang (22) See also: our coverage Noel Chia (21) See also: our coverage Alfredo Fusco (21) See also: our coverage Friedhelm Herrmann (21) See also: our coverage Stanley Rapoport (21) See also: our coverage
美国天然产物研究者撤稿 12 篇 诸平 天然抗癌药物的研究者，美国阿拉巴马大学伯明翰分校( University of Alabama, Birmingham ，UAB )研究者 Santosh Katiyar，2018年年底已经有6篇论文撤稿，但是，这并非最终结果，进入2019年没有几天， Santosh Katiyar的撤稿数量已经达到12篇（ total of 12 ）。 最近撤稿的4篇论文是 Santosh Katiyar等人在 《公共科学图书馆•综合》（ PLOS ONE ）发表,另外2篇是在《癌症研究》（ Cancer Research ）发表的。根据《科学网》 科睿唯安( Clarivate Analytics’ Web of Science )的统计结果，它 们一起已被引用超过250次,研究内容包括葡萄籽和绿茶中含有的化合物。更多信息请注意浏览《撤稿瞭望》（ The Retraction Watch ）网站，部分内容摘引如下，仅供参考。 Here’s an example, from PLOS ONE, for “ Green Tea Catechins Reduce Invasive Potential of Human Melanoma Cells by Targeting COX-2, PGE2 Receptors and Epithelial-to-Mesenchymal Transition :” Following publication of this article , concerns were raised about similarities involving two figure panels. The second and third panels in Fig 5D (Cay10580, 0.1 μM and 1.0 μM panels) are similar. The University of Alabama at Birmingham confirmed that the original data and records needed to clarify the conditions represented in these two panels are not available. Thus, the quantification data shown in the accompanying bar graph, and the conclusion regarding a concentration-dependent effects of Cay10580 on cell migration, are not supported. Fig 2A (Hs294t, 10 μg/ml EGCG) in is similar to Fig 1B (Hs294, 0 μM Berberine) in , even though the panel in question is used to represent different experimental conditions in the two articles. The University of Alabama at Birmingham confirmed that original data and records are not available to clarify the identity of the cells and treatment conditions in the reported experiments. The Carcinogenesis article was retracted in 2018 . Following a joint investigation by the Birmingham VA Medical Center and the University of Alabama at Birmingham, the institutions requested retraction of this article, as the conclusions could not be supported by available data. In line with the institutions’ recommendation, PLOS ONE Editors retract this article based upon the unavailability of original data and records and the ambiguous identification of samples and treatments. The authors did not comment on the retraction decision. And here’s one from Cancer Research, for “ Interleukin-12 Deficiency Is Permissive for Angiogenesis in UV Radiation-Induced Skin Tumors :” This article ( 1 ) has been retracted at the request of the editors. Following a joint institutional investigation by the Birmingham VA Medical Center and the University of Alabama at Birmingham, the primary affiliations for several of the authors, it was determined that the images for both the wild-type and IL-12 knockout controls originated from the same source and are not from mice with different genotypes in Fig. 4. In addition, the same β-actin Western blot image was used to represent results from different experiments in Figs. 3D and 5B. The original research records related to the figures were not available during the review. Therefore, the institutions were not able to determine which of the published images are correct and recommended retraction; upon internal review, the editors agreed with this recommendation. A copy of this Retraction Notice was sent to the last known e-mail addresses for all four authors. One author (S. Katiyar) agreed to the retraction; two authors (S.M. Meeran and S.K. Katiyar) did not agree to the retraction; the remaining author (C.A. Elmets) did not respond. As we reported in May , Katiyar left UAB last year after an investigation that resulted in the university and the Birmingham VA Medical Center requesting 20 retractions. According to the investigation report , which we obtained through a public records request, some of the evidence of image manipulation came from comments on a 2012 Retraction Watch post about an earlier Katiyar retraction.
前美国马里兰大学癌症研究人员撤稿达到21篇 诸平 据《 撤稿瞭望 》2018年11月2日报道，阿尼尔 · 贾斯瓦尔（ Anil Jaiswal ）早在一年前曾经是美国 马里兰大学的癌症研究员 , 就有四篇论文撤稿。 但是，目前的撤稿数量达到 21 篇，登上了《撤稿瞭望》撤稿最多 30 人的 排行榜。更多信息请注意浏览相关报道： Former University of Maryland cancer researcher up to 21 retractions Anil Jaiswal Anil Jaiswal, who until a year ago was a cancer researcher at the University of Maryland, Baltimore, has had four more papers retracted. That makes 21 for Jaiswal, who joins our leaderboard of the 30 researchers with the most retractions. All four new retractions appear in journals published by the American Association for Cancer Research, and are for image or data manipulation. For example, here’s the retraction notice for “ Aromatase Inhibitor–mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer ,” in Molecular Cancer Therapeutics : This article ( 1 ) has been retracted at the request of the editors. Following an institutional review by the University of Maryland (Baltimore, MD), it was determined that data used in some of the figures cannot be supported. Specifically, the University’s versions on record of Fig. 1E do not match the final published Fig. 1E. The error bars in the published figure are markedly smaller than the University’s versions on record. Further analysis showed that histograms depicting averaged data may have been created from a single datum, some samples may have been disconnected from the analysis, and values for error bars were inappropriately set. University investigators also found that data were excluded from analyses presented in Fig. 3 of the published article. The statistical significance reported in the article is nullified when these data points are included. In addition, it was concluded that a number of duplicated data points found in the data were uncorroborated. The University investigators determined that the published figure does not support significant differences between MCF-7Ca and LTLT-Ca, or the authors’ hypothesis. A copy of this retraction notice was sent to the last known email addresses for all seven authors, none of whom responded. Two of the retracted papers — “ Inactivation of the Quinone Oxidoreductases NQO1 and NQO2 Strongly Elevates the Incidence and Multiplicity of Chemically Induced Skin Tumors ” and “ Low and High Dose UVB Regulation of Transcription Factor NF-E2-Related Factor 2 ” — originally appeared in Cancer Research . One — “ NRH:Quinone Oxidoreductase 2-Deficient Mice Are Highly Susceptible to Radiation-induced B-Cell Lymphomas ” — appeared in Clinical Cancer Research . The retractions were a long time coming. As we reported last year , the university requested that journals retract more than 20 papers by Jaiswal starting in August 2016. In September of this year, the AACR apologized for delays in correcting the record in a number of cases , although it did not name Jaiswal specifically. In the meantime, since January 2017, at least two of the newly retracted papers have been cited a handful of times. Jaiswal left the university one year ago yesterday.
清华博士叶肖鑫，导师唐国翌撤稿、修改知多少 诸平 清华大学深圳研究生院2018年10月21日公布了“ 对 叶肖鑫学术不端问题调查处理情况 ” 。叶肖鑫于2010年进入清华大学深圳研究生院攻读材料科学与工程专业博士学位，2015年7月毕业并获清华大学博士学位，指导教师为清华大学深圳研究生院新材料研究所唐国翌教授。就在叶肖鑫博士毕业前夕，他 获得了 2015年清华大学第20届“学术新秀”提名表彰 。 6月6日，清华大学第20届学术新秀颁奖典礼暨分享交流会在主楼后厅举行，清华大学深圳研究生院2010级博士生叶肖鑫荣获清华大学“学术新秀”提名表彰。相关报道称： 叶肖鑫师从于清华大学研究生院新材料研究所唐国翌教授，五年博士期间，叶肖鑫在唐教授的悉心指导下，充 分发挥了科研创新的精神，砥砺前行，勇攀科学高峰，取得了丰硕的科研成果：发表SCI论文18篇，其中第一作者16篇，影响因子总和达38.4（三级学科金属材料领域期刊最高影响因子为3.9），论文被引用次数达83 次，H指数达6，其中有五篇论文被选为期刊当期封面文章；相关研究成果已申请两项国家发明专利和一项实用新型专利。 在读博士期间，叶肖鑫曾先后受邀担任国内外多家知名学术期刊的编辑（Journal of nanomedicine and nanotechnology、Journal of bioengineering and biomedical science和 International Journal of Nonferrous Metallurgy等）和审稿人（Material Science Engineering:C和Journal of materials processing technology等），受邀在本研究领域外场加 工纳米晶材料制备的顶级国际会议（ICEFP）、先进材料加工技术的顶级国际会议（AMPT，清华大 学A类重点资助国际学术会议）和深港澳台博士生国际学术交流论坛（获得大会特等奖）等多次做 口头报告。由于其在新型生物医用钛合金的杰出研究成果，受邀加入International Conference on Green Energy Expo和Spring World Congress on Engineering and Technology国际学术会 议的组织委员会。 科研不息，学术不止。叶肖鑫表示，未来计划从事科研学术工作，并且希望依托高校等研究 单位进行基础研究和技术创新类的科研工作，为科技的进步和国家的富强贡献自己的绵薄之力。 清华大学“学术新秀”评选作为清华大学最高学术水平的校级奖项之一，在20年的历史中， 众多“学术新秀”已经成长为相关学科领域中的学术领头人和科研骨干。可惜叶肖鑫没有！ 2016年3月，唐国翌教授收到对叶肖鑫为第一作者所发表论文可能存在学术问题的举报后，立即组织对叶肖鑫就读博士生期间发表的16篇论文进行全面核查，发现存在自我抄袭、图片重复利用、编造实验结果等问题，随即与相关出版机构多次沟通，提出全部撤稿的要求。通过对叶肖鑫博士学位论文的核查，发现同样存在上述问题。经进一步核查，初步判断叶肖鑫存在严重学术不端行为。2017年1月，校学术委员会成立专门工作组进行调查并经学术道德分委员会讨论，认定叶肖鑫存在严重学术不端行为，其导师唐国翌对此负有指导管理方面的责任。2017年4月28日，校学位评定委员会召开全体会议，决定撤销叶肖鑫博士学位，该处理结果在校内进行了公告。2017年6月，清华大学深圳研究生院已经停止了唐国翌教授招收研究生资格，撤销其材料学科负责人和新材料研究所副所长职务，目前其已办理退休手续。其撤稿或者修改稿摘引如下，仅供参考。其中2014年发表的有9篇，2015年3篇，2016年2篇，详见下表。 The papers , from a group at the prestigious Tsinghua University, appeared in a variety of materials journals and date back to 2014. The most recent publications arrived in 2016. 表 1 叶肖鑫博士和唐国翌教授的撤稿或者修改相关论文 14 篇 Retraction or Other Notices Title/Subject(s)/Journal --- Publisher/Affiliation(s)/Retraction Watch Post URL(s) 14 Item(s) Found Reason(s) Author(s) Original Paper Date/PubMedID/DOI Retraction or Other Notices Date/PubMedID/DOI Article Type(s) Nature of Notice Countries Paywalled? Notes Effect of electropulsing treatment on the microstructure, texture, and mechanical properties of cold-rolled Ti–6Al–4V alloy (PHY) Engineering - Electrical; (PHY) Materials Science; Journal of Materials Research ---Cambridge University Press Advanced Materials Institute, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, PR ChinaKey Laboratory for Advanced Materials of Ministry of Education, Department of Materials Science and Engineering, Tsinghua University, Beijing 100084, PR China +Duplication of Image +Manipulation of Images Xiaoxin Ye ( 叶肖鑫） Guoyi Tang （唐国翌） Guolin Song Jie Kuang 07/24/2014 00000000 10.1557/jmr.2014.171 04/12/2018 00000000 10.1557/jmr.2018.48 Research Article Retraction China No Effects of high-energy electro-pulsing treatment on microstructure, mechanical properties and corrosion behavior of Ti–6Al–4V alloy (PHY) Engineering - Chemical; (PHY) Engineering - Electrical; (PHY) Materials Science; Materials Science and Engineering: C ---Elsevier Advanced Materials Institute, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, PR ChinaKey Laboratory for Advanced Materials of Ministry of Education, Department of Materials Science and Engineering, Tsinghua University, Beijing 100084, PR ChinaCollege of Engineering, The University of Georgia, Athens, GA 30602, USA +Duplication of Image +Forged Authorship +Investigation by Journal/Publisher +Investigation by Third Party Xiaoxin Ye （叶肖鑫） Lingsheng Wang Zion T H Tse Guoyi Tang （唐国翌） Guolin Song 01/26/2015 25687017 10.1016/j.msec.2015.01.081 04/09/2018 00000000 10.1016/j.msec.2018.05.072 Research Article Retraction China United States No Microhardness and corrosion behavior of surface gradient oxide coating on the titanium alloy strips under high energy electro-pulsing treatment (BLS) Biochemistry; (PHY) Engineering - Chemical; (PHY) Materials Science; Surface and Coatings Technology ---Elsevier Advanced Materials Institute, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, PR ChinaKey Laboratory for Advanced Materials of Ministry of Education, Department of Materials Science and Engineering, Tsinghua University, Beijing 100084, PR China +Duplication of Image +Investigation by Journal/Publisher Xiaoxin Ye （叶肖鑫） Yanyang Yang Guoyi Tang （唐国翌） 08/27/2014 00000000 10.1016/j.surfcoat.2014.08.052 09/29/2017 00000000 10.1016/j.surfcoat.2014.08.052 Research Article Retraction China No The effect of electropulsing induced gradient topographic oxide coating of Ti–Al–V alloy strips on the fibroblast adhesion and growth (BLS) Biochemistry; (PHY) Engineering - Electrical; (PHY) Materials Science; Surface and Coatings Technology ---Elsevier Advanced Materials Institute, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, PR ChinaKey Laboratory for Advanced Materials of Ministry of Education, Department of Materials Science and Engineering, Tsinghua University, Beijing 100084, PR China +Forged Authorship +Investigation by Journal/Publisher +Plagiarism of Article Xiaoxin Ye Guoyi Tang Guolin Song 11/18/2014 00000000 10.1016/j.surfcoat.2014.11.028 09/29/2017 00000000 10.1016/j.surfcoat.2014.11.028 Research Article Retraction China No Effect of electropulsing treatment and ultrasonic striking treatment on the mechanical properties and microstructure of biomedical ti-6Al-4V alloy (BLS) Biochemistry; (PHY) Engineering - Chemical; (PHY) Materials Science; Journal of the Mechanical Behavior of Biomedical Materials ---Elsevier Advanced Materials Institute, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, PR ChinaKey Laboratory for Advanced Materials of Ministry of Education, Department of Materials Science and Engineering, Tsinghua University, Beijing 100084, PR ChinaGraduate School at Shenzhen, Harbin Institute of Technology, Shenzhen 518055, PR China +Duplication of Image +Duplication of Text +Investigation by Journal/Publisher +Manipulation of Images Xiaoxin Ye Yongda Ye Guoyi Tang 09/03/2014 25259667 10.1016/j.jmbbm.2014.08.022 09/19/2017 30301539 10.1016/j.jmbbm.2014.08.022 Research Article Retraction China No Effect of electroplastic rolling on deformability, mechanical property and microstructure evolution of Ti-6Al-4V alloy strip (PHY) Materials Science; Materials Characterization ---Elsevier Advanced Materials Institute, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, PR ChinaKey Laboratory for Advanced Materials of Ministry of Education, Department of Materials Science and Engineering, Tsinghua University, Beijing 100084, PR ChinaCollege of Engineering, The University of Georgia, Athens, GA 30602, USA +Duplication of Data +Duplication of Image +Duplication of Text Xiaoxin Ye Zion T H Tse Guoyi Tang Guolin Song 10/29/2014 00000000 10.1016/j.matchar.2014.10.026 09/13/2017 00000000 10.1016/j.matchar.2017.09.008 Research Article Retraction China United States No Effect of High-Energy Electropulsing on the Phase Transition and Mechanical Properties of Two-Phase Titanium Alloy Strips (PHY) Materials Science; Advanced Engineering Materials ---Wiley Key Laboratory for Advanced Materials of Ministry of Education, Department of Materials Science and Engineering, Tsinghua University, Beijing 100084, P. R. China +Complaints about Author +Duplication of Data +Duplication of Image +Forged Authorship +Investigation by Company/Institution Xiaoxin Ye Zion T H Tse Guoyi Tang Guolin Song 12/10/2014 00000000 10.1002/adem.201400273 08/29/2017 00000000 10.1002/adem.201770028 Research Article Retraction China No Effect of electropulsing on surface mechanical properties and microstructure of AISI 304 stainless steel during ultrasonic surface rolling process (PHY) Engineering - Chemical; (PHY) Materials Science; Materials Science and Engineering: A ---Elsevier Advanced Materials Institute, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, PR ChinaKey Laboratory of Advanced Materials of Ministry of Education, Department of Materials Science and Engineering, Tsinghua University, Beijing 100084, PR China +Error in Image Haibo Wang Guolin Song Guoyi Tang 03/23/2016 00000000 10.1016/j.msea.2016.03.097 06/07/2017 00000000 10.1016/j.msea.2017.05.119 Research Article Correction China No Effect of electropulsing on surface mechanical properties and microstructure of AISI 304 stainless steel during ultrasonic surface rolling process (PHY) Engineering - Chemical; (PHY) Materials Science; Materials Science and Engineering: A ---Elsevier Advanced Materials Institute, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, PR ChinaKey Laboratory of Advanced Materials, Tsinghua University, Beijing 100084, PR China +Error in Text Haibo Wang Guolin Song Guoyi Tang 03/23/2016 00000000 10.1016/j.msea.2016.03.097 04/19/2016 00000000 10.1016/j.msea.2016.04.043 Research Article Correction China No Mechanical properties and tensile fracture of Ti–Al–V alloy strip under electropulsing-induced phase change (PHY) Materials Science; (PHY) Physics; Journal of Materials Research ---Cambridge University Press Advanced Materials Institute, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, People's Republic of ChinaKey Laboratory for Advanced Materials of Ministry of Education, Department of Materials Science and Engineering, Tsinghua University, Beijing 100084, People's Republic of ChinaCollege of Engineering, The University of Georgia, Athens, Georgia 30602, USA +Duplication of Image +Forged Authorship +Manipulation of Images Xiaoxin Ye Zion T H Tse Guoyi Tang 12/15/2014 00000000 10.1557/jmr.2014.367 03/06/2017 00000000 10.1557/jmr.2017.75 Research Article Retraction China United States No Mechanical properties and tensile fracture of Ti–Al–V alloy strip under electropulsing-induced phase change (PHY) Materials Science; Journal of Materials Research ---Cambridge University Press Advanced Materials Institute, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, People's Republic of ChinaKey Laboratory for Advanced Materials of Ministry of Education, Department of Materials Science and Engineering, Tsinghua University, Beijing 100084, People's Republic of ChinaCollege of Engineering, The University of Georgia, Athens, Georgia 30602, USA +Error in Text Xiaoxin Ye Zion T H Tse Guoyi Tang 12/15/2014 00000000 10.1557/jmr.2014.367 09/16/2015 00000000 10.1557/jmr.2015.290 Research Article Correction China United States No Mechanical properties and phase transition of biomedical titanium alloy strips with initial quasi-single phase state under high-energy electropulses (BLS) Biochemistry; (PHY) Engineering - Chemical; (PHY) Materials Science; Journal of the Mechanical Behavior of Biomedical Materials ---Elsevier Advanced Materials Institute, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, PR ChinaKey Laboratory for Advanced Materials of Ministry of Education, Department of Materials Science and Engineering, Tsinghua University, Beijing 100084, PR ChinaCollege of Engineering, The University of Georgia, Athens, GA 30602, USA +Duplication of Image +Forged Authorship +Investigation by Journal/Publisher Xiaoxin Ye Zion T H Tse Guoyi Tang Goulin Song 11/20/2014 25460930 10.1016/j.jmbbm.2014.11.009 01/25/2017 30301540 10.1016/j.jmbbm.2014.11.009 Research Article Retraction China United States No Effect of coupling asynchronous acoustoelectric effects on the corrosion behavior, microhardness and biocompatibility of biomedical titanium alloy strips (HSC) Medicine - Dentistry; (HSC) Medicine - Orthopedics; (PHY) Materials Science; Journal of Materials Science. Materials in Medicine ---Springer Advanced Materials Institute, Graduate School at Shenzhen, Tsinghua University, Shenzhen, ChinaKey Laboratory for Advanced Materials of Ministry of Education, Department of Materials Science and Engineering, Tsinghua University, Beijing, China +Duplication of Image +Concerns/Issues about Referencing/Attributions +Euphemisms for Plagiarism +Plagiarism of Text Xiaoxin Ye Guoyi Tang 01/18/2015 25596862 10.1007/s10856-014-5371-5 10/05/2016 27709458 10.1007/s10856-016-5782-6 Research Article Retraction China No Influence of electropulsing globularization on the microstructure and mechanical properties of Ti–6Al–4V alloy strip with lamellar microstructure (PHY) Engineering - Structural; (PHY) Materials Science; Materials Science and Engineering: A ---Elsevier Advanced Materials Institute, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, PR ChinaKey Laboratory for Advanced Materials of Ministry of Education, Department of Materials Science and Engineering, Tsinghua University, Beijing 100084, PR ChinaCollege of Engineering, The University of Georgia, Athens, GA 30602, USA +Duplication of Image +Forged Authorship +Investigation by Journal/Publisher Xiaoxin Ye Zion T H Tse Guoyi Tang Yubo Geng Guolin Song 01/12/2015 00000000 10.1016/j.msea.2014.11.003 09/14/2016 00000000 10.1016/j.msea.2017.01.040 Research Article Retraction China No 更多信息请注意浏览相关报道。 Group in China earns nearly a dozen retractions for image duplication, forged authorship, and more
Yuhji Saitoh 撤稿进展 诸平 一年前 , 日本麻醉师协会（ JSA ）推荐 收回 9 篇论文,但期刊只收回两篇。 2017年, JSA 建议期刊收回9篇论文，因为这些论文是一位日本研究人员与一个臭名昭著的骗子（notorious fraudster）合作完成的。但是，期刊编辑部并没有将其全部收回，而截止2018年8月21日仅仅收回了两篇。 此研究人员就是日本八千代医学中心 （Yachiyo Medical Center）和东京女子医科大学（Tokyo Women’s Medical University）的Yuhji Saitoh 。Yuhji Saitoh与日本麻醉学家藤井善隆（ Yoshitaka Fujii ）有多篇合著论文。但是，藤井善隆在2012年被发现至少在172篇科学论文中（at least 172 scientific papers ）有数据造假，而且，在个人撤稿数量上是创纪录的 。Yuhji Saitoh已经收回了39篇论文,其中许多是与藤井善隆合作的。但事实证明Yuhji Saitoh并不是一个完全无辜的旁观者:收到不当行为的指控后,日本麻醉医师协会(Japanese Society of Anesthesiologists, JSA)调查了Yuhji Saitoh已经发表的大约40篇作品。JSA对Yuhji Saitoh论文的调查并非空穴来风，至少在某种程度上与2016年两名麻醉师——约翰·卡莱尔（John Carlisle）和约翰·劳兹曼（John Loadsman）对于Yuhji Saitoh数十篇论文的检查 分析 有关。《撤稿瞭望》对此也曾经有过报道（that we covered )。他们分析检查的论文中有23篇论文是与藤井善隆合作完成的。约翰·卡莱尔和约翰·劳兹曼他们确定了几个与藤井善隆合作的潜在问题,包括不太可能已经进行了随机抽样。 根据2017年9月 发布的报告 ， 审查委员会“确定10篇已经发表的作品涉嫌有明确的道德违规行为,其中一篇论文已经收回 （ a committee “identified ten publications with clear ethics violations, one of which has already been retracted .”）”。另外的9篇论文中已经收回的只有2篇，即一篇是 2004年在《麻醉》（Anesthesia）杂志发表的论文，另外 一篇是 2010年在《麻醉学报》（ Journal of Anesthesia ）发表的论文。 虽然将一篇被认为存在瑕疵的论文撤回看似一项简单的任务，但是，《撤稿瞭望》网站对于像藤井善隆（ Fujii ）和 约阿希姆·博尔特（ Joachim Boldt ）这样臭名昭著的骗子的撤稿记录有很多，在《撤稿瞭望》排行榜中获得冠军和亚军（ The Retraction Watch Leaderboard ）。不同的期刊在几年时间期间已经收回他们的一些作品。即使直接要求撤稿——如来自大学等进行的调查结果，作为 期刊而言，并非那么简单，可能需要数年的时间 。 Yuhji Saitoh的7篇论文依然在学术界有人引用: （1）2005年发表于《加拿大麻醉杂志》（Canadian Journal of Anesthesia）的论文已经被引用11次——“ Delayed recovery of vecuronium neuromuscular block in diabetic patients during sevoflurane anesthesia ,” Canadian Journal of Anesthesia, published in 2005, has been cited 11 times, according to Clarivate Analytics’ Web of Science . （2）2003年在《加拿大麻醉杂志》（Canadian Journal of Anesthesia）发表的论文，已经被引用7次——“ Neuromuscular blockade can be assessed accelerographically over the vastus medialis muscle in patients positioned prone ,” Canadian Journal of Anesthesia, published in 2003, has been cited seven times. （3）1997年在《加拿大麻醉杂志》（Canadian Journal of Anesthesia）发表的论文，已经被引用14次——“ Train-of-four and double burst stimulation fade at the great toe and thumb ,” Canadian Journal of Anesthesia, published in 1997, has been cited 14 times. （4）1996年在《加拿大麻醉杂志》（Canadian Journal of Anesthesia）发表的论文，已经被引用7次——“ Recovery of post-tetanic and train-of-four responses at the first dorsal interosseous and adductor pollicis muscles in patients receiving vecuronium ,” Canadian Journal of Anesthesia, published in 1996, has been cited seven times. （5）2003年在《英国麻醉学杂志》（British Journal of Anaesthesia）发表的论文，已经被引用16次——“ Monitoring of neuromuscular block after administration of vecuronium in patients with diabetes mellitus ,” British Journal of Anaesthesia, published in 2003, has been cited 16 times. （6）1993年在《英国麻醉学杂志》（British Journal of Anaesthesia）发表的论文，已经被引用41次——“ Recoveries of post-tetanic twitch and train-of-four responses after administration of vecuronium with different inhalation anaesthetics and neuroleptanaesthesia ,” British Journal of Anaesthesia, published in 1993, has been cited 41 times. （7）2009年在《福岛医学科学杂志》（Fukushima Journal of Medical Science）上发表的论文，因为未被Web of Science收录，被引用情况不详。但是，通过谷歌学术搜索结果显示，被引用一次。——“ Reversal of vecuronium with neostigmine: a comparison between male and female patients ,” Fukushima Journal of Medical Science, published 2009, has not yet been indexed. 根据日本麻醉医师协会（JSA）发布的报告，自从一年前开始，每篇论文的被引数量并未出现大幅改变。；另外，藤井善隆并非是9篇论文当中任何一篇建议撤销的合著者。更多信息请注意浏览原文或者相关报道。 A year ago, an academic society recommended nine papers be retracted. Journals have retracted only two. Anesthesiology society bans co-author of researcher with record-number of retractions The Retraction Watch Leaderboard Who has the most retractions? Here’s our unofficial list (see notes on methodology), which we’ll update as more information comes to light: Yoshitaka Fujii (total retractions: 183) See also: Final report of investigating committee , our reporting, additional coverage Joachim Boldt (96) See also: Editors-in-chief statement , our coverage Diederik Stapel (58) See also: our coverage Adrian Maxim (48) See also: our coverage Chen-Yuan (Peter) Chen (43) See also: SAGE , our coverage Yoshihiro Sato (42) See also: our coverage Hua Zhong (41) See also: journal notice Shigeaki Kato (39) See also: our coverage Yuhji Saitoh (39) See also: our coverage Jun Iwamoto (38) See also: our coverage James Hunton (37) See also: our coverage Hyung-In Moon (35) See also: our coverage Naoki Mori (32) See also: our coverage Jan Hendrik Schön (32) See also: our coverage Soon-Gi Shin (30) See also: our coverage Tao Liu (29) See also: our coverage Cheng-Wu Chen (28) See also: our coverage A Salar Elahi (27) See also: our coverage Richard L E Barnett (26) See also: our coverage Scott Reuben (24) See also: our coverage Gilson Khang (22) See also: our coverage Noel Chia (21) See also: our coverage Friedhelm Herrmann (21) See also: our coverage Stanley Rapoport (21) See also: our coverage Fazlul Sarkar (21) See also: our coverage Dipak Das (20) See also: our coverage Khalid Zaman (20) See also: our coverage Bharat Aggarwal (19) See also: our coverage Jin Cheng (19) See also: our coverage Andrzej Jendryczko (19) See also: our coverage
纵有撤稿16篇，教授职位在等闲 诸平 Ulrich Lichtenthaler 据《撤稿瞭望》（ Retraction Watch ）网站 2018 年 8 月 14 日报道， 管理教授乌尔里希 • 利希滕塔勒 (Ulrich Lichtenthaler) ，尽管其曾因“数据违规”而不得不撤回 16 篇论文，但是他在学术界还是有了新职位。 根据总部位于德国的国际管理学院 (International School of Management, ISM) 的一份新闻稿，利希滕塔勒已被任命为科隆校区 ( Cologne campus ) 的企业管理和创业学教授 ( Professor of Business Management and Entrepreneurship ) 。利希滕塔勒也将成为 ISM 的创业学院的主任（ Entrepreneurship Institute at ISM ）之一，负责该领域的研究。读者可能对利希滕塔勒的名字很熟悉:在杂志发表的论文中撤回了他的十多篇文章后，2015年他辞去了曼海敏大学（ University of Mannheim in ）的职位。有人通过电子邮件询问利希滕塔勒，是否对于新雇主透露过他的历史问题；他将邮件转发给ISM的市场和销售部门主管，主管的回信如下： Dr. Ulrich Lichtenthaler has been appointed Professor at International School of Management (ISM), effective as of March 1st, 2018. The appointment is based on a due appointment process. This process is by standard subject to examination by the Ministry of Culture and Science of the State of North Rhine-Westphalia. Prior discrepancies and retracted publications of Dr. Ulrich Lichtenthaler were known in advance to the appointment process. 大意是 Ulrich Lichtenthaler 博士被任命为国际管理学院 (ISM) 教授，从 2018 年 3 月 1 日起生效。任命是基于一个适当的任命过程，即此过程是由德国北莱茵 - 威斯特伐利亚州的文化和科学部审查的标准程序。在任命程序开始前，我们就知道 Ulrich Lichtenthaler 博士先前发表的不一致和撤回的出版物。 2013 年，他获得博士学位的奥托贝森管理学院 (WHU-Otto Beisheim School of Management) 撤销了 Ulrich Lichtenthaler 的教学资格 ; 我们问 ISM 的发言人这是否会影响他目前的职位。她告诉我们 : ISM 是一所以应用科学为重点的应用型大学，注重实践教学。在这方面， Ulrich Lichtenthaler 博士在商业实践方面的专业知识和教学质量都很高 。 is an application-focused University of Applied Sciences, putting emphasis on practice-oriented teaching. In this regard, Dr. Ulrich Lichtenthaler has specific expertise in business practice and high qualities in teaching. 她还补充说 : ISM 是一所属于德国教育体系 “ 应用科学大学 (Fachhochschule) ” ，它有别于德文 ‘Universität’ 即研究型 大学 (Research University)” 。 “ 应用科学大学 (Fachhochschule) ” 与 “ 研究型大学（ Universität ） ” 相比，应用科学大学 (Fachhochschule) 的聘用标准主要是博士学位、商业实践经验和教学经验，不需要 “ 授权许可 ”( 大学任教资格证书或教学许可证，如你提到的 ) 。 ISM is a ’Fachhochschule’ (University of Applied Sciences), which is within the German educational system distinct from a ‘Universität’ (Research University). Appointment criteria for a ‘Fachhochschule’ as compared to a ‘Universität’ are primarily a PhD degree, experience in business practice and experience in teaching. A ‘Habilitation’ (Venia Legendi or Teaching License, as you referred to) is not required at a ‘Fachhochschule’. Ulrich Lichtenthaler 博士 的新任命引起了一些反响 ; 在一个关于经济工作的网站上，一位评论者写道 : 天哪，这是假的还是真的 ? （ holy s**t… wtf… fake or real? ） 当美国加州克莱蒙特市凯克研究生院 (Keck Graduate Institute in Claremont, Calif. ) 的乔尔·韦斯特 (Joel West) 教授在推特（ Twitter ）上宣布这一任命时，一位读者说他 “ 目瞪口呆 ” 了。 乔尔·韦斯特诉我们 , 因为他了解 Lichtenthaler 的任命 , 他已经听到了同行的一些 “ 反应 ” 。如有人认为，这真是让人大跌眼镜，即使你有一系列学术欺诈的不良记录在案，也不会剥夺你在学术界另谋一个职位的资格。 It’s just really frustrating. Even when you have a well document case of serial academic fraud, that it’s not disqualifying for another position in academia. Ulrich Lichtenthaler 博士 过去的经历造成了一些附带的损害 : 在 2015 年，他的一位经常合作的作者，也是奥托贝森管理学院 (WHU - Otto Beisheim School of Management) 的系主任，被指控有 “ 严重的科学不端行为 ” ，因为尚未发现他与 Ulrich Lichtenthaler 博士 合作研究成果也存在违规问题。 更多信息可以浏览 《撤稿瞭望》（ Retraction Watch ）网站的相关报道。 RELATED Management researcher with 16 retractions has new professorship . August 14, 2018 After 16 retractions, management professor Lichtenthaler resigns post October 10, 2014 In germany retractions German dep't head reprimanded for not catching mistakes of co-author Lichtenthaler September 29, 2015 In germany retractions Management prof with 12 retractions loses his license to teach September 16, 2013 In business
看诺奖得主如何纠正错误 诸平 保罗·纳斯（ Paul Nurse ） 如果你一直在想要纠正一篇论文，这里有一个故事可以帮助你解除痛苦。 保罗·纳斯（ Paul Nurse ）是一位 英国生物化学家。由于发现细胞周期中的关键调节因子，他和利兰 · 哈特韦尔（ Leland Hartwell ） 、蒂姆 · 亨特（ Tim Hunt ）一起获得了 2001 年的诺贝尔生理学或医学奖。现任 英国皇家学会 会长。2015年参与研发麦立高，并取得巨大成就。 虽然保罗·纳斯在牛津大学（ Oxford University ）、洛克菲勒研究所（ Rockefeller Institute ）以及其他地方都发布帖子 , 现在他是弗朗西斯 · 克里克研究所（ Francis Crick Institute ）所长 , 但是他仍在继续做研究。本月早些时候 , 他 修正了 2017 年在《细胞科学杂志》发表的一篇论文（ corrected a 2017 paper in the Journal of Cell Science ） ”, 来自放线菌属对裂殖酵母的细胞形状产生影响的天然产物的筛选和纯化（ Screening and purification of natural products from actinomycetes that affect the cell shape of fission yeast ）。 ” 保罗·纳斯究竟是如何纠正错误和如何看待已经发表论文中出现的错误，为了避免误解，特将原文摘引如下： There was an error published in J. Cell Sci. (2017) 130, 3173-3185 ( doi:10.1242/jcs.194571) . In the above paper, we described the purification of a polyene from strain IS1 and identified it as a novel compound based on mass spectrometry data (published in Fig. 8B). We have been investigating this molecule in more detail and now believe, based on 1 H NMR data, that it is identical to the known molecule fungichromin (also known as cogomycin, pentamycin and lagosin). The original identification of the molecule as novel was based on our interpretation of the ion at m/z=693.379 as a protonated ion + , whereas we now believe that this represents a sodiated ion + . In addition, this research was also funded by a grant from The Breast Cancer Research Foundation to P.N. The authors apologise to the readers for any confusion that these errors might have caused. We asked Nurse why he and his colleagues thought it was important to correct the paper: Our paper described proof of principle experiments to demonstrate that visual screening of fission yeast for cell shape changes could be used to screen for biologically interesting natural compounds. We identified 149 activities in this screen and described in more detail four such activities. The four were characterised using mass spec, and with this technique three were shown to be previously described compounds whilst the fourth appeared novel. Our subsequent work showed that this fourth molecule had been previously described. As outlined in our correction, based on our original mass spec data we interpreted the ion as being protonated but our subsequent work indicated it was a sodiated ion. We decided to issue a correction so readers were aware that this fourth compound had also been described elsewhere. This means that anyone interested in this compound would be able to link both the early study and our present study. This summarises our (my co-authors and myself) thoughts over this. Of course, Nurse learned at an early age that failure wasn’t the end of the world. From a 2006 profile of him in The Scientist : In Britain in the late 1960s, to get into university, you had to be generally educated, and that included being able to speak some sort of foreign language. The British aren’t very good at speaking foreign languages and I’m worse than most. I failed the most basic examination in French on six separate occasions. This actually led to my rejection from all universities.” An astute professor, however, read Nurse’s entire application and decided it might be worthwhile to give the lad a chance. And he is hardly the only Nobelist who has had to retract or correct a paper . 相关报道： 保罗·纳斯（Paul Nurse）：肩负科学创新重任 保罗·纳斯 ( Paul Nurse )--中国科学院学部与院士 \0 Paul Nurse_百度百科 \0 Paul Nurse 的自传。新浪博客
Nature 撤稿：胡椒提取物抗癌有问题 诸平 Abstract Malignant transformation, driven by gain-of-function mutations in oncogenes and loss-of-function mutations in tumour suppressor genes, results in cell deregulation that is frequently associated with enhanced cellular stress (for example, oxidative, replicative, metabolic and proteotoxic stress, and DNA damage) 1 . Adaptation to this stress phenotype is required for cancer cells to survive, and consequently cancer cells may become dependent upon non-oncogenes that do not ordinarily perform such a vital function in normal cells. Thus, targeting these non-oncogene dependencies in the context of a transformed genotype may result in a synthetic lethal interaction and the selective death of cancer cells 2 . Here we used a cell-based small-molecule screening and quantitative proteomics approach that resulted in the unbiased identification of a small molecule that selectively kills cancer cells but not normal cells. Piperlongumine increases the level of reactive oxygen species (ROS) and apoptotic cell death in both cancer cells and normal cells engineered to have a cancer genotype, irrespective of p53 status, but it has little effect on either rapidly or slowly dividing primary normal cells. Significant antitumour effects are observed in piperlongumine-treated mouse xenograft tumour models, with no apparent toxicity in normal mice. Moreover, piperlongumine potently inhibits the growth of spontaneously formed malignant breast tumours and their associated metastases in mice. Our results demonstrate the ability of a small molecule to induce apoptosis selectively in cells that have a cancer genotype, by targeting a non-oncogene co-dependency acquired through the expression of the cancer genotype in response to transformation-induced oxidative stress 3 , 4 , 5 . 《 自然》 （ Nature ） 2011 年发表了一篇论文描述从胡椒中提取的一种化合物—— 荜茇酰胺（ Piperlongumine ）， 似乎可以杀死癌细胞，但健康细胞不会受到伤害 , 使得其受到关注。不仅吸引了许多 媒体 （ caught the media’s eye ） 的注意 ，同时也吸引了跟风 研究者的眼球， 继续研究此化合物（ piperlongumine ）对癌症的影响 , 以 PubMed 数据库为例，相关研究成果数量明显增加。 图 1 荜茇酰胺（ Piperlongumine ）相关研究成果的数量变化 The compound, piperlongumine, comes from the Indian long pepper plant. 但自从 2011 年的相关研究结果 出现时 , 研究人员就 对一些图 有疑虑（ concerns about some of the figures ） —— 包括一个显示小鼠巨大肿瘤 , 建议他们在研究过程中经历了不合理的痛苦。《自然》杂志编辑部通过 2012 年 和 2015 年 发布两个漫长的调整通知对此作出回应，还有 一篇社论 也 承认动物可能 “ 比最初允许经历更多的痛苦和折磨 ,” 但不会导致撤稿 , 结果仍然是 “ 有效的和有用的。 ” 然而，几年过去了，到 2018 年 7 月 25 日，《自然》杂志编辑部公布了 简短的撤稿通知 : This Letter is being retracted owing to issues with Fig. 1d and Supplementary Fig. 31b, and the unavailability of original data for these figures, which raises concerns regarding the integrity of the figures. Nature published two previous corrections related to this Letter. These issues in aggregate undermine the confidence in the integrity of this study. 大致意思是说，此快报被收回由于图 1 d 和补充图 31 b 存在问题 , 而且这些图形的原始数据是无效用的 , 这引发了对于所有图形完整性的担忧。尽管《自然》杂志之前发表过两次相关修正，但总体而言这些问题破坏了本研究的完整性。 撤稿通知中解释道 ,14 位作者当中有 4 位作者不同意撤稿 , 其中包括第一作者和最后一位作者。根据 科睿唯安 （ Clarivate Analytics’ Web of Science ）统计，撤稿论文—— Selective killing of cancer cells by a small molecule targeting the stress response to ROS 已经被引用 577 次 , 使其已经成为 “ 高被引论文 ”, 这意味着它在 2011 年出版的所有论文中被引频次是排名在前 1% 的。在 2015 年 9 月发表校正意见以来它已经被引用了 257 次。 近年来，这次被撤稿论文署名中的最后一位作者 , Sam W. Lee 已经 收回了另外两篇论文。这本身就是一个不祥之兆。 更多细节请注意浏览相关报道 ： All retractions are considered on a case-by-case basis, and decisions about whether to retract are made by Nature’s in-house editors, who may seek advice from independent peer-reviewers. Following this process, if the editors deem that a retraction is appropriate, all authors are contacted to seek their assent to the retraction and the retraction statement. Following this, the retraction notice will be published, and any dissenting authors noted in the text of the published version. More information about our retraction policy is available on our website: https://www.nature.com/authors/policies/corrections.html . We take all issues related to animal welfare very seriously and should we become aware of any breach of our policies in any published paper, we would follow an established process to investigate the issues. More details about Nature’s policies for papers that report experiments with animals are outlined in this editorial: https://www.nature.com/news/protection-priority-1.18354 . When we asked for more specifics about what happened with this particular paper, the spokesperson referred us to the retraction notice: The issues detailed in the retraction notice do not relate to the previous concerns regarding animal welfare, although all these issues in aggregate undermine the confidence in the integrity of this study. One reader forwarded us correspondence with the journal dating back to June 2016, in which he raised concerns that supplementary figure 31 contained manipulated images. We’re also trying to find out more information about why the authors were split in their agreement over the retraction. We contacted coauthor Stuart Schreiber to ask why he agreed with the retraction, and whether it has any impact on a patent related to compounds for cancer therapy, which cites the now-retracted paper ; he said he was traveling, and forwarded us to David Cameron, spokesperson for the Broad Institute of MIT and Harvard. Cameron told us: Although the scientific conclusions of the paper appear sound and its key findings have been extended by other investigators in independent publications, in an abundance of caution all authors who contributed experiments at the Broad Institute of MIT and Harvard support the Nature editors’ recommendation to retract the paper. Because the particular figures referenced were not generated at the Broad, we are not in a position to discuss them. We emailed co-authors Mandinova and Lee , who co-founded a company around the technology described in the paper — and disagreed with the retraction — but have not received a response. Mandinova and Lee have also filed patents together, including one from 2012 that mentions piperlongumine . Lee — based at Massachusetts General Hospital — has retracted two papers — a Molecular Cell paper in 2013 due to figure duplication and a Journal of Biological Chemistry paper in 2015 , citing “manipulated” data in a figure. He’s also issued at least one other mega-correction , and last year received an expression of concern on another 2011 paper, noting “credible concerns” about the data and conclusions .
新的研究表明，都灵寿衣是假的，支持其研究撤回 New study suggests Shroud of Turin a fake, supporting study retracted July 24, 2018 by Bob Yirka, Phys.org report 诸平 Full length negatives of the shroud. Credit: Public Domain 一对意大利研究人员，他们一名法医人类学家（ forensic anthropologist ），另一名化学家，对都灵覆盖物进行了测试，以确定其真实性，并报告了他们的分析结果表明，覆盖物是伪造的。在他们发表在《法医学杂志》（ Journal of Forensic Sciences ）上的论文中，马特奥·博里尼（ Matteo Borrini ）和路易吉·加拉斯切利（ Luigi Garlaschelli ）描述了他们所做的测试和他们的发现。详见 Matteo Borrini, Luigi Garlaschelli. A BPA Approach to the Shroud of Turin. Journal of Forensic Sciences, 2018. DOI: 10.1111/1556-4029.13867 2017 年发表的另一篇论文 2018 年 7 月 19 日已被撤回—— The PLoS ONE Editors. Retraction: Atomic resolution studies detect new biologic evidences on the Turin Shroud . PLoS ONE, 2018, 13(7): e0201272. https://doi.org/10.1371/journal.pone.0201272. 被撤稿的论文 2017 年 6 月 30 日 在开放存取期刊 PLoS ONE 的网站上发表（谷歌学术统计已经被引4次）—— Elvio Carlino, Liberato De Caro, Cinzia Giannini, Giulio Fanti. Atomic resolution studies detect new biologic evidences on the Turin Shroud. PloS ONE , 2017, 12 (6), e0180487. DOI: 10.1371/journal.pone.0180487 ( Published: June 30, 2017 ). https://doi.org/10.1371/journal.pone.0180487 . 此文研究者 声称，他们发现了在覆盖物上看到的人的身体受到创伤的证据。 但是，在 2018 年的一项新研究中，马特奥·博里尼（ Matteo Borrini ）和路易吉·加拉斯切利（ Luigi Garlaschelli ）通过假真血和布来模拟覆盖物的实验，测试了覆盖物的真实性。他们的目标是找出覆盖物上的血迹是否与圣经（ the Bible ）上报告的一致。其中一项实验是将血液应用到一名现场志愿者的身体上（他的姿势让人想起了在裹尸布上看到的人），然后用亚麻布把他裹起来，看看会留下什么污渍。他们还注意到，圣经中说耶稣（ Jesus ）被用矛刺穿了，为了模仿这样的伤口，研究人员把一块海绵绑在木桩上，用血浸透，然后用其作为矛刺人体模型（ mannequin ）。 研究人员报告说，在覆盖物上的血迹是不一致的 —— 在水里流动的血液不会像在裹尸布上看到的那样形成污点。举个例子，他们指出，从伤口流出来的血液只能在人直立的情况下，使裹尸布上形成污渍 —— 圣经上说，基督的身体（ the body of Christ ）在死后被放进了裹尸布里。他们给出的结论是，在裹尸布上的血迹是不可能像圣经所描述的那样形成的 ; 因此，他们认定裹尸覆盖物是伪造的。这意味着是对 2017 年 PloS ONE 发表的研究结果的全盘否定。因为 2017 年在 PloS ONE 发表的那篇论文的作者，声称他们已经发现受害者的创伤证据，是在详细研究了裹尸布之后给出上述结果的，但是，马特奥·博里尼（ Matteo Borrini ）和路易吉·加拉斯切利（ Luigi Garlaschelli ） 2018 年的实验结果与此相反，证明裹尸覆盖物是伪造的，使得 PLOS One 的出版商不得不收回 2017 年已经发表的研究结果。在其撤稿的编者按中已经明确指出，相关研究人员所使用的数据的质量和他们给出的结论备受关注。更多信息请注意浏览原文或者相关报道。 Explore further: Italian group claims to debunk Shroud of Turin (Update) 撤稿信息： Retraction Concerns have been raised that the data presented in this article are not sufficient to support the conclusions drawn; the provenance, integrity and availability of the material used for the study have also been questioned. In light of these issues, the PLOS ONE Editors reevaluated the published article in consultation with members of our Editorial Board. Based on our internal assessment and advice received from the Editorial Board members, the PLOS ONE Editors are concerned that there are not sufficient controls to support conclusions referring to human blood or physical trauma. For example, period ink and animal blood controls were not included in diffraction and STEM analyses, as would be needed to rule out alternate interpretations regarding the material on the fiber, and the creatinine findings do not provide definitive evidence of trauma or violence. Thus, we consider that the main conclusions of the article, including the following statements, are not sufficiently supported: “On the basis of the experimental evidences of our atomic resolution TEM studies, the man wrapped in the TS suffered a strong polytrauma” “the fiber was soaked with a blood serum typical of a human organism that suffered a strong trauma” “at the nanoscale it is encoded a scenario of great suffering recorded on the nanoparticles attached to the linen fibers” In addition, the results of this article were based on analysis of a single fiber (approximately 1mm in length and 15μm in diameter) from the Turin Shroud. The reliance on a single small fiber taken from the Turin Shroud in 1978 calls into question the validity of statements in the Results and Conclusions sections which compare the new findings to those reported in previous studies of the Turin Shroud. It has not been demonstrated that findings from the fiber used in the PLOS ONE article can be generalized as applying to other samples taken from the Turin Shroud, or that contamination of the sample can be ruled out. Furthermore, the Competing Interests statement for this article should have declared that the sample was provided by the Shroud of Turin Education and Research Association Inc. (STERA). In light of these issues, the PLOS ONE Editors are concerned about the validity of the conclusions and the reproducibility of the results, and so we retract this article. EC, LDC, CG, and GF do not agree with the retraction and stand by the results in the article. 19 Jul 2018: The PLOS ONE Editors (2018)Retraction: Atomic resolution studies detect new biologic evidences on the Turin Shroud . PLOS ONE 13(7): e0201272. https://doi.org/10.1371/journal.pone.0201272 View retraction
2017年撤稿十件大事 2017年刚刚结束，回头看看2017年撤稿时间，头十件大事值得回味，请浏览来自《科学家》（ The Scientist ）的相关报道： Top 10 Retractions of 2017 Making the list: a journal breaks a retraction record, Nobel laureates Do the Right Thing, and Seinfeld characters write a paper By Retraction Watch | December 18, 2017 UNSPLASH, GARY CHAN When it comes to retractions, we at Retraction Watch always have a lot to say. Especially after spending much of 2017 building our retraction database , which now holds just shy of 16,000 entries—more than 1,000 from 2017 alone. That’s an increase from the 650 total retractions counted by MEDLINE in 2016. Of course, scientific misconduct involves more than just retractions. This year, we reported on the loss of a frequently cited (but controversial) resource that deemed some journals “predatory,” the ongoing saga between a Harvard graduate student and his mentor that resulted in a forced psychiatric exam and a restraining order , and a university’s decision to pay a researcher found guilty of misconduct $100,000 to leave . There are also the stories about decisions not to retract—such as when more than a dozen editorial board members resigned from Scientific Reports after the journal decided to correct, not retract, a paper accused of plagiarism . (The journal eventually decided to add an editor’s note to the story and form a committee to review it .) But there were also plenty of retractions that caught our notice this year. Here are our picks of the 10 most notable retractions of 2017, in no particular order. 1 It seems that every year, an old record falls. This year saw the shattering of the record for the most retractions issued by one journal in a single day, when Springer retracted 107 papers from Tumor Biology after discovering all had been tainted by fake peer reviews . You read that right—107 papers. In one day. As fallout, an investigation by the Chinese government determined that nearly 500 researchers were guilty of misconduct ; a government news agency reported that hundreds had been temporarily banned from their institutions. The journal has since been delisted from Web of Science , a database of citation metrics. 2 2017 was a rough year for Brian Wansink , a food scientist at Cornell University. After researchers raised questions about his work following a blog post he published at the end of 2016 , the notices began piling up. He ended the year with five retractions (including one paper that was retracted twice , after the revised version was also retracted), and 13 corrections . Although Cornell initially determined his research was tainted by mistakes, not misconduct , the institution recently told BuzzFeed it was re-investigating . 3 Second time wasn’t the charm for a study linking vaccines to autism and other neurodevelopmental disorders. After the paper was quickly retracted from a Frontiers journal in 2016 , it was republished in the Journal of Translational Science in May, 2017—then retracted again only days later . (Strangely, a version of the paper reappeared online ; we asked the journal for an explanation but never heard back.) 4 What does a journal do when its entire editorial board resigns at once? Ask the International Journal of Occupational and Environmental Health . In November, the board of the periodical jumped ship over concerns that the publication was becoming too cozy with corporations. Particularly troubling to the erstwhile board members was the withdrawal (with little explanation) of a paper by the previous editor that had been critical of corporate-sponsored research. 5 When a pair of researchers from Sweden published a paper in Science in 2016 showing that fish larvae were getting sick eating tiny bits of plastic, environmentalists took notice. So did critics, who quickly began carping about the article by Peter Eklöv and Oona Lönnstedt of Uppsala University. Turns out the criticism was justified. Science retracted the article in May, after a review board deemed it was “remarkable” the paper was ever accepted . Uppsala originally found no evidence of misconduct , then reversed that decision in December, saying Lönnstedt fabricated the results . 6 Most mice look pretty much the same. For scientists, however, differences at the level of genes are what count. In July, Maureen Gannon and Raymond Pasek of Vanderbilt University retracted a 2016 article after learning they’d mistakenly been studying the wrong transgenic mouse line . Although the pair said they were “devastated” by the error, they knew they had to correct the record. After all, as they told us , “the scientific community and the public needs to trust published scientific results.” 7 When John McCool received an email from the Urology Nephrology Open Access Journal seeking submissions, given that he is neither a researcher nor a urologist, he did what any self-respecting Seinfeld fan would do: He submitted a bogus article dripping with Seinfeldian references. The paper, “authored” by three characters from the TV show, was a case report about a made-up urinary condition called “uromycitisis,” also familiar to watchers of the hit sitcom. Amazingly, less than an hour after submitting the manuscript, McCool received word that his article had been accepted . The journal then demanded $799 (plus tax) to publish the paper. McCool ignored the request; the paper has since been pulled . Instead, he wrote about the sting for The Scientist . 8 “Definitely embarrassing.” That’s how Nobel winner Jack Szostak of Harvard University described the retraction in December of his 2016 article in Nature Chemistry . The authors asked for the retraction after a researcher in Szostak’s lab could not reproduce the findings, which the group attributes to honest error. Szostak wasn’t the only Nobelist to lose a paper this year. In October, Science retracted a 2014 paper by Bruce Beutler , winner of the 2011 Nobel Prize in Physiology or Medicine, also for failure to reproduce the results. 9 May was a bad month for Rony Seger . The molecular biologist at The Weizmann Institute of Science in Israel lost nine papers on a single day , all of them in the Journal of Biological Chemistry . The reason: image manipulation. Seger, who has 11 retractions in all, is under investigation by his institution, which also barred him from mentoring graduate students . 10 “Boom, Headshot!” A controversial 2012 paper about violent video games was retracted over concerns about irregularities in the data. The article, by a group at the Ohio State University, purported to show that people who played first-person shooter games became better shots themselves. But in 2015, a pair of psychologists began raising questions about the data. The journal, Communication Research, decided to retract the article after the study authors could not produce their original data . One of the co-authors was stripped of her PhD by Ohio State.
弄虚作假的后果 如何 请看来自《撤稿瞭望》 的相关报道： Tracking retractions as a window into the scientific process Weekend reads: Fired for fake peer review; world’s most prolific fraudster; peer reviewers behaving badly? with one comment The week at Retraction Watch featured a post on just how much an authorship costs if you want to buy one , anger over charges to use a common research tool , and the revocation of a PhD from a once-rising star scientist. Here’s what was happening elsewhere: The author of one of the 107 studies pulled by Tumor Biology for fabricated peer review is fired by his university . (Yan Jie, Sixth Tone) The scale of Yoshitaka Fuiji’s scientific fraud is unmatched. Hannah Devlin speaks with those who brought the scandal to light . (The Guardian) In 2015, our co-founders explained how he was caught . (Nautilus) How often do peer reviewers misuse the manuscripts they’re reviewing? A survey from the staff of the Annals of Internal Medicine tried to figure that out . (Peer Review Congress) In the past five years, almost 100 Canadian scientists have been caught committing scientific misconduct . On top of that, a survey finds half of Quebec universities do not want to say anything about misconduct in their institutions . (Marie-Claude Malboeuf, La Presse, in French) The University of Tokyo has published an English language version of its report about the investigation into the work of Yoshinori Watanabe . Background here . “Is open peer review just a passing fad (like in 1832)?” asks Phil Hurst . (Phys.org) “We appreciate the vigilance of Allison and Thomas and thank them for helping us correct the public record .” (Clinical Obesity) Following revelations about undisclosed conflicts of interest for two of its contributors, and a retraction , STAT has revised its submission policies . “We have the technology to save peer review,” say Jon Tennant, Daniel Graziotin and Sarah Kearns. “ Now it is up to our communities to implement it .” (LSE Impact Blog) Results-free peer review: Has its time come ? (BMC Series blog) Learn to be a reviewer: A journal and a scientific society are partnering on a mentorship scheme . (Chris Grieves, Methods.blog) What does “ publishing in parallel ” mean? Andrew Dunn, Alice Power and Michaela Muehlberg explain. (The Royal Society Publishing Blog) How often do studies in biomedicine spin their results ? (PLOS Biology) The Committee on Publication Ethics (COPE) has published “ ethical guidelines for peer reviewers .” Peer reviews will soon be able to earn DOIs, making them citable and discoverable . (Ginny Hendricks, Jennifer Lin, CrossRef blog) “’Dodgy’ articles in academic journals threatens integrity of South African science ,” writes Tony Carnie. (News24) “ Should Research Funding Be Distributed Equally Among Scientists? ” asks Neuroskeptic, riffing on a recent paper. (Discover) “Women scientists lag in academic publishing, and it matters ,” writes Nox Makunga. (The Conversation) “So how’s it going out there in the land of the journals that will publish any flippin’ thing you send them?” Derek Lowe takes a look at the “ ugly state of the literature these days .” (In The Pipeline) Counteracting misinformation requires a multipronged approach, including innovative initiatives like Retraction Watch , suggests a meta-analysis from the Annenberg Public Policy Center. ( Psychological Science ) The vice chancellor of Australian Catholic University “ has written to his staff telling them misconduct claims are being taken seriously ” following media reports suggesting otherwise. (Rick Morton, The Australian) “She Was a Rising Star at a Major University. Then a Lecherous Professor Made Her Life Hell .” Madison Pauly looks into a troubling case at the University of Rochester. (Mother Jones) Scientists currently have next to no incentive, financial or otherwise, to replicate the work of others. How do we fix that ? (Michael Schulson, Undark) “I have had more than a few irate messages along the lines of ‘Do you expect me to just give my data away so that anyone can use it?’ The answer is ‘yes’. ” (Peter Brewer, Editors’ Vox) The Journal of Stem Cells, about which blogger Neuroskeptic earlier raised serious ethical and scientific concerns, has been removed from MEDLINE . (Discover) It turns out even predatory publishers are celebrating peer review week, as our co-founder Ivan Oransky discovered when one sent him an email . (Twitter) Eight months after Jeffrey Beall removed his list of predatory publishers, the reasons why remain unknown — and everything from a Swiss publisher to Beall himself remain prime suspects behind why he suddenly gave it up . (Paul Basken, The Chronicle of Higher Education, sub req’d) F1000Research investigated whether their model of publishing peer reviews once they’re received was influencing the thoughts of later reviewers on the same paper . (Tiago Barros, F1000Research blog) For clinical studies, the idea of a preprint server receives a mixed response, with some worried it might do harm to patients . (Martin Enserink, Science) “ sking hard questions about a clinical trial and a scientific paper should not result in a threatening letter from a lawyer .” (Larry Husten, CardioBrief) When interim results are published in a journal, the journal should give them a warning label , say researchers. (Retraction Watch co-founder Ivan Oransky, MedPage Today) Journals come far too late in the process to curb research waste. It’s up to funders and regulators to blaze the trail in implementing techniques to reduce waste , say Paul Glasziou and Iain Chalmers. (The BMJ Opinion) “Consequently, reproducibility and robustness are under-emphasized when job applicants are evaluated and when faculty members are promoted.” (Jeffrey Flier, Nature ) One poet has made it his mission to track down plagiarism in poetry. His latest case involves a former Canadian poet laureate . (Will Storr, The Guardian) “Why, after 20 years of effort, have green and gold open access not achieved more? ” (Toby Green, Learned Publishing) In India, the University Grants Commission hopes to punish plagiarists, but it may be undermined by a lack of systems to check for plagiarism . (Priyata Brajabasi, Catch News) “But enjoying research is not about trying to hit a six on every ball or publishing in Nature or Science all the time,” writes Raghu Murtugudde. “It is about seeing yourself make progress on a problem you have set out to work on .” (Huffington Post)
《肿瘤生物学》（Tumor Biol.）撤稿107篇目录 Tracking retractions as a window into the scientific process When a journal retracts 107 papers for fake reviews, it pays a price with 7 comments A company that indexes journals — thereby assigning them impact factors — has chosen to delist a cancer journal after it retracted 107 papers earlier this year for faked peer reviews . Starting July 19, anything published by Tumor Biology will not be indexed in Web of Science, part of Clarivate Analytics (formerly part of Thomson Reuters). Clarivate told us the decision was based on the fake reviews that took down more than 100 papers earlier this year. The problematic papers were released while the journal was published by Springer, not its current publisher, SAGE. Without being indexed by Web of Science, Tumor Biology will lack an impact factor — which can be the kiss of death for many journals, since researchers (and institutions) often count on such metrics when applying for grants and promotions , so many will not submit work to a journal without one. Here’s the statement from a Clarivate spokesperson : Read the rest of this entry » 将《肿瘤生物学》（Tumor Biol.）撤稿的107篇论文目录摘引 如下，仅供参考。 Zhang, J., Xu, F. Ouyang, C. (2012) Joint effect of polymorphism in the N-acetyltransferase 2 gene and smoking on hepatocellular carcinoma Tumor Biol. 33:1059-1063, doi 10.1007/s13277-012-0340-4 Chen, X., Liang, L., Hu, X. et al. (2012) Glutathione S-transferase P1 gene Ile105Val polymorphism might be associated with lung cancer risk in the Chinese population Tumor Biol. 33:1973-1981, doi 10.1007/s13277-012-0457-5 Zhang, Y. Liu, C. (2013) The Interaction between Smoking and GSTM1 variant on lung cancer in the Chinese Population Tumor Biol. 34:395-401, doi 10.1007/s13277-012-0562-5 Li, CY., Yuan, P., Lin, SS. et al. (2013) Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis Tumor Biol. 34:735-741. doi 10.1007/s13277-012-0601-2 Zhang, RC. Mou, SH. (2013) Polymorphisms of excision repair gene XPD Lys751Gln and hOGG1 Ser326Cys might not be associated with hepatocellular carcinoma risk: A meta-analysis Tumor Biol. 34:901-907, doi 10.1007/s13277-012-0625-7 Dong, Y., Zhuang, L. Ma, W. (2013) Comprehensive assessment of the association of ERCC2 Lys751Gln polymorphism with susceptibility to cutaneous melanoma Tumor Biol. 34:1155-1160, doi 10.1007/s13277-013-0657-7 Wang, J., Xu, Y., Fu, Q. et al. (2013) Association of GSTT1 Gene Polymorphisms with the Risk of Prostate Cancer: An Updating Meta-analysis Tumor Biol. 34:1431-1440, doi 10.1007/s13277-012-0640-8 Huang, Y., Liu, X., Kuang, X. et al. (2013) CYP2D6 T188C variant is associated with lung cancer risk in the Chinese population Tumor Biol. 34:2189-2193, doi 10.1007/s13277-013-0755-6 Liu, C. Wang, H. (2013) XRCC3 T241M polymorphism is associated risk of hepatocellular carcinoma in the Chinese Tumor Biol. 34:2249-2254, doi 10.1007/s13277-013-0765-4 Li, F., Liu, Y., Fu, T. et al. (2013) Associations of three common polymorphisms in CD95 and CD95L promoter regions with gastric cancer risk Tumor Biol. 34:2293-2289, doi 10.1007/s13277-013-0773-4 Li, W., Wu, H. Song, C. (2013) TGF-?1 -509C/T (or +869T/C) polymorphism might be not associated with hepatocellular carcinoma risk Tumor Biol. 34:2675-2681, doi 10.1007/s13277-013-0818-8 He, J. Xu, G. (2013) LEP gene variant is associated with prostate cancer but not with colorectal cancer Tumor Biol. 34:3131-3136, doi 10.1007/s13277-013-0881-1 Wu, D., Jiang, H., Gu, Q. et al. (2013) Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population Tumor Biol. 34:3265-3269, doi 10.1007/s13277-013-0899-4 Yin, Y., Feng, L. Sun, J. (2013) Association between Glutathione S-transferase M 1 null genotype and risk of ovarian cancer: a meta-analysis Tumor Biol. 34:4059-4063, doi 10.1007/s13277-013-0995-5 Xu, JQ., Liu, P., Si, MJ. et al. (2013) MicroRNA-126 inhibits osteosarcoma cells proliferation by targeting Sirt1 Tumor Biol. 34:3871-3877, doi 10.1007/s13277-013-0974-x Chen, H., Tang, C., Liu, M. et al. (2014) Association of XRCC1 gene single nucleotide polymorphisms and susceptibility to pancreatic cancer in Chinese Tumor Biol. 35:27-32, doi 10.1007/s13277-013-1001-y Tian, X., Ma, P., Sui, C. et al. (2014) Comprehensive assessment of the association between tumor necrosis factor-alpha G238A polymorphism and liver cancer risk Tumor Biol. 35:103-109, doi 10.1007/s13277-013-1012-8 Li, ZC., Zhang, LM., Wang, HB. et al. (2014) Curcumin inhibits lung cancer progression and metastasis through induction of FOXO1 Tumor Biol. 35:111-116, doi 10.1007/s13277-013-1013-7 Jin, B., Dong, P., Li, K. et al. (2014) Meta-analysis of the association between GSTT1 null genotype and risk of nasopharyngeal carcinoma in Chinese Tumor Biol. 35:345-349, doi 10.1007/s13277-013-1047-x Sun, HL., Han, B., Zhai, HP. et al. (2014) Association between Glutathione S-transferase M1 null genotype and risk of gallbladder cancer: a meta-analysis Tumor Biol. 35:501-505, doi 10.1007/s13277-013-1070-y Xu, W., Wang, F., Ying, L. et al. (2014) Association between Glutathione S-transferase M1 null variant and risk of bladder cancer in Chinese Han population Tumor Biol. 35:773-777, doi 10.1007/s13277-013-1105-4 Luo, S., Guo, L., Li, Y. et al. (2014) Vitamin D receptor gene ApaI polymorphism and breast cancer susceptibility: a meta-analysis Tumor Biol. 35:785-790, doi 10.1007/s13277-013-1107-2 Chen, H., Zhou, B., Lan, X. et al. (2014) Association between single nucleotide polymorphisms of OGG1 gene and pancreatic cancer risk in Chinese Han population Tumor Biol. 35:809-813, doi 10.1007/s13277-013-1111-6 Lv, S., Turlova, E., Zhao, S. et al. (2014) Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis Tumor Biol. 35:1565-1574, doi 10.1007/s13277-013-1216-y Liu, C., Yin, L., Chen, J. et al. (2014) The apoptotic effect of shikonin on human papillary thyroid carcinoma cells?through mitochondrial pathway Tumor Biol. 35:1791-1798, doi 10.1007/s13277-013-1238-5 Shen, L., Chen, XD. Zhang, YH. (2014) MicroRNA-128 promotes Proliferation in Osteosarcoma Cells by Down-Regulating PTEN Tumor Biol. 35:2069-2074, doi 10.1007/s13277-013-1274-1 Ma, Z., Guo, W., Gong, T. et al. (2014) CYP1A2 rs762551 polymorphism contributes to risk of lung cancer: a meta-analysis Tumor Biol. 35:2253-2257, doi 10.1007/s13277-013-1298-6 Geng, S., Wang, X., Xu, X. et al. (2014) Steroid receptor coactivator-3 promotes osteosarcoma progression through up-regulation of FoxM1 Tumor Biol. 35:3087-3094, doi 10.1007/s13277-013-1406-7 Cheng, C., Chen, ZQ. Shi, XT. (2014) MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase Tumor Biol. 35:4177-4183, doi 10.1007/s13277-013-1546-9 He, G., Chen, G., Chen, W. et al. (2014) Lack of association of XRCC1 rs1799782 genetic polymorphism with risk of pancreatic cancer: A meta-analysis Tumor Biol. 35:4545-4550, doi 10.1007/s13277-013-1598-x Han, M., Lv, S., Zhang, Y. et al. (2014) The prognosis and clinicopathology of CXCR4 in gastric cancer patients: a meta-analysis Tumor Biol. 35:4589-4597, doi 10.1007/s13277-013-1603-4 Han, S., Cai, Z., Peng, L. et al. (2014) Ployamidoamine dendrimer loposome mediated survivin antisense oligonucleotide inhibits hepatic cancer cell proliferation by inducing apoptosis Tumor Biol. 35:5013-5019, doi 10.1007/s13277-014-1661-2 Wang, L., Chen, Z., Wang, Y. et al. (2014) The association of c.1471GA genetic polymorphism in XRCC1 gene with lung cancer susceptibility in Chinese Han population Tumor Biol. 35:5389-5393, doi 10.1007/s13277-014-1702-x Yao, C., Lv, S., Han, M. et al. (2014) The association of Crk-like adapter protein with poor prognosis in glioma patients Tumor Biol. 35:5695-5700, doi 10.1007/s13277-014-1754-y Pei, J., Lou, Y., Zhong, R. et al. (2014) MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in none small cell lung cancer Tumor Biol. 35:6673-6678, doi 10.1007/s13277-014-1850-z Chen, J., Huang, Q. Wang, F. (2014) Inhibition of FoxO1 nuclear exclusion prevents metastasis of glioblastoma Tumor Biol. 35:7195-7200, doi 10.1007/s13277-014-1913-1 Liu, L., Zou, J., Wang, Q. et al. (2014) Novel microRNAs expression of patients with drug resistant and sensitive chemotherapy of Epithelial Ovarian Cancer and preliminary analysis Tumor Biol. 35:7713-7717, doi 10.1007/s13277-014-1970-5 Huang, J., Sun, C., Zhang, T. et al. (2014) Potent antitumor activity of HSP90 inhibitor AUY922 in adrenocortical carcinoma Tumor Biol. 35:8193-8199, doi 10.1007/s13277-014-2063-1 Mao, D., Zhang, Y., Lu, H. et al. (2014) Molecular basis underlying inhibition of metastasis of gastric cancer by anti-VEGFa treatment Tumor Biol. 35:8217-8223, doi 10.1007/s13277-014-2095-6 Lu, H., Li, H., Mao, D. et al. (2014) Nrdp1 inhibits growth of colorectal cancer cells by nuclear retention of p27 Tumor Biol. 35:8639-8643, doi 10.1007/s13277-014-2132-5 Wang, F., Xiao, W., Sun, J. et al. (2014) MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma Tumor Biol. 35:8653-8658, doi 10.1007/s13277-014-2131-6 Cen, G., Ding, HH., Liu, B. et al. (2014) FBXL5 targets Cortactin for ubiquitination-mediated destruction to regulate gastric cancer cell migration Tumor Biol. 35:8633-8638, doi 10.1007/s13277-014-2104-9 Wang, X. Cao, X. (2014) Regulation of metastasis of pediatric multiple myeloma by MMP13 Tumor Biol. 35:8715-8720, doi 10.1007/s13277-014-2147-y Zhou, X. Qi, Y. (2014) PLGF inhibition impairs metastasis of larynx carcinoma through MMP3 downregulation Tumor Biol. 35:9381-9386, doi 10.1007/s13277-014-2232-2 Xu, JQ., Zhang, WB., Wan, R. et al. (2014) MicroRNA-32 inhibits osteosarcoma cells proliferation and invasion by targeting Sox9 Tumor Biol. 35:9847-9853, doi 10.1007/s13277-014-2229-x Ding, H., Zhu, Y., Chu, T. et al. (2014) Epidermal growth factor induces FoxO1 nuclear exclusion to activates MMP7-medidated metastasis of larynx carcinoma Tumor Biol. 35: 9987-9992, doi 10.1007/s13277-014-2067-x Li, X., Zhang, G., Huai, YJ. et al. (2014) Association between APE1 T1349G polymorphism and prostate cancer risk: Evidence from a meta-analysis Tumor Biol. 35:10111-10119, doi 10.1007/s13277-014-2115-6 Yang, YQ., Qi, J., Xu, JQ. et al. (2014) MicroRNA-142-3p, a novel target of tumor suppressor Menin, inhibits osteosarcoma cell proliferation by down-regulation of FASN Tumor Biol. 35:10287-10293, doi 10.1007/s13277-014-2316-z Ye, Y., Zhou, X., Li, X. et al. (2014) Inhibition of epidermal growth factor receptor signaling prohibits metastasis of gastric cancer via downregulation of MMP7 and MMP13 Tumor Biol. 35:10891-10896, doi 10.1007/s13277-014-2383-1 Wang, J., Su, H., Han, X. et al. (2014) Inhibition of fibroblast growth factor receptor signaling impairs metastasis of hepatocellular carcinoma Tumor Biol. 35:11005-11011, doi 10.1007/s13277-014-2384-0 Duan, JH. Fang, L. (2014) MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR Tumor Biol. 35:11013-11019, doi 10.1007/s13277-014-2342-x Li, XD., Zhang, YJ. Han, JC. (2014) Betulin inhibits lung carcinoma proliferation through activation of AMPK signaling Tumor Biol. 35:11153-11158, doi 10.1007/s13277-014-2426-7 Piao, YR., Jin, ZH., Yuan, KC. et al. (2014) Analysis of Tim 3 expression in prostate cancer Tumor Biol. 35:11409-11414, doi 10.1007/s13277-014-2464-1 Liu, S., Gong, Z., Chen, M. et al. (2014) Lgr5-positive cells are cancer stem cells in skin squamous cell carcinoma Tumor Biol. 35:11605-11612, doi 10.1007/s13277-014-2488-6 Xu, WJ., Guo, BL., Han, YG. et al. (2014) Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels Tumor Biol. 35:12069-12074, doi 10.1007/s13277-014-2506-8 Su, ZX., Zhao, J., Rong, ZH. et al. (2014) Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer Tumor Biol. 35:12119-12125, doi 10.1007/s13277-014-2516-6 Li, K., Zhong, C., Wang, J. et al. (2014) Association of androgen receptor Exon 1 CAG repeat length with risk of hepatocellular carcinoma: a case-control study Tumor Biol. 35:12519-12523,doi 10.1007/s13277-014-2570-0 Luo, K., Shi, Y. Peng, J. (2014) The effect of Chemokine CC Motif Ligand 19 on the proliferation and migration of Hepatocellular Carcinoma Tumor Biol. 35:12575-12581, doi 10.1007/s13277-014-2578-5 Zhang, G., Zhao, Q., Yu, S. et al. (2015) Pttg1 inhibits TGF? signaling in breast cancer cells to promote their growth Tumor Biol. 36:199-203, doi 10.1007/s13277-014-2609-2 Peng, C., Zhou, K., An, S. et al. (2015) The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer Tumor Biol. 36:329-335, doi 10.1007/s13277-014-2642-1 Han, G., Xie, S., Fang, H. et al. (2015) The AIB1 gene polyglutamine repeat length polymorphism contributes to risk of Epithelial Ovarian Cancer Risk: a case-control study Tumor Biol. 36:371-374, doi 10.1007/s13277-014-2661-y Lu, J., Yin, X. Jiang, J. (2015) Sports-induced blood sugar utilization prevents development of pancreatic ductal adenocarcinoma Tumor Biol. 36:663-667, doi 10.1007/s13277-014-2684-4 Jiang, Y., Sun, S., Liu, G. et al. (2015) Nrdp1 inhibits metastasis of colorectal cancer cells by EGFR-signaling-dependent MMP7 modulation Tumor Biol. 36:1129-1133, doi 10.1007/s13277-014-2726-y Zhang, Z., Yan, Z., Yuan, Z. et al. (2015) SPHK1 inhibitor suppresses cell proliferation and invasion associated with the inhibition of NF-?B Pathway in hepatocellular carcinoma Tumor Biol. 36:1503-1509, doi 10.1007/s13277-014-2665-7 Huang, J., Jia, J., Tong, Q. et al. (2015) Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize Metastatic Castration-Resistant Prostate Cancer Cells to Cabazitaxel Chemotherapy Tumor Biol. 36:1589-1594, doi 10.1007/s13277-014-2748-5 Lin, ZY., Song, QQ., Chen, J. et al. (2015) Local curative effect of MRI-guided radiofrequency ablation on small hepatocellular carcinoma Tumor Biol. 36:2105-2110, doi 10.1007/s13277-014-2819-7 Li, C., Zhao, Z., Zhou, Z. et al. (2015) Augmented TGF? receptor signaling induces apoptosis of pancreatic carcinoma cells Tumor Biol. 36:2815-2819, doi 10.1007/s13277-014-2908-7 Liao, A., Wang, W., Sun, D. et al. (2015) Bone morphogenetic protein 2 mediates epithelial-mesenchymal transition via AKT and ERK signaling pathways in gastric cancer Tumor Biol. 36:2773-2778, doi 10.1007/s13277-014-2901-1 Liu, M., Zhang, K., Zhao, Y. et al. (2015) Evidence for involvement of steroid receptors and coactivators in neuroepithelial and meningothelial tumors Tumor Biol. 36:3251-3261, doi 10.1007/s13277-014-2954-1 Xu, Y., Lu, Y., Song, J. et al. (2015) Cancer-associated fibroblasts promote renal cell carcinoma progression Tumor Biol. 36:3483-3488, doi 10.1007/s13277-014-2984-8 Guo, Z., Liu, D. Su, Z. (2015) CIP2A mediates prostate cancer progression via the c-MYC signaling pathway Tumor Biol. 36:3583-3589, doi 10.1007/s13277-014-2995-5 Li, S., Lei, X., Zhang, J. et al. (2015) Insulin-like growth factor 1 promotes growth of gastric cancer by inhibiting foxo1 nuclear retention Tumor Biol. 36:4519-4523, doi 10.1007/s13277-015-3096-9 Guo, Z., Liu, D. Su, Z. (2015) CIP2A mediates prostate cancer progression via the c-MYC signaling pathway Tumor Biol. 36:4777-4783, doi 10.1007/s13277-015-3129-4 Chen, Y., Tian, Y., Ji, Z. et al. (2015) CC-chemokine receptor 7 is Overexpressed and Correlates with Gowth and Metastasis in Prostate Cancer Tumor Biol. 36:5537-5541, doi 10.1007/s13277-015-3222-8 Liu, H., Li, W., Chen, C. et al. (2015) MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma Tumor Biol. 36:6613-6319, doi 10.1007/s13277-015-3317-2 Chen, B., Hou, Z., Li, C. et al. (2015) MiRNA-494 inhibits metastasis of cervical cancer through Pttg1 Tumor Biol. 36:7143-7149, doi 10.1007/s13277-015-3440-0 Li, R., Shi, X., Ling, F. et al. (2015) MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL Tumor Biol. 36:7277-7283, doi 10.1007/s13277-015-3445-8 Zhang, Y., Li, A., Peng, W. et al. (2015) Efficient inhibition of growth of metastatic cancer cells after resection of primary colorectal cancer by soluble Flt-1 Tumor Biol. 36:7399-7407, doi 10.1007/s13277-015-3434-y Jiang, Y., Meng, Q., Qi, J. et al. (2015) MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition Tumor Biol. 36:7641-7647, doi 10.1007/s13277-015-3489-9 Zhao, Z., Xi, H., Xu, D. et al. (2015) Transforming growth factor ? receptor signaling restrains growth of pancreatic carcinoma cells Tumor Biol. 36:7711-7716, doi 10.1007/s13277-015-3466-3 Guo, H., Xu, Y. Fu, Q. (2015) Curcumin inhibits growth of Prostate carcinoma via miR-208-mediated CDKN1A activation Tumor Biol. 36:8511-8517, doi 10.1007/s13277-015-3592-y Liu, G., Zhu, Z., Lang, F. et al. (2015) Clinical significance of CUL4A in human prostate cancer Tumor Biol. 36:8553-8558, doi 10.1007/s13277-015-3580-2 Zhao, J., Kong, Z., Xu, F. et al. (2015) A role of MMP-14 in the regulation of invasiveness of nasopharyngeal carcinoma Tumor Biol. 36:8609-8615, doi 10.1007/s13277-015-3558-0 Chen, L., Xu, L. Wang, G. (2015) Regulation of Met-mediated proliferation of thyroid carcinoma cells by miR-449b Tumor Biol. 36:8653-8660, doi 10.1007/s13277-015-3619-4 Du, Y., Wang, Y., Zhang, F. et al. (2015) Regulation of metastasis of bladder cancer cells through WNT signaling pathway Tumor Biol. 36:8839-8844, doi 10.1007/s13277-015-3563-3 Zhang, XT., Zhang, Z., Xin, YN. et al. (2015) Impairment of growth of gastric carcinoma by miR-133-mediated Her-2 inhibition Tumor Biol. 36:8925-8930, doi 10.1007/s13277-015-3637-2 Gong, C., Zhang, Y., Chen, Y. et al. (2015) High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC) Tumor Biol. 36:9189-9199, doi 10.1007/s13277-015-3625-6 Date: 16th June 2017As an update to the retraction note, further investigation has revealed that the compromised peer review process was through no fault of the authors. Ma, X., Li, X., Lu, X. et al. (2015) Interaction between TNFR1 and TNFR2 dominates the clinicopathologic features of human hypopharyneal carcinoma Tumor Biol. 36:9421-9429, doi 10.1007/s13277-015-3684-8 Fang, C., Shen, Y., Qi, P. et al. (2015) Astrocyte elevated gene-1 mediates insulin-like growth factor 1-induced the progression of cardiac myxoma Tumor Biol. 36:9769-9777, doi 10.1007/s13277-015-3739-x Song, JG., Xie, HH., Li, N. et al. (2015) SUMO-specific protease 6 promotes gastric cancer cells growth via de-SUMOylation of FoxM1 Tumor Biol. 36:9865-9871, doi 10.1007/s13277-015-3737-z Sun, E., Zhang, W., Wang, L. et al. (2016) Down-regulation of Sphk2 Suppresses Bladder Cancer Progression Tumor Biol. 37:473-478, doi 10.1007/s13277-015-3818-z Wang, H., Yang, M., Xu, J. et al. (2016) Survivin mRNA-circulating tumor cells are associated with tumor metastasis in prostate cancer Tumor Biol. 37:723-727, doi 10.1007/s13277-015-3812-5 Yan, J., Zhang, Y., Shi, W. et al. (2016) The critical role of HMGA2 in regulation of EMT in epithelial ovarian carcinomas Tumor Biol. 37:823-828, doi 10.1007/s13277-015-3852-x Niu, H., Zhang, X., Wang, B. et al. (2016) The clinical utility of image-guided iodine-125 seed in patients with unresectable pancreatic cancer Tumor Biol. 37:2219-2223, doi 10.1007/s13277-015-4045-3 Xu, G., Qi, F., Zhang, J. et al. (2016) Overexpression of OCT4 contributes to progression of hepatocellular carcinoma Tumor Biol. 37:4649-4654, doi 10.1007/s13277-015-4285-2 Fan, JY., Yang, Y., Xie, JY. et al. (2016) MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1 Tumor Biol. 37:6855-6860, doi 10.1007/s13277-015-4558-9 Pan, J., Lu, F., Xu, H. et al. (2016) Low p21 level is necessary for the suppressive effects of micoRNA-31 on glioma cell migration and invasion Tumor Biol. 37:9663-9670, doi 10.1007/s13277-016-4788-5 Li, J., Song, Z., Wang, Y. et al. (2016) Overexpression of SphK1 enhances cell proliferation and invasion in triple-negative breast cancer via the PI3K/AKT signaling pathway Tumor Biol. 37:10587-10593, doi 10.1007/s13277-016-4954-9 Li, Y., Dong, M., Kong, F. et al. (2015) Octamer transcription factor 1 mediates epithelial-mesenchymal transition in colorectal cancer Tumor Biol. 36:9941-9946, doi 10.1007/s13277-015-3766-7 Li, S., Gao, Y., Ma, W. et al. (2016) Ginsenoside Rh2 inhibits invasiveness of glioblastoma through modulation of VEGF-A Tumor Biol. 37:15477-15482, doi 10.1007/s13277-015-3759-6 Shi, Y., Tan, Y., Zeng, D. et al. (2016) MiR-203 suppression in gastric carcinoma promotes Slug-mediated cancer metastasis Tumor Biol. 37:15483-15488, doi 10.1007/s13277-015-3765-8 Sun, J., Ding, W., Zhi, J. et al. (2016) MiR-200 suppresses metastases of colorectal cancer through ZEB1 Tumor Biol. 37:15501-15507, doi 10.1007/s13277-015-3822-3 Gao, F., Wang, T., Zhang, Z. et al. (2016) Regulation of activating protein-4-associated metastases of non-small cell lung cancer cells by miR-144 Tumor Biol. 37:15535-15541, doi 10.1007/s13277-015-3866-4 Peng, Z., Xu, T., Liao, X. et al. (2016) Effects of radiotherapy on nasopharyngeal carcinoma cell invasiveness Tumor Biol. 37:15559-15566, doi 10.1007/s13277-015-3960-7 Liu, W., An, J., Li, K. et al. (2016) MiR-429 regulates gastric cancer cell invasiveness through ZEB proteins Tumor Biol. 37:15575-15581, doi 10.1007/s13277-015-4094-7 Zhang, Z., Zhou, Q., Miao, Y. et al. (2016) MiR-429 induces apoptosis of glioblastoma cell through Bcl-2 Tumor Biol. 37:15607-15613, doi 10.1007/s13277-015-4291-4 Zhang, Z., Song, X., Feng, X. et al. (2016) Norcantharidin modulates miR-655-regulated SENP6 protein translation to suppresses invasion of glioblastoma cells Tumor Biol. 37:15635-15641, doi 10.1007/s13277-015-4447-2
NgAgo 终于还是撤稿了，终于该告一个段落了。注意，是主动撤稿，不是“被撤”！春雨君从一鸣惊人，到千夫所指，如今终于低头撤退，好一个跌宕起伏的一年。既然本博主围绕此事没少讲过话，在此也补几句。 1 、即便春雨君失败了，但他做学问的态度本人是一直认可。更准确说，是那种学术品位，瞄准有价值的专题和研究方向，做与别人不一样的工作。这种科学品位，是做好学术工作必须要有的。 2 、从此前春雨君的发表记录来看，他做学问能沉下心来，并不追求快速的发表和发表的数量，这一点也是应该肯定的。 3 、撤稿信的结尾处亮了。通篇没有亲口承认这个研究有错，只是说因别人不能重复，所以撤稿。最后却话风一转，今后可能会提交一个优化的实验方案。这是什么状况啊？ 4、更有意思的是，韩春雨团队在撤稿同时发布声明，他们找到了其他实验室不能重复的原因，而且认为： NgAgo可以实现基因编辑！！！ 并准备展开第三方验证。河北科技大学发布声明，将对韩组研究开展调查（实际上是配合验证）。什么情况？什么情况？ 5、是否可以认为：韩组找到了别人不能重复的关键，也发现原文在实验细节上缺失了关键环节，所以在撤稿同时，开始进入战略反攻？是不是？ 无论怎么说，稿子撤了，一切回到原点。但事情还似乎没完。因为没看出春雨君彻彻底底的服输。最终的最终，如果真错了，那也就是错了，科学虽然为了真理，但科学家是会犯错误的，我们该同情和宽容认真的犯错。 BTW: 需注意，韩组给出的撤稿理由是“维护科学记录的‘完整性（ integrity ）’”，这个词也用的非常好， integrity 有两个意思，“完整性”和“诚信”。那么也可以解读为两个兼而有之的信息；其一，文章因为缺少了此前没有注意到的关键信息，内容不完整，所以需要撤回补正；其二，既然文章因关键信息的缺少而被普遍质疑，为了保护 诚信的声誉，所以撤回不完整的文章。 Retraction:DNA-guided genome editing using the Natronobacterium gregoryi Argonaute Feng Gao, Xiao Z Shen, Feng Jiang, Yongqiang Wu Chunyu Han Nat. Biotechnol . 34 ,768 –773 (2016); published online 2 May 2016; addendum published afterprint 28 November 2016; retracted 2 August 2017; doi:10.1038/nbt.3547 We are retractingour study because of the continued inability of the research community toreplicate the key results in Figure 4, using the protocols provided in ourpaper. In this figure we report that the Natronobacterium gregoryi Argonaute can efficiently createdouble-strand breaks and edit the genome of human cells using 5 ʹ phosphorylated single-stranded DNA as a guide. Despite theefforts of many laboratories ( Protein Cell 7 ,913 –915, 2016; Nat. Biotechnol . 35 ,17–18, 2017; Cell Res . 26 ,1349–1352, 2016; PLOS One 12 ,e0177444, 2017), an independent replication of these results has not beenreported. We are therefore retracting our initial report at this time tomaintain the integrity of the scientific record. We nevertheless continue toinvestigate the reasons for this lack of reproducibility with the aim ofproviding an optimized protocol. 撤稿声明链接： http://www.nature.com/nbt/journal/v34/n7/full/nbt.3547.html 中文翻译版本： 撤稿：利用NgAgo进行DNA引导的基因组编辑 高峰，沈啸，姜峰，武永强和韩春雨 Nat. Biotechnol . 34 , 768-773 (2016); 2016 年5月2日在线发表，论文进入印刷版后2016年11月28日在线发表补编；2017年8月2日撤稿；doi:10.1038/nbt.3547 由于科研界一直无法根据我们论文提供的实验方案重复出论文图4所示的关键结果，我们决定撤回这项研究。在该图中，我们报告说，利用5′磷酸化单链DNA作为引导，NgAgo（ Natronobacteriumgregoryi Argonaute）能够有效引起双链断裂，并对人体细胞基因组进行编辑。虽然许多实验室都进行了努力（ ProteinCell 7 ,913-915, 2016; Nat. Biotechnol . 35 ,17-18, 2017; Cell Res .26,1349-1352, 2016; PLOS One 12 ,e0177444, 2017) ，但是没有独立重复出这些结果的报告。因此，我们现在撤回我们的最初报告，以维护科学记录的完整性。不过，我们会继续调查该研究缺乏可重复性的原因，以提供一个优化的实验方案。 河北科技大学官网发布声明： http://news.hebust.edu.cn/zhxw/85838.htm 8月3日，韩春雨团队发布了声明。 声明表示，为确保科学研究的严谨性，韩春雨及其论文共同作者决定主动将2016年5月2日在国际期刊《自然·生物技术》（Nature Biotechnology）杂志上发表的论文撤回，同时将进一步研究不能重复的原因。 声明表示，韩春雨团队同意按学校安排选择一家第三方实验室，在同行专家支持下开展实验，验证NgAgo-gDNA基因编辑的有效性，并将实验结果公布，以回应社会关切。 鉴于该论文已撤稿，学校决定启动对韩春雨该项研究成果的学术评议及相关程序。 ***韩春雨研究团队声明: http://sgxy.web.hebust.edu.cn/xwdt/85837.htm 自2016年5月2日国际期刊《自然·生物技术》（Nature Biotechnology）发表《NgAgo-gDNA为导向的基因编辑技术》论文以来，多家实验室发表论文提出，采用该论文中提供的实验方法与流程（protocol），不能重复其关键结果（Figure4），且至今尚无第二篇表明NgAgo-gDNA可以有效进行基因编辑的论文发表，韩春雨及其论文共同作者决定主动将该论文撤回，同时，将进一步研究不能重复其关键结果的原因，以期提供更详实有效的实验方法与流程。关键实验条件标准化后的实验方法与流程将会尽快发布。 韩春雨团队一直在进行深入的实验研究工作。在近期的实验中已经发现，将ssDNA guide 成功导入细胞以结合NgAgo是NgAgo进行有效基因编辑的关键。在满足一些关键条件的情况下，NgAgo-gDNA系统可以进行有效的基因编辑。 下一步，韩春雨团队将按照学校的安排做好相关工作，选择一家第三方实验室，在同行专家支持下开展实验，验证NgAgo-gDNA基因编辑的有效性，并将实验结果公布，回应社会关切。 对论文发表以来社会各界给予的关切、鼓励和支持，我们表示衷心感谢！对积极关注论文相关工作，并提出学术质疑和批评意见，促进NgAgo-gDNA基因编辑技术不断进步和完善的专家学者，深表敬意！ 特此声明 基因编辑技术研究中心 韩春雨研究团队 致谢：感谢郑保敬、余波等同行在“Mesheless-BEM”及时提供讯息！ NgAgo撤稿1年后，韩春雨团队归于沉寂，看来失败的研究和冒进的发表已成定局。甚感遗憾！ 2018年10月31日。
文章一旦被接收了，是不是就一定会发表呢？不一定！即使文章已经发表了，也有可能会被撤销。 在以下几种情况下，我们会给已经发接收函的文章作者发信说明文章不予发表： 1.稿件接收后，发现作者有一稿多投的情况。一般情况下，在正式发表前，我们会对稿件再作一次Crosscheck检测，一稿多投并且已经发表的文章很容易就被检测出来。 2.稿件接收后，通过crosscheck检测发现文章存在抄袭行为。 检测系统会显示与本文相似度较高的相关文献,一旦与其它文献的相似度达到一定量或者文章抄袭了他人重要的学术思想。 3.给作者发接收函以后，编辑人员会对文章进行细致的编辑，然后会要求作者进一步修改，如果作者拒绝修改或者修改后仍然无法达到发表要求，编辑部会作出撤销稿件接收决定（这种情况相对来说比较少）。 4.稿件接收后，发现作者投稿时的邮箱和最终版稿件的邮箱不一致，并且在投稿时使用的邮箱在网上和数据库中均无法查到。 最近我们发现,有一篇稿件在接收后请作者签定版权转让协议时，通讯作者（导师）来信 （ 我暂且相信这封信是导师写来 的!因为这封信用的是 QQ邮箱，在最后一版的修改稿中通讯作者的邮箱是机构邮箱。投稿系统中通讯作者的邮箱是163邮箱。 ）要求在文章中增加两位作者。该封来信说,第一作者( 学生）只顾论文的学术质量了,没有考虑作者署名的问题,在签版权转让协议时才了解到没有将两位对这篇论文有较大贡献的人员纳入到作者名单之中！ 在JMS的作者指南中有明确的说明:文章一经接受，便不得增减作者或者改变作者顺序。目前这篇文章的问题还不仅是接收后增加两位作者的问题，而是投稿时使用的通讯作者的邮箱（163邮箱）与最后修改稿中的导师的邮箱不一致，投稿中使用的作者的邮箱也与最后一版的稿件中的作者邮箱也不一致。投稿中使用的邮箱很可能是中介机构代为申请的邮箱(据国外的某位编辑人员介绍，很多请中间机构代为操刀的中国作者的文章大多采用126,163,QQ等邮箱)。鉴于出现这样的问题，我们对该篇文章作出撤稿的决定的决定！ Springer在给期刊主编的一封信中Springer近期撤销的58篇稿件的主要原因进行了分析归类，我拷贝在此，与各位分享： Dear Editor-in-Chief, I would like to inform you of a research integrity issue affecting seven Springer Nature journals. We have identified a systematic attempt to manipulate publication processes and our findings are suggestive of attempts to subvert the peer review and publication system to inappropriately obtain or allocate authorship. The reason for this is most likely ‘pressure to publish’. Given our findings we no longer have confidence in the veracity of the contents of these 58 articles and have taken the decision to retract them to maintain the integrity of the scientific record. Our investigations indicate that the attempt to manipulate our processes in the affected journals is confined to this group of articles. The problems we have identified include: o Changes in authorship and author email addresses. Author names changed completely or significantly between original submission and revised submission. In some cases attempts were made to change the names of authors after acceptance. In addition, in some cases, email addresses have been used interchangeably between different authors and peer reviewers in the group. o Unverified reviewers. In a majority of the cases the authors suggested potential reviewers for their manuscript. We have been unable to identify publication records or institutional email addresses for these reviewers in most instances. In some cases where institutional email addresses for the reviewers could be identified, the researcher informed us that he did not review the article. o Overlap in text. Many of the articles contain differing degrees of overlap in text with previously published articles (both by the same author group and other unrelated authors), which constitute significant plagiarism. o Changes of version of articles during peer review. In some cases, revised manuscripts submitted after revisions describe different studies from those described in the manuscripts before peer review. o Data. There are also a number of instances where figures are duplicated across different articles. Some numbers in results tables are also different between versions of the same article without a legitimate explanation. o Non-existent departments. In some cases the specific departments provided as author affiliations on the submitted manuscripts appear to be non-existent and in some cases are changed without a proper explanation supporting the change after the manuscripts have been revised. Please note that some of these issues are more difficult to detect than others. Detection depends on the recognition of patterns. We are seeking aid from the Iranian Ministry of Health to inform the authors’ institutions should they wish to conduct their own investigations. We have taken steps to prevent these authors from continuing to manipulate our publication processes. We would like to ask you to be observant. In the attached guidelines you will find some pointers that might be of help to you. If you have come across anomalies resembling any of the above-mentioned issues please contact me immediately.
Sarah 2016 年 1 月 5 日，华中科技大学某研究团队的论文 “Biomechanical Characteristics of HandCoordination in Grasping Activities of Daily Living” 在开放获取期刊 PLOSONE 上发表。他们通过运动数据统计分析检视手部协调性的特征，并寻找肌腱关联特性与抓取协调性的相关性，最终确定人手结构与协调性之间的机能关系。这篇从设计到结果看似完美的论文却因一字错用而引起轩然大波。 3 月 2 日曼彻斯特大学计算分子进化学者 James McInerney 首先在 Twitter 上，矛头直指期刊： PLOS ONE is now a joke. ...proper design of the Creatorabsolute joke of a journal. 该论文被攻击是神创论，宣扬上帝造人。 3 月 3 日，论文第一作者 Mingjin Liu 在 PLOS ONE 论文评论区郑重道歉并予以说明。 We are sorry for drawing the debates about creationism. Our study hasno relationship with creationism. English is not our native language. Ourunderstanding of the word Creator was not actually as a native English speakerexpected. Now we realized that we had misunderstood the word Creator. What wewould like to express is that the biomechanical characteristic of tendiousconnective architecture between muscles and articulations is a proper design bythe NATURE (result of evolution) toperform a multitude of daily grasping tasks. We will change the Creator to nature in the revisedmanu. We apologize for any troubles may have caused by this misunderstanding. We have spent seven months doing the experiments, analysis, and writeup. I hope this paper will not bediscriminated only because of this misunderstanding of the word. Please could you read the paper beforemaking a decision . 作者的道歉并未挽救这篇论文。 PLOS ONE 于 3 月 3 日公告：综合内部讨论以及两位编委会专家的意见，这篇 论 文确实存在问题，并暴露出同行评议过程并没有对该文各方面给予充分的考量。 PLOS ONE 编辑部决定，此文将被尽快撤回。 目前在 PLOS ONE 的网站上能看到如下声明： Following publication,readers raised concerns about language inthe article that makes references to a'Creator' , and about the overallrationale and findings of the study. Upon receiving theseconcerns, the PLOS ONE editors have carried out an evaluationof the manuscript and the pre-publication process, and they sought furtheradvice on the work from experts in the editorial board. This evaluationconfirmed concerns with the scientific rationale, presentation and language,which were not adequately addressed during peer review. Consequently,the PLOS ONE editors consider that the work cannot be reliedupon and retract this publication. The editors apologizeto readers for the inappropriatelanguage in the article and the errors during the evaluation process. 撤稿事件之后，不少中国科研工作者为该文作者感到委屈。认为英语并不是我们的母语，中国作者不理解英文中 Creator 的特定含义并没有什么好奇怪的。况且论文已经通过了编辑、审稿人审阅。那么责任到底在谁？ 让我们来仔细读读这篇论文， “The Creator ” 在文中出现了三次，第一次 在摘要：即 “ Theexplicit functional link indicates that the biomechanical characteristic oftendinous connective architecture between muscles and articulations is theproper design by the Creator to perform a multitude of daily tasks in acomfortable way. ” 通常而言，摘要需要简明扼要的表达出研究目的、方法、结果和结论。而且摘要中的结论一定是要能被研究结果支持和证实的。那么作者这句话合不合适呢？我们认为，不仅 “the Creator” 不适合， “ properdesign ” 的使用也是不合适的。 第二次出现在引言：即 “ Hand coordinationshould indicate the mystery of the Creator’s invention. ” 同样，不仅 “the Creator” ， “ mystery ” 的使用也是大错特错的。 第三次出现在结论：即 “ In conclusion, ourstudy can improve the understanding of the human hand and confirm that themechanical architecture is the proper design by the Creator for dexterousperformance of numerous functions following the evolutionary remodeling of theancestral hand for millions of years. ” 作者在 “ the proper design bythe Creator ” 之前还用了单词 “ confirm” 。这真的被本研究 confirm 了吗？ 如果只是一次出现 “the Creator” ，我们还可以尽量理解作者是想表达 “ 巧夺天工 ” 、 “ 天衣无缝 ” 等意思。但是这三次出现的 “ the Creator” ，还有文中的 “ Invention ” ， “ Mystery ” ， “ Superior ” 等词，都是很不合适的表达。 科技论文写作，不是文学，不是为了审美。我们不仅要把我们的科研工作真实、客观、准确的呈现出来，更要从根本上回答我们的研究解决了什么科学问题，逻辑性在其中发挥最关键的作用！ 而作者的错误，并不只是用错了英文词汇，更是没有从逻辑上正确解释自己的研究成果。作者本来已经恰当地描述了实验方法和结果，却在结论中不恰当地使用了文学语言来赞美 “ 造物主 ” 之 “ 神奇 ” 、感叹 “ 大自然 ” 之 “ 美妙 ” 。结果 “ 画蛇添足、弄巧成拙、贻笑大方 ” 。当然，这个错误责任不只是在第一作者，其他作者也有份。 其实，这样的错误在同行评审阶段就应该被发现，被提出，被修改。但是为什么这篇论文带着这样的错误走到了公开发表的阶段？ PLOSONE 更难辞其咎。 PLOSONE 的编审体系到底出了什么问题，以至出现这么大的失误？而且， PLOSONE 仅仅匆匆回应和迅速撤稿，并未彻底反省审查自身的评审机制，也未表明以后将采取什么具体措施以改进自己的评审机制。这些都令母语非英文的作者，尤其中国作者担忧 ! 作为母语非英文的我们，不能坐以待毙。我们必须努力提高自己的英文科技论文写作水平，谨慎选择期刊，并有技巧性的与期刊编辑沟通。同时在必要时寻求质量优异、声誉良好的专业编辑公司的帮助。 －－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－－ 本文由美捷登编辑原创，转载请注明来自美捷登微信：http://dwz.cn/3ccCM4 1.5月 免费在线讲座 点击报名 2.美捷登近期线下讲座讯息（临床医师科研素养提高班，万用模版） 详细 3.更多精彩内容欢迎关注我们的微信
2016 年 1 月 5 日，华中科技大学熊蔡华及其合作者共同完成的论文 Biomechanical Characteristics of Hand Coordination in Grasping Activities of Daily Living 在开放获取期刊 PLoS ONE 上在线发表。 2016 年 3 月 2 日，英国曼彻斯特大学进化生物学教授 James McInerney 发表 twitter 称 “ 该论文是个笑话， PLoS ONE 是个笑话 ” 。这条评论引起了众多学者的关注，这篇论文一举成名。 2016 年 3 月 3 日， Nature 杂志网站大篇幅报道了这篇发表在 PLoS ONE 上的论文引起的诸多争议。 2016 年 3 月 4 日， PLoS ONE 发表了该篇论文的撤稿声明。 到目前为止，这篇论文目前已经成为 PLoS ONE 网站上阅读量最高的论文。 这篇论文研究了手部生物机械结构与其协调运动能力的联系。引发争论的关键在于论文的摘要、引言和结论部分三次使用了 “the Creator” （注：前加 the ，并 creator 首字母大写时指 “ 造物主 ” 、 “ 上帝 ” 、 “ 天主 ” ）的表达，因而被认为在宣扬神创论，引发了科学界无神论者的质疑。 “The explicit functional link indicates that the biomechanical characteristic of tendinous connective architecture between muscles and articulations is the proper design by the Creator to perform a multitude of daily tasks in a comfortable way.” “Hand coordination should indicate the mystery of the Creator’s invention . ” “our study can improve the understanding of the human hand and confirm that the mechanical architecture is the proper design by the Creator for dexterous performance of numerous functions following the evolutionary remodeling of the ancestral hand for millions of years.” “ 造物主恰当的设计 ” ， “ 造物主造物的神秘 ” ，这些表达在科学界引起轩然大波，因为这看上去是在直白的赞颂 “ 造物主 ” ，也就是在赞颂 “ 上帝 ” 。自从达尔文提出生物进化论之后，神创论与科学处于对立面，神创论是科学家的死敌，这一次在科学期刊上公然提出神创论，引发的波动有多激烈可想而知。一时间各方指责纷至沓来。 将此事件引入大众眼帘的是曼彻斯特大学进化生物学教授 James McInerney ，他在 3 月 2 日将其在 twitter 上曝光，话题迅速传播开来，引起广泛的讨论。 有评论说作者应当受到惩罚，审稿编辑应该受到惩罚。有的评论说希望这篇论文是个骗局。有的称如果这篇论文不撤稿，将拒绝继续做 PLoS ONE 编辑。 在接受 Nature 杂志访问时，论文通讯作者熊蔡华教授称： “ 实际情况是，我们是来自母语非英语国家，因此完全误解了如 “Creator” 这样词语的隐含之意。我对此非常抱歉。 ” 论文第一作者 Mingjin Liu 在文章评论区发表道歉声明。他表示研究与神创论没有关系。因为英语并非母语，对于 “Creator” 一词的理解与母语为英语的人不同，作者把 “Creator” 理解成了大自然。并愿在修改稿中把 “Creator” 改成 “nature” 。不过该声明并未得到国外学者的认可。 3 月 4 日， PLoS ONE 编辑部发表撤稿声明：经过对稿件和评审过程进行评估，并征求了编委会的进一步意见，确定这篇文章在同行评审过程中，论文的理论、叙述与语言方面没有进行充分的考量。因此对该论文进行撤稿处理。 值得一提的是，论文作者均为中国学者，该论文的编辑也是在美国任职的中国学者，均为母语非英语学者。 理文编辑通过与出版商和杂志编辑交流，以及通过我们的第一手经验了解到，许多母语非英语作者的稿件 存在语言问题 ，理文编辑《重塑作者体验》白皮书调查显示，作者在撰写论文时，在遇到的困难里， “ 以英文明确表述自己的观点 ” 占百分之 24% 。 在这个撤稿事件中，论文作者在实验、分析和论文写作方面花费了长达 7 个月的时间，从提交稿件到文章上线花费了 2 个月零 8 天的时间。花费如此多的时间与精力，最终，在一定程度上，论文因为语言问题而招致撤稿处理，这对论文作者来说是一件非常不幸的事。 如何避免这样的惨况发生？母语非英语的作者在投稿之前可以在语言润色方面寻求一些帮助。理文编辑全球英语语言润色行业的领跑者，拥有一支由英语母语资深编辑组成的专家编辑团队。在 2015 年间，理文编辑帮助中国大陆作者修改稿件共计 22508 篇，通过举办 workshop 帮助上万名作者提高写作技巧及发表技巧。理文编辑的服务可以帮助作者克服语言障碍，从而顺利发表论文。 理文编辑 | Since 1995
怪哉：撤稿论文依然频频被引 诸平 被不少科学家多次引用论文曾经是已经撤稿的论文，听到这样的信息一定感到好奇吧？说来也奇怪，伊凡 · 奥兰斯基（ IvanOransky ） 2015 年 12 月 28 日在 “ 撤稿瞭望（ Retraction Watch ） ” 网站就列举了 10 篇类似的论文，这些论文不仅在撤稿之前已经获得数百次的引用，就是在撤稿之后依然获得上百次或者数百次的引用 , 我们将这些论文摘引如下，供大家参考。 读者会看到一些熟悉的条目 , 比如臭名昭著的 《柳叶刀》（ LANCET ） 论文作者安德鲁 · 韦克菲尔德（ Andrew Wakefield ）撰写的 最初认为自闭症和儿童疫苗之间的联系 （ originally suggested a link between autism and childhood vaccines ）。除此之外，你会注意到许多论文，包括常被引用的论文，就是在撤稿之后依然获得更多引用 , 研究表明这是一个持续性的问题 （ research has shown is an ongoing problem ）。下面是撤稿之后仍然获得高引的前十篇论文（ Top10 most highly cited retracted papers ）。 论文信息 撤稿之年 撤稿前 被引 撤稿之 后被引 总被引 1. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin . SCIENCE, JAN 21 2005 Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I. 2007 247 776 1023 2. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells . BLOOD, NOV 1 2001 Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. 2009 655 214 869 3. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children . LANCET, FEB 28 1998 Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA. 2010 675 308 983 4. An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus . PLANT JOURNAL, MAR 2003 Voinnet O, Rivas S, Mestre P, Baulcombe D. 2015 897 N/A 897 5. Viral pathogenicity determinants are suppressors of transgene silencing in Nicotiana benthamiana . EMBO JOURNAL, NOV 16 1998 Brigneti G, Voinnet O, Li WX, Ji LH, Ding SW, Baulcombe DC. 2015 792 N/A 792 6. TREEFINDER: a powerful graphical analysis environment for molecular phylogenetics . BMC EVOLUTIONARY BIOLOGY, JUN 28 2004 Jobb G, von Haeseler A, Strimmer K. 2015 748 N/A 748 7. Spontaneous human adult stem cell transformation . CANCER RESEARCH, APR 15 2005 Rubio D, Garcia-Castro J, Martín MC, de la Fuente R, Cigudosa JC, Lloyd AC, Bernad A. 2010 371 269 640 8. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial . LANCET, JAN 11 2003 Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. 2009 572 101 673 9. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis . CELL, JUN 12 2009 Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA. 2015 530 N/A 530 10. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids . NATURE MEDICINE, MAR 2000 Kugler A, Stuhler G, Walden P, Zöller G, Zobywalski A, Brossart P, Trefzer U, Ullrich S, Müller CA, Becker V, Gross AJ, Hemmerlein B, Kanz L, Müller GA, Ringert RH. 2003 348 166 514 许培扬 ： 造假论文进入文献数据库 危害极大 造假、抄袭、剽窃的论文一旦进入文献数据库，危害很大，属于信息污染。 大型文献数据库全世界每天的访问量、检索量非常大（如SCI引文数据库、PUBMED医学文献数据库、SCOPUS数据库等），造假论文成为检索的相关文献命中，有些文献可以被检索者识别出来，有些文献不能准确判定，造成大量人力和时间的损失。 这些造假文献需要做大量的文献处理、数据维护，占用数据库储存空间，加大数据库管理成本。 根据信息传播的传染病原理，错误信息会成倍增加，这些错误的、无用的文献信息，一旦被利用、引用，就造成更大的传播和坏影响。 因此，期刊出版机构撤销论文的同时会通告数据库生产机构，从相应的数据库中撤除这些问题论文。
The Top 10 Retractions of 2014 A look at this year’s most memorable retractions By Adam Marcus and Ivan Oransky | December 23, 2014 FLICKR, JUDY VAN DER VELDEN This year, stories about scientific retractions were dominated by big numbers—60 at once in one case, 120 in one fell swoop in another—as well as the eyebrow-raising practice of researchers submitting fake peer reviews , often ones they themselves had written . Here are our picks for the top 10 stories, in no particular order. 1. It would be difficult to chronicle 2014’s key retractions without noting the two STAP stem cell paper retractions from Nature . Readers detected significant problems with the research, and Haruko Obokata, who led the studies, was ultimately unable to replicate the findings . Nature has defended its decision to publish the articles, saying editors couldn’t have detected the errors . Science , however, had earlier rejected one of the manuscripts for being too flawed to publish. One of Obokata’s colleagues, Yoshiki Sasai, was not responsible for any misconduct, but committed suicide following the scandal . 2. Although this story technically broke last year, it was late enough not to make our 2013 list , and the retraction happened in 2014 : A former researcher at Iowa State University (ISU) spiked rabbit blood samples with human blood to make it look as though his HIV vaccine was working. Dong-Pyou Han is now facing criminal charges, and ISU was forced to pay back nearly $500,000 of his salary —both rare events. 3. In July, the publisher SAGE retracted 60 articles from the Journal of Vibration and Control after an investigation revealed a “peer review and citation ring” in which at least one professor in Taiwan, Peter Chen, allegedly assumed false identities to promote his own work. 4. Just two weeks after publishing a paper on the psychology of Facebook users, PNAS issued an Expression of Concern about the work . The article’s many critics complained that the study violated ethical norms because it did not alert participants that they were taking part in a research project. As The Atlantic put it: “ Even the Editor of Facebook’s Mood Study Thought It Was Creepy .” 5. Two major publishers were caught out after having published more than 120 bogus papers produced by the random text generator SCIgen . French computer scientist Cyril Labbé of Joseph Fourier University in Grenoble catalogued computer-generated papers that made it into more than 30 published conference proceedings between 2008 and 2013. Sixteen appeared in publications by Springer, and more than 100 were published by the Institute of Electrical and Electronic Engineers (IEEE). 6. So much for science in the public interest: Bowing to commercial pressure, the authors of a paper in the African Journal of Food Sciences on cassava yanked it after a company claimed the article was damaging to its business . 7. A highly controversial 2012 study retracted in 2013 resurfaced this year . The paper by Gilles-Eric Séralini and colleagues on genetically modified organisms (GMOs) and rats was republished— without going through peer review , according to the editor of the journal where it ran. 8. The investigation into the work of social psychologist Jens Förster, which has been going on for most of the year, resulted in its first retraction in November . Förster, who is accused of manipulating data, has vehemently denied wrongdoing. 9. Stem cell research popped up on Retraction Watch a number of times this year. In one significant case, Circulation retracted a 2012 study by a group of Harvard heart specialists over concerns of corrupt data, and the university is investigating. There has also been an expression of concern in The Lancet . The group was led by Piero Anversa, a leading cardiologist, who along with a colleague filed suit against the institution on the grounds that the inquiry was damaging to his career prospects. 10. Finally, in the last few weeks of the year, Elsevier retracted 16 papers by one researcher after it became clear that fake peer reviews were behind the acceptances of Khalid Zaman’s papers. Adam Marcus and Ivan Oransky are co-founders of Retraction Watch.
为什么癌症研究者论文多次修改最终还是为撤稿？ 诸平 据《撤稿瞭望》（ Retraction Watch ）网站 2014 年 8 月 28 日 报道， 美国乔治华盛顿大学 医学与健康科学学院（ SMHS ）的研究者， Catharine Birch McCormick 生化与分子生物学部主席、生物化学及分子生物学教授拉凯什·库马尔（ Rakesh Kumar ）博士等人在 2007 年 8 月发表于《分子内分泌学》（ Molecular Endocrinology ）的论文—— Gururajet al, “Estrogen Induces Expression of BCAS3, A Novel Estrogen Receptor-alphaCoactivator, through Proline-, Glutamic Acid-, and Leucine-Rich Protein-1(PELP1)” (Mol Endocrinol 21:1847–1860, doi: 10.1210/me.2006-0514 ，尽管经过了 6 次修改，但是最终还是以撤稿而结束。本文最初发表的时候，拉凯什·库马尔是在美国乔治华盛顿大学从事生物化学研究，但是目前已经离开了乔治华盛顿大学。他是一位印度喀拉拉邦（ Kerala ）拉吉夫 · 甘地生物技术中心（ Rajiv Gandhi Center for Biotechnology in Kerala, lndia ）生物技术的特聘来访教授（ visiting distinguished professor of biotechnology ）。对于为何撤稿的原因目前尚未作出回应。根据汤姆森科技的知网（ Thomson Scientific’s Web of Knowledge ）统计结果，原论文已经被引用了九次。《撤稿瞭望》的相关信息摘引如下： Retraction Watch Tracking retractions as a window into the scientific process Cancer researcher has correction upgraded to retraction leave a comment » Rakesh Kumar, a researcher with six recent corrections and one retraction , has had one of those corrections upgraded to a retraction. Here’s the unhelpful notice , from Molecular Endocrinology : The August 2007 Molecular Endocrinology article by by Gururaj et al, “Estrogen Induces Expression of BCAS3, A Novel Estrogen Receptor-alpha Coactivator, through Proline-, Glutamic Acid-, and Leucine-Rich Protein-1 (PELP1)” (Mol Endocrinol 21:1847–1860, doi: 10.1210/me.2006-0514), is withdrawn by the authors. This was the correction : In the August 2007 Molecular Endocrinology article by Gururaj et al. “Estrogen induces expression of BCAS3, a novel estrogen receptor-alpha coactivator, through proline-, glutamic acid-, and leucine-rich protein-1 (PELP1)” (Mol Endocrinol 21:1847–60; Epub 2007 May 15. PubMed PMID: 17505058; doi: 10.1210/me.2006–0514), the authors note certain inadvertent errors in the Actin mRNA lanes in Figure 3H and splicing in the pS2 ChIP in Figure 7A upper panel while composing the panels. The authors are replacing the published Figures 3H and 7A panels with an erratum using data from repeat experiments. There is no change in the text and figure legends. These changes do not change the original scientific conclusions and the validity of the findings remains the same. The authors regret the error . The original paper has been cited nine times, according to Thomson Scientific’s Web of Knowledge. Kumar, who was at MD Anderson when the paper was originally published. appears to have left the George Washington University, where he was recently chair of biochemistry. He is a visiting distinguished professor of biotechnology at the Rajiv Gandhi Center for Biotechnology in Kerala, lndia. Our requests for comment from him have gone unanswered.
参考文献信息不完整，导致编辑发现重复发表端倪 诸平 在作者投稿过程中，对于自己已经发表的研究成果，要么加以引用，要么避而不谈。加以引用者是想说明自己的投稿是在已有工作基础上的更深入的研究结果；而避而不谈则另有隐情，有可能与已经发表的研究成果有很多重复内容，或者方法相同，内容有所差异；或者与以前的研究不相干或关系不大； ……. 。不管属于何种原因，合理、规范、科学的引用参考文献是必要，《撤稿瞭望》 ( Retraction Watch ) 网站 2014 年 8 月 26 日 就出现了因为作者参考文献信息不完整，而导致编辑发现作者重复发表而撤稿的案例。《博茨瓦纳农业与应用科学杂志》（ Botswana Journal of Agriculture Applied Sciences ）主编 O. R. Madibela 教授在给作者的撤稿信中谈到，作者 Mabe, R. 对《博茨瓦纳农业与应用科学杂志》的投稿 —— Capacitydevelopment and the need for extension services: A case of mentorship foremerging sugarcane farmers’ in South Africa ，编辑部已经进行了编辑和校对，但是在最后校对过程中发现有一条参考文献中缺少卷号 —— Enshayan, K., Stinner, D. andStinner, B. (1992). Farmer to Farmer. Journal of Soil and WaterConservation, 47 :127–130 ，本应该可以打电话让作者告诉即可，但是这样时间太长，倒不如编辑自己通过网络进行查找补充来的更快一些。但是，查找的结果使人感到惊讶，类似的研究结果已经在其他杂志上发表了。所以《博茨瓦纳农业与应用科学杂志》主编 O. R. Madibela 教授不得不告知作者 Mabe, R. ，你的待发表稿件尽管已经进行了最后终校，但是还是必须撤稿，不得重复发表。使得作者重复发表的黄樑美梦未能成真，当然编辑一丝不苟对待一字一句，精益求精斟酌一点一滴 的敬业精神更是令人敬佩，也值得我们的编辑工作者仿效。 《博茨瓦纳农业与应用科学杂志》编辑部的回信摘引如下，供大家引以为戒。 Incompletereference helps editor find duplicate paper — and retract article Tracking retractions as a window into thescientific process Incomplete reference helps editor findduplicate paper — and retract article leavea comment » Pro-tip: If you’re going to try to publish your work twice, don’t give editors a reasonto go searching the internet for your previous work. Here’s case in point, a retraction notice from the Botswana Journal of Agriculture Applied Sciences: Below is the letter written to theauthor(s) of the article “Mabe, R. Capacity development and the need forextension services: A case of mentorship for emerging sugarcane farmers’ in South Africa ”by the Chief Editor of BOJAAS with regard to redundant publication. Professor O. R. Madibela (2014) This memo is about the paper that yousubmitted to Botswana Journal of Agriculture and Applied Sciences titled“Capacity development and the need for extension services: A case of mentorshipfor emerging sugarcane farmers’ in South Africa ” This paper is with printers and we weredoing the last proof reading when we noticed that one of the references,Enshayan, K., Stinner, D. and Stinner, B. (1992). Farmer to Farmer.Journal of Soil and Water Conservation, 47 :127–130 was missing a volume number.We could have called you to supply us with this information but we thought itwill waste time so we search the internet for the information. We weresurprised that the same work you have submitted to us has already beingpublished somewhere else (see attached article). It would be unethical for youand for me as the Chief Editor to go ahead and publish this research. It isclearly stated in the Guidelines for Authors that “It is understood thatsubmitting an article to BOJAAS means that it is not concurrently beingconsidered by another journal elsewhere” As such, your paper has been withdrawnfrom publishing.
2013最难忘的撤稿十件事 诸平 据 《科学家》（ The Scientist ） 杂志网站 2013 年 12 月 30 日 报道，援引“撤稿观察”（ Retraction Watch ）的信息，自 2010 年创办该博客以来，科学文献的撤稿情况接二连三，可以说是络绎不绝。据汤姆森科技知网（ Thomson Scientific’s Web of Knowledge ）报道， 有 511 篇论文撤稿。作者（ Adam Marcus and Ivan Oransky ）根据读者的反应和其他 “ 科学 ” 的因素列出了 2013 年撤稿最令人难忘的前 10 名，排名不分先后，具体内容摘引如下供大家参考。 FLICKR, JUDY VAN DER VELDEN 1. One of our favorite stories this yearwas about a 15-year-old retraction by David Vaux, of the Walter and Eliza HallInstitute of Medical Research. Vaux, who has fought the good fight forscientific integrity many times, had a heck of a time publishing a rebuttal toa flawed piece of research in Nature. So he decided to retract his own essay about that study . 2. Another retraction story took a page outof a spy novel: Investigators looking into research by a star researcher wereforced to install hidden cameras that revealed he was tampering with the evidence . He has now retracted three papers from the literature. 3. Graduate students take note: Faking datain your dissertation can still get you a PhD, as long as the thesis remains “ scientifically valid .” That would seem to be the take-homemessage of the tale of Nitin Aggarwal, whom the Office of Research Integrity(ORI) found guilty of misconduct . The case has led to one retraction so far . 4. Speaking of ORI investigations, werecommend reading about the case of Michael W. Miller , who faked data on his federal grantapplications and had several papers retracted in 2012. This year, however,Miller bounced back, landing a job as, you guessed it, a consultant for grant applications ! (He lost that gig afterwe called his employers to ask if they knew about his past.) 5. For sheer controversy value, one of thebiggest retractions of 2013 has to be that of a 2012 paper on genetically modified maize and rats by Gilles Séraliniand colleagues. In the retraction—which Séralini strongly opposed—the editor of Foodand Chemical Toxicology didn’t cite any of the usual reasons forretraction, such as fraud or gross error, instead basically saying that thepaper shouldn’t have passed peer review to begin with . 6. The flip side of author objections mightbe, “What does it take to get your own paper retracted?” That question occurredto anyone who had followed the story of Robert Trivers, who finally succeededin having a 2005 Nature paper he’d co-authored—and soon doubted— retracted in November . 7. We have to hand it this year toscientists who’ve done the right thing , which in our case means retractingpapers even if it comes at great professional cost. Biologists PamelaRonald and Daniel St. Johnston , who voluntarily retracted papers from Science and Nature,respectively, are on that list. And scientists reward that kind of behaviortoo, it appears . 8. In January, we wrote about a successfuleffort by “ Clare Francis ,” the pseudonymous scourge of journalsworldwide, to force a retraction of a 2006 paper in the Journal of CellBiology —providing proof positive of our contention that anonymouswhistleblowers deserve a fair hearing by editors. Love him or hate him—and yes,Clare is a “he”— Francis is right more often than a broken clock, to mangle afavorite phrase of Ivan’s father. 9. We have several candidates in a category we call “ Plagiarism Euphemism of the Year .” There’s “unattributedoverlap,” “a significant originality issue,” and an “approach.” Why, we wonder,do journals have such a hard time naming It That Cannot Be Named? 10. For some comic . . . well, not quiterelief, given the subject, but the retraction of “ Penile Strangulation by Metallic Rings ” deserves a mention. Finally, although it was not a retraction,an honorable mention goes to Serbian academics who managed to get an Alan Sokal-esque paper citing Borat and porn star Ron Jeremy publishedin a Romanian magazine. Happy 2014! Here’s hoping you don’t have toretract too many of your New Year’s resolutions. Ivan Oransky and Adam Marcus areco-founders of RetractionWatch .
山东、河南、江西八单位被撤稿件11篇，聊城大学最多 诸平 Acta Crystallographica Section E 2005-2009年发表的论文中有 11 篇论文存在数据或者原子位置指定有问题而被撤销，其中包括聊城大学 4 篇，山东轻工业学院与山东农科院合作 2 篇，曲阜师大、井冈山大学、河南大学、山东教育学院、江西财经大学各 1 篇，具体论文见下表。 Retraction of articles This article reports the retraction of 11 articles published in Acta Crystallographica Section E between 2005 and 2009. After further thorough investigation (see Harrison et al., 2010 ), 11 additional articles are retracted by the authors or by the journal as a result of problems with the data sets or incorrect atom assignments. Full details of all the articles are given in Table 1 . Table 1 Details of articlesto be retracted, in order of publication Title Reference DOI zinc(II)( 曲阜师大 ： Chen Guang; Zhao Bin; Sun Min; Qi Wei ) Chen et al. (2005 ) 10.1107/S1600536805026796 Diazidobis(2,2'-biimidazole)copper(II) （ 聊城大学 ： Liu Ying; Dou Jianmin; Li Dacheng; Zhang Xianxi ） Liu et al. (2007 ) 10.1107/S1600536807047873 Dichlorido(1,10-phenanthroline)copper(II) （ 井冈山大学 ： Liu Yin-Qiu ） Liu (2007 ) 10.1107/S1600536807056735 Diazidobis(2,2'-biimidazole)cobalt(II) （ 河南大学 ： Sheng Li; Shou-Bin Wang; Fu-Li Zhang; Kun Tang ） Li et al. (2008 ) 10.1107/S1600536807062873 Diazidobis(2,2'-biimidazole)manganese(II) （ 山东教育学院 ： Zhang Xiutang; Wei Peihai; Li Bin ） Zhang et al. (2008 ) 10.1107/S1600536808017984 Diazidobis(2,2'-biimidazole)iron(II) （ 山东轻院 ； Hao Lujiang; Kong Binbin ； 山东农科院 ： Mu Chunhua ） Hao et al. (2008 a ) 10.1107/S1600536808018539 Bis(pentane-2,4-dionato)bis nickel(II) （ 山东轻院 ； Hao Lujiang; Kong Binbin ； 山东农科院 ： Mu Chunhua ） Hao et al. (2008 b ) 10.1107/S1600536808018552 Bis(pentane-2,4-dionato- 2 O,O')bis " word_img="file:///C:/DOCUME~1/ADMINI~1/LOCALS~1/Temp/msohtml1/01/clip_image003.gif" style="background:url(/static/ueditor/themes/default/images/word.gif) no-repeat center center;border:1px solid #ddd" /> N 2 ]manganese(II) （ 聊城大学 ： Liu Ying; Zhang Xianxi; Xue Zechun; He Qingpeng ） Liu, Zhang et al. (2008 ) 10.1107/S1600536808022952 Bis bis manganese(II) （（ 聊城大学 ： Liu Ying ; He Qingpeng; Zhang Xianxi; Xue Zechun ） Liu, He et al. (2008 ) 10.1107/S1600536808038440 Di- -chlorido-bis " word_img="file:///C:/DOCUME~1/ADMINI~1/LOCALS~1/Temp/msohtml1/01/clip_image003.gif" style="background:url(/static/ueditor/themes/default/images/word.gif) no-repeat center center;border:1px solid #ddd" /> 2 N,N')zinc(II)] （ 江西财经大学： Xiao-Mao Yang; Qing-Bo Leng; Yi Chen; You-Gang He; Shi-Wu Luo ） Yang et al. (2009 ) 10.1107/S1600536809014482 Tris(ethylenediamine)manganese(II) sulfate （ 聊城大学： Jing Lu ） Lu (2009 ) 10.1107/S1600536809034874 References Chen, G., Zhao, B., Sun, M. Qi, W. (2005). ActaCryst. E 61 ,m1869-m1870. Hao, L., Mu, C. Kong, B. (2008 a ). Acta Cryst. E 64 , m956. Hao, L., Mu, C. Kong, B. (2008 b ). ActaCryst. E 64 ,m957. Harrison, W. T. A., Simpson, J. Weil, M. (2010). ActaCryst. E 66 , e1-e2. Li, S.,Wang, S.-B., Zhang, F.-L. Tang, K. (2008). Acta Cryst. E 64 , m76. Liu, Y.-Q. (2007). Acta Cryst. E 63 ,m2991. Liu, Y.,Dou, J., Li, D. Zhang, X. (2007). Acta Cryst. E 63 , m2661. Liu, Y., He, Q., Zhang, X., Xue, Z. Lv, C. (2008). ActaCryst. E 64 , m1604. Liu, Y., Zhang, X., Xue, Z., He, Q. Zhang, Y.(2008). Acta Cryst. E 64 , m1077. Lu, J. (2009). Acta Cryst. E 65 ,m1187. Yang, X.-M., Leng, Q.-B.,Chen, Y., He, Y.-G. Luo, S.-W. (2009). Acta Cryst. E 65 , m567. Zhang, X., Wei, P. Li, B. (2008). Acta Cryst. E 64 , m934. 详见： Acta Cryst (2011).E 67 , e14
年末撤稿大盘点：Acta Cryst. E撤稿信息200条（修改稿） 诸平 2013年即将结束，负面新闻接二连三，兰迪·谢克曼在《卫报》发表文章，除了呼吁抵制顶尖期刊的博眼球式的用稿原则之外，也对中国的科研“贿赂”（我们称其为科研激励）政策进行了指名道姓的抨击，也有人认为，看来中国的“贿赂”已经扰乱了国际学术界的正常秩序。前不久又有国外记者经过数月的调查，撰文揭露中国的论文黑市 交易内幕。这些的确是我们应该考虑的问题，面对铺天盖地的论文代理广告，面对SCI数论与平均被引频次的发展的不平衡形象，面对中国形象在国际大环境中的影响严重受损的局面，我们不应该思考我们的现行相关评价体系的科学性、合理性吗？改革开放30余年，需要继续深化；引入SCI评价同样30余年难道依然需要继续沿用，没有改革与完善的必要吗?一直受国人青睐的 Acta Cryst. E终于在2013年有了一些新变化，发表论文的数量明显下降， 这种局面的出现，除了我们的觉醒之外，造假来带的严查也是一个重要影响因素。看看我们2001年以来在 Acta Cryst. E 发表的1.6万多篇论文中，有多少已经撤稿。下图是CHINA年发表论文的变化，图后附上200条撤稿信息（不一定全部是与CHINA有关，但是我们是重灾区）。 图1 2001年以来CHINA作者在 Acta Cryst. E 发表情况 部分高校的撤稿详见： 撤稿论文作者来自山东轻院、通化师院、东北师大、吉林师大等 ； 山东理工、聊城大学、河南大学、潍坊学院的部分撤稿情况 更多阅读（可以链接到相关文献） 井冈山大学处理钟华和刘涛学术造假行为 井冈山大学校领导回应学校 70 篇论文被撤事件 国际期刊一次性撤销中国科学家 70 篇论文 井冈山大学教师论文造假事件调查：另一名黑龙江大学学者 5 年发文 279 篇 井冈山大学论文造假始末 井冈山大学教师论文造假事件调查 科学网曹聪博客相关博文 《晶体学报》再度回应井冈山大学讲师造假事件 《柳叶刀》社论：中国需对学术造假采取行动：应以井冈山大学事件为契机，重建相关伦理标准，健全处罚程序 ， 《柳叶刀》社论原文（英文） 以下是 Acta Cryst. E 发布的撤稿信息200条： IUCr Editorial Office (2012). Retraction of articles. Acta Cryst. E 68 , e10-e11. IUCr Editorial Office (2012). Retraction of articles. Acta Cryst. E 68 , e14-e15. S. A. Awan , M. N. Tahir , I. K. Muhammad , S. Ahmad M. I. Tariq (2012). cyclo -Tetrakis( 2 -3-sulfidopropyl- 3 C 1 , S : S )tetrakis . Retraction. Acta Cryst. E 68 , e13. IUCr Editorial Office (2011). Retraction of articles. Acta Cryst. E 67 , e14. IUCr Editorial Office (2011). Retraction of articles. Acta Cryst. E 67 , e16. S.-W. Jin , B.-X. Chen , Y.-S. Ge , H.-B. Yin Y.-P. Fang (2011). Oxonium picrate. Acta Cryst. E 67 , o1694. S. A. Awan , M. N. Tahir , I. K. Muhammad , S. Ahmad M. I. Tariq (2011). cyclo -Tetrakis( 2 -3-sulfidopropyl- 3 C 1 , S : S )tetrakis . Acta Cryst. E 67 , m576-m577. IUCr Editorial Office (2010). Retraction of articles. Acta Cryst. E 66 , e21-e22. T. Liu , Y.-X. Wang , Z.-W. Wang , Z.-P. Xie J. Y. Zhu (2010). Retraction of articles by T. Liu et al. . Acta Cryst. E 66 , e13-e14. H. Zhong , S.-H. Duan , Y.-P. Hong , M.-L. Li , Y.-Q. Liu , C.-J. Luo , Q.-Y. Luo , S.-Z. Xiao , H.-L. Xie , Y.-P. Xu , X.-M. Yang , X.-R. Zeng Q. Y. Zhong (2010). Retraction of articles by H. Zhong et al. . Acta Cryst. E 66 , e11-e12. W. T. A. Harrison , J. Simpson M. Weil (2010). Editorial. Acta Cryst. E 66 , e1-e2. S. Li , Y. Chen , H.-M. He Y.-F. Ma (2009). catena -Poly - -6-carboxynicotinato- -pyridine-2,5-dicarboxylato] dihydrate]. Acta Cryst. E 65 , m411. G. Xia Z. Sun (2009). Diaquabis(pyridine-2-carboxylato- 2 N , O )iron(II). Acta Cryst. E 65 , m315-m316. X. Zhang , P. Wei , J. Dou , B. Li B. Hu (2009). Bis(6-methoxy-2-{ iminomethyl}phenolato)copper(II) dihydrate. Acta Cryst. E 65 , m151-m152. L. Hao X. Liu (2009). Tetrakis( -2,4-difluorobenzoato)bis . Acta Cryst. E 65 , m150. Y. Liu , X. Zhang , Z. Xue C. Lv (2009). 1-Phenyl-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one. Acta Cryst. E 65 , o2724. J. Lu (2009). Tris(ethylenediamine)manganese(II) sulfate. Acta Cryst. E 65 , m1187. Q. Huang , Y.-H. Sui G.-X. Zhang (2009). {6,6'-Dimethoxy-2,2'- diphenolato-1 4 O 1 , O 1' , O 6 , O 6' :2 4 O 1 , N , N ', O 1' }(ethanol-1 O )- -nitrato-1:2 2 O : O '-dinitrato-1 4 O , O '-samarium(III)zinc(II). Acta Cryst. E 65 , m1161-m1162. S. Wang , T. Yang , Z. Li X. Yu (2009). Terephthalic acid-4,4'-bipyridine (2/1). Acta Cryst. E 65 , o2198. X.-M. Yang , Q.-B. Leng , Y. Chen , Y.-G. He S.-W. Luo (2009). Di- -chlorido-bis " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 2 N , N ')zinc(II)]. Acta Cryst. E 65 , m567. H. Zhong , X.-R. Zeng , X.-M. Yang Q.-Y. Luo (2008). Bis(4-phenylpyridinium) tetrakis(nitrato- 2 O , O ')stannate(IV). Retraction. Acta Cryst. E 64 , e28. H. Zhong , X.-R. Zeng , X.-M. Yang Q.-Y. Luo (2008). Bis(4,4'-bipyridine- N )tetrakis(nitrato- 2 O , O ')tin(IV). Retraction. Acta Cryst. E 64 , e29. Q. Meng , L. Wang , Y. Liu Y. Pang (2008). Bis " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 3 N , N ', N '']manganese(III) perchlorate monohydrate. Acta Cryst. E 64 , m332. H. Zhong , X.-M. Yang , Q.-Y. Luo Y.-P. Xu (2008). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 2 N , N ')praseodymium(III)]-di- -phenoxyacetato- 4 O : O '- " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 2 N , N ')praseodymium(III)]-di- -phenoxyacetato- 4 O : O '-di- -phenoxyacetato- 3 O , O ': O ; 3 O : O , O ']. Acta Cryst. E 64 , m317-m318. L. Hao X. Liu (2008). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 2 N , N ')copper(II)]- -5-nitroisophthalato- 3 O 1 , O 1' : O 3 ]. Acta Cryst. E 64 , m1500. Y. Liu , Q. He , X. Zhang , Z. Xue C. Lv (2008). catena -Poly - -5-nitroisophthalato]. Acta Cryst. E 64 , m1605-m1606. Y. Liu , Q. He , X. Zhang , Z. Xue C. Lv (2008). Bis bis manganese(II). Acta Cryst. E 64 , m1604. Y.-A. Xiao , Y. Sui , X.-G. Yi , J.-H. Wu L.-P. Zhang (2008). { -6,6'-Dimethoxy-2,2'- diphenolato}- -nitrato-dinitratoholmium(III)zinc(II). Acta Cryst. E 64 , m804-m805. Y.-A. Xiao , X.-K. Fu , Y. Sui , Q. Wu S.-H. Xiong (2008). { -6,6'-Diethoxy-2,2'- diphenolato}trinitratoholmium(III)nickel(II). Acta Cryst. E 64 , m806-m807. S. Li , S.-B. Wang , F.-L. Zhang K. Tang (2008). -Oxido-bis{chlorido chromium(III)} bis(hexafluoridophosphate). Acta Cryst. E 64 , m2. Q. Meng , L. Wang , Y. Liu Y. Pang (2008). -Oxido-bis({4,4'-dibromo-2,2'-ethane-1,2-diylbis(nitrilomethylidyne)]diphenolato}iron(III)). Acta Cryst. E 64 , m63. Q. Meng , L. Wang , Y. Liu Y. Pang (2008). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> N 3 )palladium(II)]- -benzene-1,4-dicarboxylato- 2 O 1 : O 4 ]. Acta Cryst. E 64 , m133. S. Li , S.-B. Wang , F.-L. Zhang K. Tang (2008). Diazidobis(2,2'-biimidazole)cobalt(II). Acta Cryst. E 64 , m76. Q. Meng , L. Wang , Y. Liu Y. Pang (2008). -Oxido-bis{chlorido manganese(III)} bis(hexafluoridophosphate). Acta Cryst. E 64 , m204. Q.-G. Meng , L.-T. Wang , Y.-Z. Liu Y. Pang (2008). Oxalatobis(propane-1,3-diamine)manganese(II) chloride monohydrate. Acta Cryst. E 64 , m170-m171. Z. Li , X. Zhang X. Pu (2008). Bis(4-chloro-2-formylphenolato)nickel(II). Acta Cryst. E 64 , m215. S. Li , X.-L. Yan , S.-B. Wang Y.-F. Ma (2008). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 2 N , N ')nickel(II)]- -oxalato- 4 O 1 , O 2 : O 1' , O 2' ]. Acta Cryst. E 64 , m1258. L. Hao , C. Mu B. Kong (2008). Bis(pentane-2,4-dionato)bis nickel(II). Acta Cryst. E 64 , m957. L. Hao , C. Mu B. Kong (2008). Tris " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 2 N , O ]iron(III). Acta Cryst. E 64 , m955. R.-H. Hu , Y. Sui , L. Chen C.-M. He (2008). { -6,6'-Dimethoxy-2,2'- diphenolato}- -nitrato-dinitratoeuropium(III)zinc(II). Acta Cryst. E 64 , m8-m9. X. Zhang , P. Wei B. Li (2008). Diazidobis(2,2'-biimidazole)manganese(II). Acta Cryst. E 64 , m934. X. Zhang , P. Wei B. Li (2008). Diaqua-1 O ,3 O -di- -cyanido-1:2 2 N : C ;2:3 2 C : N -dicyanido-2 2 C -bis{4,4'-dibromo-2,2'- diphenolato}-1 4 O , N , N ', O ';3 4 O , N , N ', O '-1,3-diiron(III)-2-nickel(II). Acta Cryst. E 64 , m926. S. Li , F.-L. Zhang , K. Tang Y.-F. Ma (2008). Tetra- -2,5-difluorobenzoato-bis . Acta Cryst. E 64 , m1142. Z.-Q. Han (2008). Bis(2-ethoxy-6-formylphenolato- 2 O 1 , O 6 )nickel(II). Acta Cryst. E 64 , m592. J.-R. Chen , Y. Sui , L. Chen , J.-W. Wen L.-Y. Yin (2008). { -6,6'-Dimethoxy-2,2'- diphenolato}- -nitrato-dinitratoterbium(III)zinc(II). Acta Cryst. E 64 , m562-m563. G. S. Huang (2008). Diaquabis(pyridine-2-carboxylato- 2 N , O )cobalt(II). Acta Cryst. E 64 , m685-m686. L. Hao , C. Mu B. Kong (2008). Bis{ -2,2'- diphenolato}bis " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> N )iron(III)]. Acta Cryst. E 64 , m1034. Y. Liu , X. Zhang , Z. Xue , Q. He Y. Zhang (2008). Bis(pentane-2,4-dionato- 2 O , O ')bis " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> N 2 ]manganese(II). Acta Cryst. E 64 , m1077. T. Liu J. Y. Zhu (2008). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> O )(1,10-phenanthroline- 2 N , N ')manganese(II)]- -nitrato- 2 O : O ']. Acta Cryst. E 64 , m28. L. Hao , C. Mu B. Kong (2008). Diazidobis(2,2'-biimidazole)iron(II). Acta Cryst. E 64 , m956. J.-L. Lu , D.-S. Zhang , L. Li B.-P. Liu (2007). 1,4-Dihydro-3,6-dipyrazin-2-yl-1,2,4,5-tetrazine-benzene-1,3-dicarboxylic acid (1/1). Retraction. Acta Cryst. E 63 , e21. Y.-X. Gao , L.-B. Wang Y.-L. Niu (2007). Tetraaquabis(4,4'-bipyridine)manganese(II) pyridine-2,6-dicarboxylate tetrahydrate. Acta Cryst. E 63 , m2283. Z. Li , S. Wang , Q. Zhang X. Yu (2007). catena -Poly - -pyridine-2,6-dicarboxylato] tetrahydrate]. Acta Cryst. E 63 , m2438-m2439. H. Zhong , X.-M. Yang , H.-L. Xie C.-J. Luo (2007). 2-Fluoro-3,5-dinitrobenzoic acid-ammonia (1/1). Acta Cryst. E 63 , o3831. Z.-F. Li , S.-W. Wang , Q. Zhang X.-J. Yu (2007). Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 4 -4,4'-carbonylbis(benzene-3,4-dicarboxylato)]tetrakis(1,10-phenanthroline)dipalladium(II)] dihydrate]. Acta Cryst. E 63 , m2312. H. Zhong , X.-M. Yang , H.-L. Xie C.-J. Luo (2007). 2-Fluoro-3,5-dinitrobenzamide monohydrate. Acta Cryst. E 63 , o3780. L.-J. Hao T.-L. Yu (2007). catena -Poly - -imidazole-4,5-dicarboxylato]. Acta Cryst. E 63 , m2374. H. Zhong , X.-M. Yang , H.-L. Xie C.-J. Luo (2007). N -(2-Hydroxyphenyl)carbamic acid-ammonia (1/1). Acta Cryst. E 63 , o3882. T. Liu J.-Y. Zhu (2007). 2-Amino-3,5-dinitrobenzoic acid-ammonia (1/1). Acta Cryst. E 63 , o3829. Y. Sui , X.-N. Fang M.-W. Yuan (2007). {6,6'-Dimethoxy-2,2'- diphenolato}methanol- -nitrato-dinitratopraseodymium(III)zinc(II). Acta Cryst. E 63 , m2275-m2276. Y. Sui , J.-H. Zhang , R.-H. Hu R.-Q. Jiang (2007). {6,6'-Dimethoxy-2,2'- diphenolato}methanol- -nitrato-dinitratosamarium(III)nickel(II). Acta Cryst. E 63 , m2256-m2257. T. Liu J. Y. Zhu (2007). 2-Hydroxy-3,5-dinitrobenzamide monohydrate. Acta Cryst. E 63 , o3830. Y. Sui , Y.-H. Sui , Q.-Y. Luo Y.-D. Wang (2007). {6,6'-Dimethoxy-2,2'- diphenolato}methanol- -nitrato-dinitratolutetium(III)zinc(II). Acta Cryst. E 63 , m2277-m2278. Z.-F. Li , S.-W. Wang , Q. Zhang X.-J. Yu (2007). Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 3 -malonato- -pyrazine-dimanganese(II)]. Acta Cryst. E 63 , m2360. H. Zhong , X.-M. Yang , H.-L. Xie C.-J. Luo (2007). 1-Hydroxy-4,6-dinitropyridine-2-carboxamide monohydrate. Acta Cryst. E 63 , o3881. Z.-F. Li , Y. Liu , Q. Zhang X.-J. Yu (2007). Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 3 -malonato- -pyrazine-diiron(II)]. Acta Cryst. E 63 , m2315. T. Liu J.-Y. Zhu (2007). 2-(1-Hydroxy-2-pyridyl)acetamide monohydrate. Acta Cryst. E 63 , o3860. Y.-X. Gao , L.-B. Wang Y.-L. Niu (2007). Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 3 -1,2,4-triazolato)copper(II)]. Acta Cryst. E 63 , m2366. Z.-F. Li , S.-W. Wang , Q. Zhang X.-J. Yu (2007). Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 3 -pyridine-3,4-dicarboxylato)cobalt(II)] monohydrate]. Acta Cryst. E 63 , m2373. H. Zhong , X.-R. Zeng , X.-M. Yang Q.-Y. Luo (2007). Tetrakis(nitrato- 2 O , O ')bis(4-phenylpyridine- N )cerium(IV). Acta Cryst. E 63 , m1455. X.-M. Li , Y.-H. Dong , Q.-W. Wang B. Liu (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 2 N , N ')zinc(II)]- -imidazole-4,5-dicarboxylato- 4 N 1 , O 5 : N 3 , O 4 ]. Acta Cryst. E 63 , m1274-m1276. H. Zhong , X.-R. Zeng , X.-M. Yang Q.-Y. Luo (2007). Tetrakis(pyridine- N )bis(thiocyanato- N )cobalt(II). Acta Cryst. E 63 , m1379. H. Zhong , X.-R. Zeng , X.-M. Yang Q.-Y. Luo (2007). Tetrakis(pyridine- N )bis(thiocyanato- N )copper(II). Acta Cryst. E 63 , m1445. Y. Sui , X.-N. Fang , P. Hu J. Lin (2007). {6,6'-Dimethoxy-2,2'- diphenolato-1 4 O 1 , O 1' , O 6 , O 6' :2 4 O 1 , N , N ', O 1' }(methanol-1 O )- -nitrato-1:2 2 O : O '-dinitrato-1 4 O , O '-cerium(III)zinc(II). Acta Cryst. E 63 , m2135-m2136. Y.-X. Gao , L.-B. Wang , Y.-L. Niu L.-J. Hao (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 2 N 1 , O )manganese(II)]- -pyrazine-2-carboxylato- 3 N 1 , O : N 4 ]. Acta Cryst. E 63 , m2185. Y. Sui , J.-H. Zhang , R.-H. Hu L.-Y. Yin (2007). { -6,6'-Diethoxy-2,2'- diphenolato}trinitratocerium(III)zinc(II). Acta Cryst. E 63 , m2089-m2090. Y. Sui , X.-F. Li , G.-S. Huang G.-J. Wang (2007). { -6,6'-Diethoxy-2,2'- diphenolato}trinitratopraseodymium(III)nickel(II). Acta Cryst. E 63 , m2093-m2094. Y.-X. Gao , L.-B. Wang X.-R. Hao (2007). Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 3 -1,2,4-triazolato-iron(II)]. Acta Cryst. E 63 , m2232. J.-R. Chen , Y. Sui , Q.-Y. Luo R.-Q. Jiang (2007). { -6,6'-Diethoxy-2,2'- diphenolato}trinitratopraseodymium(III)zinc(II). Acta Cryst. E 63 , m2091-m2092. Y.-X. Gao , L.-B. Wang Y.-L. Niu (2007). cyclo -Tetrakis " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" />- N -(2-hydroxybenzoyl)- N '-(2-hydroxy-3-methoxybenzylidene)hydrazine(2-)]tetrazinc(II) N , N -dimethylformamide tetrasolvate. Acta Cryst. E 63 , m2180. T. Liu , Z.-W. Wang , Y.-X. Wang Z.-P. Xie (2007). Tetrakis " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" />-(2-pyridyloxy)acetato- 2 O : O ']bis{(1,10-phenanthroline- 2 N , N ') " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> O ]neodymium(III)}. Acta Cryst. E 63 , m2196-m2197. R.-H. Hu , Y. Sui , X.-N. Fang H.-M. Chen (2007). {6,6'-Diethoxy-2,2'- diphenolato}trinitratoeuropium(III)zinc(II). Acta Cryst. E 63 , m2039-m2040. H. Zhong , X.-M. Yang , Q.-Y. Luo Y.-P. Xu (2007). Bis(2,2'-bipyridyl- 2 N , N ')bis(thiocyanato- N )nickel(II). Acta Cryst. E 63 , m2062. H. Zhong , X.-M. Yang , Q.-Y. Luo Y.-P. Xu (2007). (1,10-Phenanthroline- 2 N , N ')tris(3-phenylpropanoato- O )neodymium(III). Acta Cryst. E 63 , m2209-m2210. Y.-X. Gao , L.-B. Wang , Y.-L. Niu L.-J. Hao (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 2 N 1 , O )zinc(II)]- -pyrazine-2-carboxylato- 2 N 1 , O : N 4 ]. Acta Cryst. E 63 , m2143. H. Zhong , X.-M. Yang , Q.-Y. Luo Y.-P. Xu (2007). Bis(2,2'-bipyridyl- 2 N , N ')bis(thiocyanato- N )zinc(II). Acta Cryst. E 63 , m2208. T. Liu , Z.-W. Wang , Y.-X. Wang Z.-P. Xie (2007). Tetrakis( -2-pyridyloxyacetato)bis . Acta Cryst. E 63 , m2080-m2081. T. Liu , Z.-W. Wang , Y.-X. Wang Z.-P. Xie (2007). (Dihydroxyglyoxime- 2 N , N ')bis(1,10-phenanthroline- 2 N , N ')cobalt(II) dinitrate dihydrate. Acta Cryst. E 63 , m2027-m2028. L.-J. Hao T.-L. Yu (2007). catena -Poly - -pyridine-2,6-dicarboxylato] tetrahydrate]. Acta Cryst. E 63 , m2182-m2183. H. Zhong , X.-M. Yang , Q.-Y. Luo Y.-P. Xu (2007). Bis(2,2'-bipyridyl- 2 N , N ')bis(isothiocyanato- N )copper(II). Acta Cryst. E 63 , m2141. Y.-X. Gao , L.-B. Wang Y.-L. Niu (2007). cyclo -Tetrakis " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" />- N -(2-hydroxybenzoyl)- N '-(2-hydroxy-3-methoxybenzylidene)hydrazinate(2-)]tetracobalt(II) N , N -dimethylformamide tetrasolvate. Acta Cryst. E 63 , m2128. T. Liu , Z.-W. Wang , Y.-X. Wang Z.-P. Xie (2007). (Dihydroxyglyoxime- 2 N , N ')bis(1,10-phenanthroline- 2 N , N ')manganese(II) dinitrate dihydrate. Acta Cryst. E 63 , m2198-m2199. T. Liu , Z.-W. Wang , Y.-X. Wang Z.-P. Xie (2007). Polymeric KNOF 2 . Acta Cryst. E 63 , i170. Y.-X. Gao , L.-B. Wang X.-R. Hao (2007). Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 3 -1,2,4-triazolato)manganese(II)]. Acta Cryst. E 63 , m2142. H. Zhong , X.-R. Zeng Q.-Y. Luo (2007). Aquachlorobis(1,10-phenanthroline)cobalt(II) chloride thioacetamide solvate. Acta Cryst. E 63 , m221-m223. L.-J. Hao T.-T. Liu (2007). catena -Poly - -pyrazine-2-carboxylato]. Acta Cryst. E 63 , m169-m171. L.-J. Hao , C.-H. Mu T.-T. Liu (2007). Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" />-pyrazine-2-carboxylato)nickel(II)]. Acta Cryst. E 63 , m281-m283. H. Zhong , X.-R. Zeng , Y.-Q. Liu Q.-Y. Luo (2007). (8-Quinolinol- 2 N , O )bis(8-quinolinolato- 2 N , O )nickel(II) glyoxal hemisolvate monohydrate. Acta Cryst. E 63 , m187-m189. H. Zhong , X.-R. Zeng , X.-M. Yang Q.-Y. Luo (2007). Bis(4-phenylpyridinium) tetrakis(nitrato- 2 O , O ')stannate(IV). Acta Cryst. E 63 , m1567. H. Zhong , X.-R. Zeng , X.-M. Yang Q.-Y. Luo (2007). Bis(4,4'-bipyridine- 2 N , N ')tetrakis(nitrato- 2 O , O ')cerium(IV). Acta Cryst. E 63 , m1592-m1593. X.-M. Li , Y.-L. Niu , Q.-W. Wang B. Liu (2007). Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 3 -pyridine-3,4-dicarboxylato)manganese(II)] monohydrate]. Acta Cryst. E 63 , m1737-m1738. H. Zhong , X.-R. Zeng , X.-M. Yang Q.-Y. Luo (2007). Bis(4,4'-bipyridine- N )tetrakis(nitrato- 2 O , O ')tin(IV). Acta Cryst. E 63 , m1566. Y.-M. Yang , P.-C. Lu , T.-T. Zhu C.-H. Liu (2007). Bis(2-formylphenolato- 2 O , O ')iron(II). Acta Cryst. E 63 , m1613. G. Qadeer , N. H. Rama W.-T. Chen (2007). 2,6-Dimethoxybenzohydrazide. Acta Cryst. E 63 , o2892. H. Zhong , X.-R. Zeng , X.-M. Yang , Q.-Y. Luo S.-Z. Xiao (2007). Chloridobis(1,10-phenanthroline- 2 N , N ')copper(I) hexahydrate. Acta Cryst. E 63 , m826-m828. H. Zhong , X.-M. Yang , H.-L. Xie C.-J. Luo (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> O )(1,10-phenanthroline- 2 N , N ')nickel(II)]- -acetato- 2 O : O ']. Acta Cryst. E 63 , m3053. T. Liu J. Y. Zhu (2007). N '-(3-Nitro-4-pyridylcarbonyl)pyridine-4-carbohydrazide. Acta Cryst. E 63 , o4574. D. Liu , J. Lin , Y. Xu , C. Huang X. Li (2007). -Acetato-tri- -ferrocenecarboxylato-bis . Acta Cryst. E 63 , m3094. H. Zhong , H.-L. Xie C.-J. Luo (2007). Hexaaquacobalt(II) bis(4-aminobenzenesulfonate). Acta Cryst. E 63 , m3054. T. Liu J. Y. Zhu (2007). N '-Benzoyl-4-nitronicotinohydrazide. Acta Cryst. E 63 , o4527. H. Zhong , X.-M. Yang , H.-L. Xie C.-J. Luo (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> O )(1,10-phenanthroline- 2 N , N ')cobalt(II)]- -acetato- 2 O : O ']. Acta Cryst. E 63 , m2895-m2896. Y.-Q. Liu H.-R. Wen (2007). Aqua(dimethylglyoxime- 2 N , N ')(3,5-dinitro-2-oxidobenzoato- 2 O 1 , O 2 )copper(II). Acta Cryst. E 63 , m2928. Y.-Q. Liu (2007). Dichlorido(1,10-phenanthroline)copper(II). Acta Cryst. E 63 , m2991. H. Zhong , X.-M. Yang , S.-H. Duan Y.-P. Hong (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" />-anilinoacetato-bis(1,10-phenanthroline)dieuropium(III)]-di- -anilinoacetato]. Acta Cryst. E 63 , m3142-m3143. T. Liu J.-Y. Zhu (2007). Ethylenediammonium sulfate. Acta Cryst. E 63 , o4660. T. Liu J. Y. Zhu (2007). Ethylenediammonium perchlorate. Acta Cryst. E 63 , o4874. H. Zhong , X.-M. Yang , H.-L. Xie C.-J. Luo (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> O )(1,10-phenanthroline- 2 N , N ')copper(II)]- -acetato- 2 O : O ']. Acta Cryst. E 63 , m2979. H. Zhong , Q. Y. Zhong , H.-L. Xie C.-J. Luo (2007). Hexaaquanickel(II) bis(4-aminobenzenesulfonate). Acta Cryst. E 63 , m2913-m2914. H. Zhong , Q.-Y. Zhong , H.-L. Xie C.-J. Luo (2007). Hexaaquazinc(II) bis(4-aminobenzenesulfonate). Acta Cryst. E 63 , m2990. H. Zhong , X.-M. Yang , C.-J. Luo M.-L. Li (2007). (Dimethylglyoxime- 2 N , N ')bis(1,10-phenanthroline- 2 N , N ')copper(II) dinitrate dihydrate. Acta Cryst. E 63 , m3160-m3161. T. Liu J.-Y. Zhu (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> O )(1,10-phenanthroline- 2 N , N ')nickel(II)]- -acetamido- 2 O : N ]. Acta Cryst. E 63 , m2977-m2978. T. Liu J. Y. Zhu (2007). Tetrakis(pyridine- N )bis(thiocyanato- N )vanadium(II). Acta Cryst. E 63 , m2912. Y. Liu , J. Dou , M. Niu X. Zhang (2007). -Oxido-bis({4,4'-dibromo-2,2'- diphenolato}chromium(III)). Acta Cryst. E 63 , m3032. T. Liu J. Y. Zhu (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> O )(1,10-phenanthroline- 2 N , N ')cobalt(II)]- -acetamidato- 2 O : N ]. Acta Cryst. E 63 , m3144. T. Liu J. Y. Zhu (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> O )(1,10-phenanthroline- 2 N , N ')copper(II)]- -acetamido- 2 O : N ]. Acta Cryst. E 63 , m3108. H. Zhong , X.-R. Zeng , X.-M. Yang , Q.-Y. Luo M.-L. Li (2007). (Dimethylglyoxime- 2 N , N ')bis(1,10-phenanthroline- 2 N , N ')zinc(II) dinitrate dihydrate. Acta Cryst. E 63 , m642-m644. H. Zhong , X.-R. Zeng , Q.-Y. Luo , M.-L. Li S.-Z. Xiao (2007). (8-Quinolinol- 2 N , O )bis(8-quinolinolato- 2 N , O )zinc(II) glyoxal hemisolvate monohydrate. Acta Cryst. E 63 , m492-m494. H. Zhong , X.-R. Zeng , X.-M. Yang , Q.-Y. Luo M.-L. Li (2007). (Dimethylglyoxime- 2 N , N ')bis(1,10-phenanthroline- 2 N , N ')nickel(II) dinitrate dihydrate. Acta Cryst. E 63 , m639-m641. Z. An , Y.-L. Wu , F. Lin L. Zhu (2007). Triaqua(1,10-phenanthroline)sulfatocopper(II) monohydrate. Acta Cryst. E 63 , m477-m478. H. Zhong , X.-M. Yang , H.-L. Xie C.-J. Luo (2007). Hexaaquamanganese(II) bis(4-methylbenzenesulfonate). Acta Cryst. E 63 , m2825. T. Liu J. Y. Zhu (2007). 2-Ammonio-3-carboxy-5-nitrobenzoate monohydrate. Acta Cryst. E 63 , o4267. H. Zhong , X.-M. Yang , H.-L. Xie C.-J. Luo (2007). Hexaaquachromium(II) bis(4-methylbenzenesulfonate). Acta Cryst. E 63 , m2774. Y. Liu , J. Dou , D. Li X. Zhang (2007). -Oxido-bis{chlorido iron(III)} bis(hexafluoridophosphate). Acta Cryst. E 63 , m2722. G. Guan , Y. Gao , L. Wang T. Wang (2007). Bis(cyanido- C )bis(1,10-phenanthroline- 2 N , N ')chromium(III) bis(azido- N ) " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 4 N ]chromate(III) monohydrate. Acta Cryst. E 63 , m2750. H. Zhong , X.-M. Yang , H.-L. Xie C.-J. Luo (2007). Hexaaquacopper(II) bis(4-methylbenzenesulfonate). Acta Cryst. E 63 , m2724-m2725. H. Zhong , X.-M. Yang , H.-L. Xie C.-J. Luo (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" />-anilinoacetato-bis(1,10-phenanthroline)dineodymium(III)]-di- -anilinoacetato]. Acta Cryst. E 63 , m2680-m2681. N.-G. Li , R.-M. Tao B.-F. Fu (2007). N -(2-Amino-3-pyridyl)urea monohydrate. Acta Cryst. E 63 , o4228. Y.-Q. Liu , X.-R. Zeng , Q.-Y. Luo Y.-P. Xu (2007). {2,2'- diphenolato}manganese(II). Acta Cryst. E 63 , m2854. X.-M. Yang (2007). N -(2-Fluorophenyl)carbamic acid monohydrate. Acta Cryst. E 63 , o4453. G. Guan , Y. Gao , L. Wang T. Wang (2007). cyclo -Tetrakis " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" />- N -(2-hydroxybenzoyl)- N '-(2-hydroxy-3-methoxybenzylidene)hydrazinato(2-)]tetranickel(II) N , N -dimethylformamide tetrasolvate. Acta Cryst. E 63 , m2662. T. Liu J. Y. Zhu (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 2 -anilinoacetamide)bis(1,10-phenanthroline)dipraseodymium(III)]. Acta Cryst. E 63 , m2659-m2660. T. Liu J. Y. Zhu (2007). Tetrakis(pyridine- N )bis(thiocyanato- N )chromium(II). Acta Cryst. E 63 , m2809. T. Liu J. Y. Zhu (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" />-anilinoacetamidato-bis(1,10-phenanthroline)dicerium(III)]-di- -anilinoacetamidato]. Acta Cryst. E 63 , m2775-m2776. Z. Li , S. Wang , Q. Zhang X. Yu (2007). Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 3 -pyridine-2,4-dicarboxylato)palladium(II)]. Acta Cryst. E 63 , m2642. Y.-Q. Liu X.-R. Zeng (2007). " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 4 N ]nickel(II). Acta Cryst. E 63 , m2684. Z. Li , S. Wang , Q. Zhang X. Yu (2007). Bis iron(III) perchlorate monohydrate. Acta Cryst. E 63 , m2781. T. Liu J. Y. Zhu (2007). 2-(Benzoylhydrazinocarbonyl)benzoic acid. Acta Cryst. E 63 , o4441. H. Zhong , X.-M. Yang , H.-L. Xie C.-J. Luo (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" />-anilinoacetato-bis(1,10-phenanthroline)dilanthanum(III)]-di- -anilinoacetato]. Acta Cryst. E 63 , m2772-m2773. Y. Liu , J. Dou , D. Li X. Zhang (2007). Diazidobis(2,2'-biimidazole)copper(II). Acta Cryst. E 63 , m2661. Y. Liu , J. Dou , M. Niu X. Zhang (2007). -Oxido-bis({4,4'-dibromo-2,2'- diphenolato}manganese(III)). Acta Cryst. E 63 , m2771. Z. Li , S. Wang , Q. Zhang X. Yu (2007). Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 3 -pyridine-3,4-dicarboxylato)nickel(II)] monohydrate]. Acta Cryst. E 63 , m2604. X.-M. Li , Q.-W. Wang B. Liu (2007). Poly - 3 -pyridine-2,4-dicarboxylato] monohydrate]. Acta Cryst. E 63 , m2443. T. Liu J. Y. Zhu (2007). 3-Hydroxy-2,4,6-trinitropyridine monohydrate. Acta Cryst. E 63 , o4112. Y.-Q. Liu , X.-R. Zeng W.-T. Chen (2007). trans -Bis(ethylenediamine- 2 N , N ')bis(nitrato- O )zinc(II). Acta Cryst. E 63 , m2462. H. Zhong , X.-M. Yang , H.-L. Xie C.-J. Luo (2007). 2-Hydroxy-5-nitrobenzene-1,3-dicarboxylic acid monohydrate. Acta Cryst. E 63 , o4191. Z.-F. Li , S.-W. Wang , Q. Zhang X.-J. Yu (2007). 2-(Benzyliminomethyl)-6-methoxyphenol. Acta Cryst. E 63 , o3930. T. Liu J. Y. Zhu (2007). Bis(2,2'-bipyridine- N , N ')bis(thiocyanato- N )iron(II). Acta Cryst. E 63 , m2506-m2507. T. Liu J.-Y. Zhu (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 2 -anilinoacetamide)bis(1,10-phenanthroline)disamarium(III]. Acta Cryst. E 63 , m2592-m2593. G. Guan , Y. Gao , L. Wang T. Wang (2007). Tetraaquabis(4,4'-bipyridine)cobalt(II) pyridine-2,6-dicarboxylate tetrahydrate. Acta Cryst. E 63 , m2601. Z.-F. Li , S.-W. Wang , Q. Zhang X.-J. Yu (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 2 N , N ')iron(II)]- -5-carboxy-4-carboxylatoimidazol-1-ido- 4 N 3 , O 4 : N 1 , O 5 ]. Acta Cryst. E 63 , m2445. Y.-Q. Liu X.-R. Zeng (2007). " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 4 N , N ', N '', N ''']cobalt(II). Acta Cryst. E 63 , m2547. L.-J. Hao T.-L. Yu (2007). Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 4 -benzene-1,3-dicarboxylato- 4 O : O ': O '': O ''')bis(imidazole- N )palladium(II)]. Acta Cryst. E 63 , m2555. H. Zhong , X.-M. Yang , H.-L. Xie C.-J. Luo (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" />-anilinoacetato- 2 O : O ')bis( -anilinoacetato- 3 O , O ': O )bis " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 2 N , N ')samarium(III)]- -anilinoacetato- 2 O : O ']. Acta Cryst. E 63 , m2508-m2509. L.-J. Hao , Z.-M. Bao T.-L. Yu (2007). catena -Poly - -imidazole-4,5-dicarboxylato]. Acta Cryst. E 63 , m1871. T. Liu , Z.-W. Wang , Y.-X. Wang Z.-P. Xie (2007). (Dihydroxyglyoxime- 2 N , N ')bis(1,10-phenanthroline- 2 N , N ')copper(II) dinitrate dihydrate. Acta Cryst. E 63 , m1887-m1888. Y.-X. Gao , L.-B. Wang X.-R. Hao (2007). Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 3 -1,2,4-triazolato-nickel(II)]. Acta Cryst. E 63 , m1800. T. Liu Z.-P. Xie (2007). Tetrakis(pyrazine- N )bis(thiocyanato- N )manganese(II). Acta Cryst. E 63 , m1820. Y.-X. Gao , L.-B. Wang , Y.-L. Niu L.-J. Hao (2007). catena -Poly - -pyrazine-2-carboxylato]. Acta Cryst. E 63 , m2006. H. Zhong , X.-R. Zeng , X.-M. Yang , Q.-Y. Luo Y.-P. Xu (2007). (1,10-Phenanthroline)tris(phenoxyacetato)lanthanum(III). Acta Cryst. E 63 , m1868-m1869. H. Zhong , X.-M. Yang , Q.-Y. Luo Y.-P. Xu (2007). (1,10-Phenanthroline)tri(3-phenylpropanoato)lanthanum(III). Acta Cryst. E 63 , m1909. Y.-X. Gao , L.-B. Wang , Y.-L. Niu L.-J. Hao (2007). catena -Poly - -pyrazine-2-carboxylato]. Acta Cryst. E 63 , m1882. Y.-X. Gao , L.-B. Wang Y.-L. Niu (2007). Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 4 -carbonyldibenzene-3,3',4,4'-tetracarboxylato)tetrakis(1,10-phenanthroline)dicadmium(II)] dihydrate]. Acta Cryst. E 63 , m1844. H. Zhong , X.-M. Yang , Q.-Y. Luo Y.-P. Xu (2007). (1,10-Phenanthroline- 2 N , N ')tris(phenoxyacetato)- O ; O ; O , O '-neodymium(III). Acta Cryst. E 63 , m2019. T. Liu Z.-P. Xie (2007). Tetrakis(pyrazine- N )bis(thiocyanato- N )zinc(II). Acta Cryst. E 63 , m1908. H. Zhong , X.-M. Yang , Q.-Y. Luo Y.-P. Xu (2007). (1,10-Phenanthroline)tris(phenoxyacetato)cerium(III). Acta Cryst. E 63 , m1885-m1886. L.-J. Hao T.-L. Yu (2007). catena -Poly " border="0" src="http://scripts.iucr.org/logos/entities/kappa_rmgif.gif" /> 3 O , N , O ')gadolinium(III)]- -pyridine-2,6-dicarboxylato- 4 N , O , O ': O ''] tetrahydrate]. Acta Cryst. E 63 , m1967. L.-J. Hao T.-L. Yu (2007). Poly - 3 -pyridine-3,4-dicarboxylato] monohydrate]. Acta Cryst. E 63 , m1926. Y.-X. Gao , L.-B. Wang Y.-L. Niu (2007). Tetraaquabis(4,4'-bipyridine)iron(II) pyridine-2,6-dicarboxylate tetrahydrate. Acta Cryst. E 63 , m1845-m1846. T. Liu , Z.-W. Wang , Y.-X. Wang Z.-P. Xie (2007). Tetrakis( -2-pyridyloxyacetato)bis . Acta Cryst. E 63 , m2020-m2021. C.-F. Huang H.-L. Chen (2007). catena -Poly -di- -chlorido- - -4,4'-methylenebis(3,5-dimethylpyrazole)- 2 N 2 : N 2' ]. Acta Cryst. E 63 , m2356-m2357. Y.-Q. Liu , X.-R. Zeng , Q.-Y. Luo Y.-P. Xu (2007). {2,2'- diphenolato}zinc(II). Acta Cryst. E 63 , m2396. G. Qadeer , N. H. Rama W.-T. Chen (2007). 2-(2,4-Dichlorophenylsulfanyl)acetohydrazide. Acta Cryst. E 63 , o2932. Y. Liu , J.-M. Dou , D.-Q. Wang , X.-X. Zhang L. Zhou (2006). catena -Poly - -pyridine-2,6-dicarboxylato] tetrahydrate]. Acta Cryst. E 62 , m2794-m2795. Y. Sui , Y.-A. Xiao , X.-N. Fang , X.-R. Zeng M.-H. Li (2006). A new dinuclear Cu II -Lu III complex with a salen-type Schiff base ligand. Acta Cryst. E 62 , m3205-m3207. H. Zhong , X.-R. Zeng , Y.-Q. Liu Q.-Y. Luo (2006). Tris(quinolin-8-olato- 2 N , O )cobalt(III) glyoxal hemisolvate monohydrate. Acta Cryst. E 62 , m3557-m3559. H. Zhong , X.-R. Zeng Q.-Y. Luo (2006). cis -Dichlorobis(1,10-phenanthroline)cobalt(II). Acta Cryst. E 62 , m3330-m3332. X.-Y. Qiu (2006). Bis(2-formylphenolato)cobalt(II). Acta Cryst. E 62 , m1190-m1191. Y.-G. Li H.-J. Chen (2006). Bis(2-formylphenolato- 2 O , O ')nickel(II). Acta Cryst. E 62 , m1038-m1039. Q. Chen (2006). Bis(4-bromo-2-formylphenolato- 2 O , O ')zinc(II). Acta Cryst. E 62 , m56-m57. J.-T. Liu , S.-D. Fan D.-Q. Li (2006). Tetraaqua(1,10-phenanthroline- 2 N , N ')copper(II) naphthalene-1,5-disulfonate dihydrate. Acta Cryst. E 62 , m2165-m2166. Q. Wang X.-N. Fang (2006). Bis(2-formylphenolato- 2 O , O ')manganese(II). Acta Cryst. E 62 , m1492-m1493. J.-T. Liu S.-D. Fan (2006). Tetraaqua(1,10-phenanthroline- 2 N , N ')nickel(II) naphthalene-1,5-disulfonate dihydrate. Acta Cryst. E 62 , m2507-m2508. H. Zhong , X.-R. Zeng , Y.-Q. Liu Q.-Y. Luo (2006). Aquachlorobis(1,10-phenanthroline)cobalt(II) chloride thiourea solvate. Acta Cryst. E 62 , m2925-m2927. J.-L. Lu , D.-S. Zhang , L. Li B.-P. Liu (2006). 1,4-Dihydro-3,6-dipyrazin-2-yl-1,2,4,5-tetrazine-benzene-1,3-dicarboxylic acid (1/1). Acta Cryst. E 62 , o4855-o4857. Z.-Y. Xiong L.-J. Liu (2005). Bis(salicylaldehydo)zinc(II). Acta Cryst. E 61 , m863-m864. Y.-X. Sun G.-Z. Gao (2005). Bis(4-bromo-2-formylphenolato- 2 O,O ')copper(II). Acta Cryst. E 61 , m354-m355. G. Chen , B. Zhao , M. Sun W. Qi (2005). zinc(II). Acta Cryst. E 61 , m1869-m1870. Y. Liu , J. Dou , D. Wang , G. Ma D. Li (2005). Poly " border="0" src="http://scripts.iucr.org/logos/entities/mu_rmgif.gif" /> 3 -malonato- -pyrazine-dinickel(II)]. Acta Cryst. E 61 , m1834-m1836. P. Zhang (2004). trans -Bis{1- -2-naphtholato}copper(II) dichloride dihydrate. Acta Cryst. E 60 , m1808-m1810. Y.-X. Sun Y. Nie (2004). Ammonium 2,6-dicarboxy-4-nitrophenolate. Acta Cryst. E 60 , o1742-o1744.
真正的科学家是讲理的，针对6国（加拿大、美国、英国、意大利、印度、菲律宾）24名科学家的抗议信，食品与化学毒理学杂志该如何应对呢？撤稿造成了有识之士对转基因安全性的更大怀疑。 本文链接：http://blog.sina.com.cn/s/blog_6188d2520102efoo.html 收信人 Wallace Hayes 主编 FCT 抄送 Elsevier 贵刊的撤稿决定，是公开而明确地违反国际论文伦理标准委员会的规定（ COPE ），虽然贵刊也是该机构成员。 如此无理地撤销经同行认真评审的论文，在科学出版史上前所未有。它令我们对科学的尊严和公正深感忧虑。与此撤稿事件相关的一系列事件使得我们的忧虑更为深重。 1. 为孟山都公司前雇员理查德古德曼设定专职职位，雇佣他为助理编辑专职处理生物技术稿件 2. 另一篇关于转基因潜在有害性研究的论文也被撤稿（但几乎立即被其他刊物采用） 3. 孟山都公司科学家 2004 年发表在同一杂志上的论文虽被发现重大错误却不撤稿。 此次撤稿事件将即从公共信息记录中抹去一条对公共健康极为重要的信息。这是对科学研究、对知识和观点的扼杀，是践踏科学，是对科学和民主、对大众福祉的诛心之击。 我们敦促贵刊改变错误的决定，并且向塞拉利尼及工作团队公开道歉。设若此要求归于无果，我们就抵制出版商 Elsvier ，我们将拒绝购买你的出版物，不在你出版物发表文章，不为你们做评审和编辑 。 签名 6国24位知名科学家 并向科学家和公众公开征求签名 Signed (24 scientists from 6 countries) 1. Henry A Becker, BE, MSc, ScD,FCIC, Killam Laureate 1992, Engineering Medal 1990, Prof Emeritus, Queen’s university, Kingston, Ontario, Canada, henry.becker@chee.queensu.ca 2. E. Ann Clark, PhD, Plant Agriculture, University of Guelph (retired), Ontario, Canada eaclark@uoguelph.ca 3. Joe Cummins, Ph D Genetics, Prof Emeritus of Genetics, Distinguished Fellow of ISIS, London, Ontario, Canada, jcummins@uwo.ca 4. Robert M Davidson, MD PhD, FAIS, Internal Medicine, Fellow of the American Institute of Stress, Texas, USA patrons99@yahoo.com 5. Emilio DelGiudice, PhD, High Energy and Quantum Field Theorist, Prigogine Medalist 2009, Milan, Italy, Emilio.delgiudice@mi.infn.it 6. James DeMeo PhD, Geographical Earth Science and Climatology, Orgone Biophyscial Research Lab, Ashland, Oregon, USA, demeo@mind.net 7. Robert S. Dotson MD, Clinical Instructor, University of Washington Medical Center, Ophthalmology Department, Seattle, Washington, USA, rdotson@tds.net 8. Christopher Exley PhD, Professor Bioinorganic Chemistry, Aluminium and Silicon Research Group, Birchall Centre, Lennard ‐ Jones Laboratory, Keele University, Staffordshire, UK, c.exley@keele.ac.uk 9. Julian Haffegee, M Sc Biophysics, Webmaster Productions Editor, Science in Society, Milton Keynes, UK jules@i ‐ sis.org.uk 10. Mae ‐ Wan Ho, Ph D. Biosafety Expert, Quantum Biologist, Prigogine Medalist 2014, Director, Institute of Science in Society, London, UK m.w.ho@i ‐ sis.org.uk 11. Brian John, MA D Phil, Ex Durham University, Dept of Geography, Wales, UK, brianjohn4@mac.com 12. Rosemary Mason MB ChB FRCA, Award winning ex ‐ editor of medical journal, Scotland, UK, rosemary.mason@btinternet.com 13. Ted Mendoza, PhD, Agronomist, University of the Philippines Los Banos, Philippines, ecofarm.mndz2011@gmail.com 14. Eva Novotny, PhD Astrophysicist, Pollen flow, Cambridge, UK, en@en.clipse.co.uk 15. John W. Oller, Jr., PhD, Professor of Communicative Disorders, University of Louisiana at Lafayette, USA, oller@bellsouth.net 16. Gerald Pollack, PhD, Editor ‐ in ‐ Chief, Water, Prof Bioengineering University of Washington, Prigogine Medalist 2011, Seattle, Washington, USA, ghp@u.washington.edu 17. Arpad Pusztai, FRSE, chemist/biochemist, expert on nutritional and toxicological studies, Budapest, Hungary, bardocz.Zsuzsa@t ‐ online.hu 18. Peter T Saunders, Ph D. Theoretical Cosmology, Prof Emeritus Applied Mathematics,Biomathematician, Co ‐ Director, Institute of Science in Society, London, UK peter.saunders@kcl.ac.uk 19. Vandana Shiva, Ph D. Quantum physics, winner of Right Livelihood award numerous other prizes, honorary degrees from numerous universities worldwide, Director of Navdanya, New Delhi, India, vandana.shiva@gmail.com 20. Eva Sirinathsinghji, Ph D. Neuroscience Molecular Biology, Staff Writer for Science in Society, Institute of Science in Society, London, UK eva@i ‐ sis.org.uk 21. Nancy Swanson Ph D. Quantum optics, 5 US patents author of books, Seattle, Washingon, USA swanson@abacus ‐ ent.com 22. Stephanie Seneff Ph D. Senior Research Scientist, MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, Mass, USA, seneff@csail.mit.edu 23. Lucija Tomljenovic PhD, Senior Research Scientist, University of British Columbia Faculty of Medicine, Canada, lucijat77@gmail.com 24. Oscar Zamora PhD Professor and Vice Chancellor for Academic Affairs, University ofthe Philippines Los Banos, The Philippines, obzamora@yahoo.com
【微观察】一篇影响因子不很高的论文，引起全球的关注，其实际影响力已经超过了美国的《科学》和英国的《自然》，通过专家评审正式发表的论文，却不是因为学术问题而撤稿，背后的利益之争是相当激烈的。问题是，撤稿的理由是捏造的，且捏造的相当荒唐。明显造假的论文不撤稿，严谨第一手数据的论文却遭人暗算。具体原因，且听留美学者直言了先生的分析。 科学也会很无耻。 直言了，2013-12-04 | 2013-12-5 14:32:17 http://zhiyanle.blog.hexun.com/90345093_d.html . 关于学术杂志服从孟山都公司商业意志而撤掉法国学者塞拉利尼调查报告论文的事情，新华社做了报道。我很同意吕永远先生等人的批评见解：该媒体报道只报道撤稿方故事和理由、却不报道被撤方和国际社会学界的故事和理由（尽管新华社记者编辑上网做做查询、那些信息是垂手可得的），用虚假信息或至少是片面信息搞挺转宣传的倾向足够明显。下面，就本人所见所闻来说说新华社报道没告诉您的一些相关事实。 一：撤稿的理由是捏造的、且捏造得很荒唐。 那整个故事情节不复杂：法国学者塞拉利尼的调查报告论文说明了老鼠长期食用转基因食品可发生病变、因而相关观察实验不能只是90天。该调查结果粉碎了孟山都等转基因种子公司规定的相关实验只要90天的所谓“规范”，当然，妨碍了转基因食品商业利益，孟山都公司就要想方设法地铲除那样的调查报告；14个月后，终于搞通了发表报告的学术杂志、把法国学者的论文撤掉，理由是该报告的对癌症肿瘤的 风险调查来说、数据“不完整”。 按照欧美学界规范，因数据问题撤稿，成因大体是：一是数据作弊即涉及学术不端问题，这是要有道德规范惩罚的；二是数据本身有错误而难以成立、但因正直错误造成而不实行道德规范惩罚。 法国学者的调查报告论文之数据，与上述两个成因都是毫无关系的。诚如福布斯等欧美媒体报道所说，欧美学界一些人指明，该调查数据既没任何作弊问题、本身也没任何错误（对任何统计数据，目标不同、审视、分析和应用角度也不同；那些不同不是数据本身的错误导致）；所谓“不完整”的借口也不成立：该调查及报告的目标并非是肿瘤癌症问题，而是超过90天食用转基因食品是否会发生病变（有常识就该知道：就此实验目标，不要说一组或更多的样品老鼠发生了病变，就是发生一例、也足以说明病变可能存在、即该调查报告成立）。此外，该调查实验方法采用的主要就是孟山都公司自己的方法、不同点是食用观察时间的长短而已；由此，法国学者的为时720天的实验数据“不完整”、而孟山都公司90天的实验数据倒是“完整”了？ 可见，该杂志的撤稿理由整个就是捏造、且捏造得十分荒唐，其撤稿行为是违背了国际学术规范的。大概正因为如此吧，那些欧美媒体报道说，该学术杂志不但面临服从商业利益而违背学术规范的信用危机问题，且还面临被撤稿方把该杂志告上法庭的法律责任问题。 注：其实，不管该官司结果如何，撤稿难以挽回转基因食品全球化在欧洲和发达国家的惨败命运：首先，转基因种子公司已被赶出了欧洲市场，而法国德国等发达国家早在塞拉利尼报告发表之前、就已经采取严限或禁止转基因食品作物商业化的政策措施了。其次，美国本身也正在开始纠正或抛弃转基因食品作物商业化的进程了，譬如：夏威夷通过了严限转基因作物商业化的法规、加州等正考虑采取同样措施；要求转基食品标识的立法工作此起彼伏，不管成败，许多食品公司由此听到了消费者拒绝转基因食品的强烈呼声、决定或已开始采取拒绝出售含有转基因成分的食品的管理措施。第三，美国官方已经在联合国会议表态、不反对转基食品标识的贸易立法，意味着美国官方已经开始抛弃转基食品作物商业化所依据的“实质等同”原则，……。简而言之，转基因化工食品就是含有毒素农药的有害食品或垃圾食品；跟其它垃圾食品或有害食品被淘汰一样，转基因化工食品被淘汰是必然趋势。 一：挺转数据作弊，却拒绝撤稿、甚至拒绝改正。 就本人的一段亲身经历，来看看挺转帮的表现。那是2010年，我与纽约时报的一位资深记者发生了一个关于挺转或反转的双方谁的数据可靠的讨论。讨论后，我看到所谓“权威”学术刊物《科学》发表的一篇调查报告论文，鼓吹孟山都公司等转基因种子为美国某农区农户带来了多大“经济效益”、譬如收入多大多高等等。因当时讨论数据可靠性，我就格外注意该论文的数据如何，发现那是作弊夸张。估计没多少人对那报告数据数字做字字阅读，这里就用简单比方来说说它搞作弊伪造的主要手段： 净水原料出售：10美元；咖啡原料出售：15美元；咖啡成品出售：30美元；合计收入：55美元。 鉴于咖啡成品包括水份和咖啡原料，论文把咖啡成品收入添加到净水和咖啡原料，为： 净水出售：10+30=40美元；咖啡原料出售：15+30=45美元；合计收入：40+45=85美元。 显然，知道小学算术就该知道，那是用重叠加法搞了数字夸张、即虚假数据。您把净水、咖啡原料和咖啡成品换成BT类型、HT类型和STACKED类型的转基因作物，那就是该报告的数据手段。 我指出了该报告数据系伪造作弊。开始，他们狡辩；后来，我说：那好，请你们说明获得所谓“经济效益”和多大收入的具体农户名单，我就请美国税务局按照你们报告说的收入数据去征税；否则，你们就是逃税、是故意犯法。这一来，报告的数据作者成了哑巴、以此表示拒绝改正虚假数据的立场；而《科学》杂志呢，明明知道和不得不承认了那报告使用的是故意伪造的虚假数据来为转基因商业做宣传服务、是应该按照学术刊物规范做处理的，可却耍赖、把他们编辑部的责任推到了我这读者的头上。譬如，该编辑部给我的相关信件说： Date: Wed, 5 Jan 2011 18:04:56： I apologize for the long delay in reply but there was some question regarding who should handle your request and there was some delay due to the Thanksgiving and end of year Holidays. We have looked over your comment and wanted to inform you that we only issues corrections from the author. It seems you have already discussed this with the author and they have declined so we will uphold their decision in this matter. 大意说，既然我已经向作者指明了问题，那该杂志就尊重作者的立场（即以哑巴方式拒绝改错）。于是，我回答该杂志编辑部，说： Sent: Fri 1/07/11 12:01 PM： The mentioned data is obviously wrong. How to avoid knowingly misleading/how to make a correction is an obligation/integrity issue of your author(s) and of your magazine, which published the information, and not of the reader. I do not want to see this matter snowball. A public correction should be made. 大意说：很明显，所说数据是错误数据。针对故意误导的错误数据，如何防范等等是你们编辑部和作者的责任、而不是读者的责任。我不想看到这件事情成为“滚雪球”。（当时，我看到那些报告背后可能有联邦官员的参与、甚至可能与联邦预算有关。在美国，通过虚假统计数据搞联邦预算或获得联邦资助，那不但是政治丑闻且属于刑事犯罪。我不想搞什么“学术打假”而使之成为政治丑闻。因此，我对该杂志编辑部说了，我不想看到那个本来是一个声明就可解决的问题、象滚雪球一样越搞越大。）。 一：科学也会很无耻。 以上两个案例，都是跟调查数据有关，可对比十分鲜明：指明了转基因食品作物有危害风险的调查报告，被扣上莫须有的罪名而予以撤稿；而用伪造数据和虚假信息为转基因商业服务的调查报告却受到权威科学刊物的袒护而可逍遥法外。两个例子都说明：科学可以走向高尚、更可以是很无耻的。 按说，科学也会很无耻，应该不是新鲜事。有作品《拿破仑以后的欧洲简史》的“19世纪的两类文化”篇章说：工业革命和现代化创造了两类新的世俗文化，其中一类是“科学”的“世俗化”（尤其是产业化或商业化），即：“科学”在宗教经院的象牙塔里发展为独立而走了出来、成为世俗社会的一个文化组成部分；因此，世俗社会的生活有什么欢乐，科学就可以给人们带来什么欢乐；同样，世俗社会有什么诈骗和罪恶行径，科学也都可以做得出来；由于“科学”和“科学家”往往以“真理”和“真理代言人”的面目出现，因而，“科学”搞诈骗的欺骗性更大、其犯罪行径之危害性更大，甚至是前所未有的；越是落后愚昧的地方，“科学”出来搞欺骗和犯罪等无耻行为就越容易发生、破坏性也越大。 比较看看：转基因食品作物的推销行为是很厚颜无耻和不择手段的，其手段包括上述的掩盖事实和封杀真话、或是用伪造数据搞欺骗。在中国，其手段还包括官商勾结公开搞各种营私舞弊而逍遥法外，还有打击报复、砸饭碗、造谣诽谤、政治攻击、软禁，还有莫名其妙的桑律师的死亡，等等。不过分地说，在中国，转基因食品推销是建国以来规模最大和程度最严重的商业诈骗活动，其旗号就是“科学”、其推销人往往以“科学家”、“院士”或“科学共同体”等面目出现。 再来比较看看：孟山都和盖兹基金会大力推销转基因食品，可他们自己却是使用天然有机食品和避免转基因食品的；同样，中国农业部官员以“科学”旗号大力诱骗民众食用转基因化工食品，可他们自己却有食堂制度保障他们和他们的子女能享用天然有机食品和避免转基因食品。嘿嘿，不管洋的还是国产的，用“科学”搞欺骗手段都是一样的。 看看传统的、健康的、安全的和货真价实的食品，有哪个是要用那样的手段搞推销的？古今中外的一个市场事实：只有假货才需要用欺骗等不择手段的推销，转基因食品就是那样的假货，所以其推销需要搞欺骗等等不择手段的无耻行为是一再发生。 今年年初，美国白宫发布了继续强化防御以转基因技术武器攻击为主要内容的生物国防政策之公文，名称就是“生物科技应用研究的双重性”，明白说明“科学”及其应用和研究也有危害风险，转基因技术及其应用也不例外。因此，为国家安全、为美国的国土安全和人口安全，在生物技术应用一开始的科研阶段，就要辨别真假和危害风险、防止其落到搞欺骗和危害活动的坏人手里。 美国官方被看作是全球最大的转基因食品作物推手。可是，那是对外国。对本国，美国当局不仅反复说明转基因化工食品的危害风险和不断强化防范措施，且还有奥巴马总统夫人出面和带领全家以身作则、鼓励全国民众使用天然有机健康食品和尽量防用转基因化工等垃圾食品。为维护本国人口安全和食品安全，美国方面和欧盟与日本先后签定了保障各方市场有充足的天然有机食品供应的合作协约；至此，发达国家保障天然有机健康食品的框架大体完成；与此同时，转基因化工食品的作物商业化及其种植却开始从发达国家向发展中国家做规模战略转移、其主要转移目标就是中国。 又来比较看看，中国将怎么办？中国当局能不能象美国当局那样，清楚地看到和明确地向民众说明“生物科技应用研究的双重性”即转基因技术应用和转基因食品的危害风险？在“与国际接轨”的时候，为什么中国农业部门不能与发达国家保障本国有充足的天然有机食品供应的政策做法搞接轨、而偏偏要与发达国家已经开始向外转移的转基因化工食品作物搞什么“国际接轨”呢？ 在这类问题方面，我赞同一些国内学者提出的见解：西欧二三百年前形成的“科学主义”邪门歪道，在中国已经盛行了多年、在思想理论方面为不择手段的转基因食品推销活动即“科学也会很无耻”泛滥成灾而打开了方便之门。因此，要保障国家安全、要维护国土安全和人口安全而做好防御转基因技术武器的攻击的生物国防建设，不仅需要国家行政政策措施等等来保障其实现，且还需要在思想理论方面清除“科学主义”的危害或毒害。用国内一位学者的话来说，那就是：科学技术可以是第一生产力，也可以是第一破坏力和第一杀伤力。一句话：“科学”也会很无耻的；不要以为贴上个“科学”和“科学家”的标签、就是“真理”或“真理代言人”了。说实在的，越是“科学”和自封“科学家”叫得响亮的、就越可能是在搞欺骗，其叫得有多响、那背后的欺骗性和罪恶性也就有多大。 参考阅读： 吕永岩评点漏洞百出的转基因歪嘴报道 2013-12-01 20:21. http://blog.sina.com.cn/s/blog_4b7683ce0102eod8.html . # # #
【微评论】科学应当是中立的，公正的。针对《食物与化学毒理学》对法国科学家团队搞的撤稿行为，被指公然嘲弄科学。如果法国科学家团队的实验，还是用的现在的材料与方法，得出的是认为转基因食品无害且有益的结论的话，他们还会因方法（实验老鼠重量，老鼠数量，实验周期，统计意义等等）问题去撤稿吗？可能不会吧。。。 以下文章链接：http://blog.sina.com.cn/s/blog_4b7683ce0102eofy.html 陈一文提示要点： 荷兰爱思唯尔出版集团，《食物与化学毒理学》的出版方，发表声明，承认刊物总编A·瓦莱斯·海斯博士组织对色拉里尼教授论文的重新审查“未发现欺诈或者故意歪曲数据方面的任何证据”。该项声明提到撤稿的唯一一项理由，称之为“提交的结果（尽管并非有错误）是非决定性的”。《欧洲对社会与环境负责科学家 网络》评论： 论文研究结果“非决定性”不是《食物与化学毒理学》参加与承诺的科学出版中撤稿的指导原则。与此相反， 由于撤掉这篇文章是与转基因产业相关的许多人的愿望，不能不怀疑这是“科学”屈服于特别孟山都的产业利益的结果。《 欧洲对社会与环境负责科学家 网络》对 总编A·瓦莱斯·海斯博士提出的问题逐点予以反驳，最后强调：色拉里尼教授的发现目前比以前更加挺立，即便该项秘密的审查在数据的技术、行为或数据的透明度方面都没有能够找到任何错误 – 这是独立科学的基础。他们的数据的决定性，将由未来独立科学决定，而非由一小圈秘密人士决定。 《 欧洲对社会与环境负责科学家网络》就撤除色拉里尼论文 致《食物与化学毒理学》总编 A ·瓦莱斯·海斯的公 开信： 嘲弄科学而且看来是屈服于产业 转载自《转基因 — 色拉里尼教授教授》网站： http://gmoseralini.org/ensser-comments-on-the-retraction-of-the-seralini-et-al-2012-study/ Open letter to A. Wallace Hayes, editor of Food Chemical Toxicology 致《食物与化学毒理学》总编 A ·瓦莱斯·海斯的公开信 ENSSER (European Network of Scientists for Social and Environmental Responsibility), 30 Nov 2013 《欧洲对社会与环境负责科学家网络》（ ENSSER ） 2013 年 11 月 30 日 ENSSER Comments on the retraction of the Séralini et al. 2012 study 《 欧洲对社会与环境负责科学家 网络》对撤除色拉里尼教授团队 2012 年研究论文的评论 Journal’s retraction of rat feeding paper is a travesty of science and looks like a bow to industry 《食物与化学毒理学》 撤除 色 拉里尼教授团队团队喂养老鼠研究论文是嘲弄科学而且看来是屈服于产业 Elsevier’s journal Food and Chemical Toxicology has retracted the paper by Prof. Gilles-Eric Séralini’s group which found severe toxic effects (including liver congestions and necrosis and kidney nephropathies), increased tumor rates and higher mortality in rats fed Monsanto’s genetically modified NK603 maize and/or the associated herbicide Roundup . 荷兰爱思唯尔出版集团属下刊物《食物与化学毒理学》撤除了色拉里尼教授团队的研究论文，他们发现喂养孟山都转基因玉米NK603的老鼠出现了数项严重的毒性影响（包括肝充血与细胞坏疽以及肾病）、以及肿瘤发生率增大与死亡率更高。 The arguments of the journal’s editor for the retraction, however, violate not only the criteria for retraction to which the journal itself subscribes, but any standards of good science. Worse, the names of the reviewers who came to the conclusion that the paper should be retracted, have not been published. 《食物与化学毒理学》编辑撤稿的理由，不仅违反该刊物参加并承诺的撤稿标准，而且 践踏良好科学的任何标准。更差的是，做出这篇文章撤除决定的审查者的姓名没有公开发布。 Since the retraction is a wish of many people with links to the GM industry, the suspicion arises that it is a bow of science to industry. 由于撤掉这篇文章是与转基因产业相关的许多人的愿望，不能不怀疑这是“科学”屈服于产业利益的结果。 ENSSER points out, therefore, that this retraction is a severe blow to the credibility and independence of science, indeed a travesty of science. 《欧洲对社会与环境负责科学家 网络》指出，因此， 该项撤稿是对科学的可信性与毒理学的严重打击，是对科学的嘲弄。 Inconclusive results claimed as reason for withdrawal 将非决定性结果作为撤稿的理由 Elsevier, the publisher of Food and Chemical Toxicology, has published a statement saying that the journal’s editor-in-chief, Dr. A. Wallace Hayes, “found no evidence of fraud or intentional misrepresentation of the data”. 荷兰爱思唯尔出版集团，《食物与化学毒理学》的出版方，发表了一项声明 ，说刊物总编A·瓦莱斯·海斯博士“未发现欺诈或者故意歪曲数据方面的任何证据”。 The statement mentions only a single reason for the retraction, namely that “the results presented (while not incorrect) are inconclusive”. 该项声明提到撤稿的唯一一项理由，称之为“提交的结果（尽管并非有错误）是非决定性的”。 According to Hayes, the low number of rats and the tumour susceptibility of the rat strain used do not allow definitive conclusions. 依据海斯的说法，较低数量老鼠样本以及所使用的老鼠品系的肿瘤易发生性不允许获得确定性的结论。 Now there are guidelines for retractions in scientific publishing, set out by the Committee on Publication Ethics (COPE) . 但是，《出版伦理委员会》设立了科学出版中撤稿的指导原则。 Inconclusiveness of research results is not one of the grounds for retraction contained in these guidelines. 科学出版中撤稿的指导原则中，研究结果非决定性并非是撤稿的基础之一。 The journal Food and Chemical Toxicology is a member of COPE . 《食物与化学毒理学》是《出版伦理委员会》成员之一。 ‘Conclusive’ results are rare in science, and certainly not to be decided by one editor and a secret team of persons using undisclosed criteria and methods. Independent science would cease to exist if this were to be an accepted mode of procedure. “决定性”结果在科学中相当少见，而且一项研究结果是否“决定性”， 肯定不能由一位编者与食用未公开标准与方法的秘密人士团队能够决定 。如果存在程序的可以接受样式的话，独立科学不可能存在。 Séralini paper a chronic toxicity study, not a full-scale carcinogenicity study 色拉里尼教授的论文是一项毒理学研究，不是全规模致癌性研究 Most notably, Séralini and his co-authors did not draw any definitive conclusions in the paper in the first place; they simply reported their observations and phrased their conclusions carefully, cognizant of their uncertainties. 最明显的是，色拉里尼教授及其合作作者在论文中并没有提出任何决定性的结论，他们仅仅简单的报告了他们的观察，提出审慎用词的结论，论文也提出他们的不确定性。 This is because the paper is a chronic toxicity study and not a full-scale carcinogenicity study, which would require a higher number of rats. 这是因为，这篇论文不是一项慢性毒理学研究，也不是要求更大数量老鼠的全规模致癌性研究。 The authors did not intend to look specifically for tumours, but still found increased tumour rates. 作者们原先没有打算特定观察是否出现肿瘤，但是依然发现肿瘤发生率增加了。 Secondly, both of Hayes’s arguments (the number of rats and their tumour susceptibility) were considered by the peer reviewers of the journal, who decided they formed no objection to publication. 其次，编辑海斯的两项论据（老鼠的数量及其肿瘤易发生性）已经由当初的同行审查者予以考虑，这没有形成他们反对出版的决定。 Thirdly, these two arguments have been discussed at length in the journal following the publication of the paper and have been refuted by the authors of the paper and other experts. 第三，这篇论文发表之后刊物发表了对这两项论据长时间讨论的文章，而且遭到文章作者与其他专家的反驳。 Higher numbers of animals are only required in this type of safety studies to avoid missing toxic effects (a ‘false negative’ result), but the study found pronounced toxic effects and a first indication of possible carcinogenic effects. 对这种类型安全性研究而言，仅在为了避免漏掉毒性影响（“误负面”结果）情况下才要求更大数量的动物，但是该项研究已经发现非常显著毒性影响以及可能的致癌作用的第一迹象。 The Sprague-Dawley strain of rat which was used, is the commonly used standard for this type of research. 该项研究使用的SD品系鼠，是这种类型研究普遍使用的标准 。 注：2003年， 中国疾病预防控制中心营养与食品安全所接受孟山都委托与样品对孟山都抗草甘膦转基因大豆“食用安全性”做的《抗农达大豆 40-3-2及其产品食用安全性检验的大鼠90 天喂养试验》与对抗草甘膦转基因玉米 NK603 “食用安全性”做的《NK 603 玉米大鼠 90 天喂养试验报告》 都选用了同样的 SD 鼠。 For these reasons, the statistical significance of the biochemical data was endorsed by statistics experts. The biochemical data confirm the toxic effects such as those on liver and kidney, which are serious enough by themselves. The tumours and mortality rates are observations which need to be confirmed by a specific carcinogenicity study with higher numbers of rats; in view of public food safety, it is not wise to simply ignore them. 由于这些理由，统计学专家赞同论文列出的生物化学数据的统计学显著性。 这些生物化学数据确认了例如对肝脏与肾脏的毒性作用，仅这些就足够严重 。研究中观察到的肿瘤与死亡率，需要通过使用更大数量老鼠的特定致癌性研究予以确认； 考虑到公共安全性，简单忽略这些问题并非明智。 Unpleasant results should be checked, not ignored. And the toxic effects other than tumours and mortality are well-founded. 不愉快的结果应当进一步核实，而不是忽略。 肿瘤与死亡率以外的毒性作用是有根据的。 Who did the reevaluation? 谁进行了该项再审查？ Even more worrying than the lack of good grounds for the retraction is the fact that the journal’s editor-in-chief has not revealed who the reviewers were who helped him to come to the conclusion that the paper should be retracted; nor has he revealed the criteria and methodology of their reevaluation, which overruled the earlier conclusion of the original peer-review which supported publication. 比撤稿缺乏有效根据更令人担心的是，刊物总编没有公开是哪些审查者帮助他得到这篇论文应当撤除的结论；他也没有公开他们推翻当初同行审查者早先支持发表结论的该项重新评价时依据的标准与方法。 In a case like this, where many of those who denounced the study have long-standing, well-documented links to the GM industry and, therefore, a clear interest in having the results of the study discredited, such lack of transparency about how this potential decision was reached is inexcusable, unscientific and unacceptable. 在像这样的案例中，对这篇论文进行指责的许多人士具有与转基因产业关系的长期记录，因此清楚的利益造成力图败坏这篇论文声誉。关于该项撤稿决定如何形成方面缺乏透明性， 是不可原谅的、不科学的与不可接受的 。 It raises the suspicion that the retraction is a favour to the interested industry, notably Monsanto. 此事不能不引出这样的怀疑： 该项撤稿是对相关利益产业投其所好，特别是孟山都公司。 ENSSER promotes independent critical discourse 《 欧洲对社会与环境负责科学家 网络》促进独立的批判性话语 It is part of ENSSER’s mission to promote the critical discourse, particularly in Europe, on new technologies and their impacts. 对新技术及其影响推进批评性话语，是《欧洲对社会与环境负责科学家 网络》职责的一部分，特别在欧洲。 As scientific and technological advances are increasingly driven by private interest, disinterested independent health and environmental safety information often lags behind. 由于 科学技术进展越来越收到私人利益的驱动， 缺乏兴趣的独立健康与环境安全信息往往滞后。 Uncertainty is inherent to science, as is the debate between conflicting explanations of findings. Openness of this debate and independent research to find the truth are crucial prerequisites for the survival of independent science. 不确定性是科学固有的特性，如同对某些发现相互冲突解释之间的辩论那样。这样的辩论的公开性以及通过独立研究发现真相，是独立科学得以生存的至关重要先决条件。 This holds true in particular for the technology of genetically modified crops, where the safety studies done by the producers for authorisation of the crops are all too often not published at all because of business confidentiality of the data and may not hold up to an independent peer-review. 对于转基因作物技术而言，这更是真的，因为转基因作物研发者为获得授权所做的安全研究往往不公开发表，因为这些研究数据的商业秘密性使其可能通不过独立同行审查过程。 These studies, not only the independent ones like Séralini’s, should be subject to debate. The public have a right to be informed of anything related to the safety of their food. 转基因作物研发者为获得授权所做的这些安全研究，而不是仅仅色拉里尼教授所做的独立研究，都应当成为进行辩论的议题。公众有权了解与他们食物安全性相关的所有信息。 In short, the decision to retract Séralini’s paper is a flagrant abuse of science and a blow to its credibility and independence. 简短的说，撤除色拉里尼教授论文的决定是公然滥用科学，对科学的可信性与独立性的严重打击。 It is damaging for the reputation of both the journal Food and Chemical Toxicology and its publisher Elsevier. It will decrease public trust in science. And it will not succeed in eliminating critical independent science from public view and scrutiny. Such days and times are definitively over. 撤除色拉里尼教授论文的决定损害《食物与化学毒理学》以及 爱思唯尔出版集团的信誉。它减少公众对科学的信任。它在使关键独立科学从公共视野和细查中消失不会获得成功。这样的日子与时代确定性已经过去。 Prof. Séralini’s findings stand today more than before, as even this secret review found that there is nothing wrong with either technicalities, conduct or transparency of the data – the foundations on which independent science rests. The conclusiveness of their data will be decided by future independent science, not by a secret circle of people. 色拉里尼教授的发现目前比以前更加挺立，即便该项秘密的审查在数据的技术、行为或数据的透明度方面都没有能够找到任何错误 – 这是独立科学的基础。他们的数据的决定性，将由未来独立科学决定，而非由一小圈秘密人士决定。 Contact: office@ensser.org 联系人： office@ensser.org 参考文献： Séralini, G.-E., Clair, E., Mesnage, R., Gress, S., Defarge, N., Malatesta, M., Hennequin, D., de Vendômois, J.S.: Long term toxicity of a Roundup herbicide and a Roundup-tolerant genetically modified maize, Food and Chemical Toxicology 50 (11), pp. 4221-4231 (2012) http://www.elsevier.com/about/press-releases/research-and-journals/elsevier-announces-article-retraction-from-journal-food-and-chemical-toxicology http://publicationethics.org/files/retraction guidelines.pdf http://publicationethics.org/members/food-and-chemical-toxicology
转基因玉米致癌论文被撤 编委曾就职孟山都 http://www.wyzxwk.com/Article/shidai/2013/11/309924.html 作者：宗和 发布时间：2013-11-30 来源：财经网等 字体： 大 | 中 | 小 法国研究人员2012年在《食品和化学毒物学》杂志上发表转基因玉米致癌论文，已成为部分人士反对转基因食品的重要证据。但杂志出版方爱思唯尔公司28日在美国宣布，由于进一步分析显示论文数据不足以支持其结论，因此决定撤除这篇论文。 爱思唯尔公司在声明中说，《食品和化学毒物学》杂志对所发表的论文及论文所报告的数据进行了彻底的、长时间的分析，对论文发表的同行评议过程也进行了调查，“没有发现欺诈或对数据有意曲解的证据”，然而，“有理由担忧”论文所提及实验中研究人员使用的实验大鼠数量和类型。 声明说：“对原始数据的深入调查表明，用如此小规模的样本数据无法得出明确结论”、“考虑到(实验中所用的)斯普拉格-道利大鼠的已知肿瘤高发生率，喂食转基因玉米组所观察到的更高的死亡率及肿瘤发生率的原因不能排除是正常变化”。 声明说，归根结底，论文的结果“尽管无不妥之处”，但是“没有说服力”，因此这篇论文达不到《食品和化学毒物学》的出版要求。 声明还说，这篇论文发表后编辑部收到多封来信，对论文描述结果的有效性、实验动物的合理使用表达关切，有些来信甚至称其中存在欺诈，多数来信呼吁撤回这篇论文。这些来信以及支持这篇论文的来信，都已和作者的回应一并发表。 英国《自然》杂志网站说，这一撤稿举动并不令人意外，《食品和化学毒物学》杂志主编本月初曾要求作者主动撤回论文，并表示如果作者拒绝，杂志方也将予以撤稿。报道还说， 论文作者把撤稿形容为“丑闻”，并声称，这是因为杂志任命的一名编委此前曾在转基因农业巨头孟山都公司工作过7年 。 2012年，《食品和化学毒物学》杂志刊登了法国卡昂大学分子生物学家塞拉利尼等人的一份研究报告。该报告称，将100只雄性和100只雌性大鼠分成10组，分别喂食孟山都公司的NK603转基因玉米及其他食物，两年后发现，喂食转基因玉米的实验大鼠出现肿瘤的风险高、寿命短。 这一结论在全球引起风波。法国国家卫生安全署、生物技术最高委员会和欧洲食品安全局均对塞拉利尼等人的研究展开调查，结果均认为，该研究存在诸多不足，不能作为评估转基因玉米健康风险的有效依据。 【下面是塞拉利尼团队声明中英对照本。2013-11-28。引用自顾秀林博客】 我们是FCT一年多前发表的论文的作者，关于农达和耐受农达的转基因生物的事（塞拉利尼等2012） 。 对于同样的质疑， 我们已经在同一个刊物上回应过（塞拉利尼等，2013），即：作为正常的科学辩论，仅仅由于实验鼠品系的选择和数量的原因，就判定研究结果“结论不完整”，这是不能接受的。我们坚持我们的结论。我们早已公布了对相同的质疑所做的回答，但至今没有见到对我们的任何回应（塞拉利尼等，2013）。 We, authors of the paper published in FCT more than one year ago on the effects of Roundup and a Roundup-tolerant GMO (Séralini et al., 2012), and having answered to critics in the same journal (Séralini et al., 2013), do not accept as scientifically sound the debate on the fact that these papers are inconclusive because of the rat strain or the number of rats used. We maintain our conclusions. We already published some answers to the same critics in your Journal, which have not been answered (Séralini et al., 2013). 关于实验大鼠品系 同一个大鼠品系，被用在研究致癌性和慢性化学毒理学的美国国家毒理学项目中(King-Herbert et al., 2010)。SD大鼠是常规性用于毒理和致癌效果实验中的动物，其中有孟山都公司的90天实验，被当做批准NK603转基因玉米应用的依据，其他转基因农作物也是这样做的(Sprague Dawley rats did not came from Harlan but from Charles-River) (Hammond et al., 2004; Hammond et al., 2006a; Hammond et al., 2006b). Rat strain The same strain is used by the US national toxicology program to study the carcinogenicity and the chronic toxicity of chemicals (King-Herbert et al., 2010). Sprague Dawley rats are used routinely in such studies for toxicological and tumour-inducing effects, including those 90-day studies by Monsanto as basis for the approval of NK603 maize and other GM crops (Sprague Dawley rats did not came from Harlan but from Charles-River) (Hammond et al., 2004; Hammond et al., 2006a; Hammond et al., 2006b). 这里有一个简明的初步的文献清单，表明在同行评审的杂志上SD大鼠被用在36个月的实验如(Voss et al., 2005) or in 24-month studies by (Hack et al., 1995), (Minardi et al., 2002), (Klimisch et al., 1997), (Gamez et al., 2007).，其中有一些文章就发表在FCT上。 A brief, quick and still preliminary literature search of peer-reviewed journals revealed that Sprague Dawley rats were used in 36-month studies by (Voss et al., 2005) or in 24-month studies by (Hack et al., 1995), (Minardi et al., 2002), (Klimisch et al., 1997), (Gamez et al., 2007).Some of these studies have been published in Food and Chemical Toxicology. Number of rats, OECD guidelines 实验动物数量与OECD实验规范 OECD 实验规范：第408条，关于90天实验，第452条关于慢性毒性试验，第453条关于综合致癌性/慢性毒性试验，都要求用20只动物为一组(1981和2009的规定都这样要求)，尽管可以用10只动物的实验就能取得生物化学参数。我们做的是长期毒性研究而不是致癌性研究，从一开始就不是这样设想的。根据常规10只动物一组已经足够在生物化学水平上进行研究，我们测量的参数数量是非常大的。 OECD guidelines (408 for 90 day study, 452 chronic toxicity and 453 combined carcinogenicity/chronic toxicity study) always asked for 20 animals per group (both in 1981 and 2009 guidelines) although the measurement of biochemical parameters can be performed on 10 rats, as indicated. We did not perform a carcinogenesis study, which would not have been adapted at first, but a long-term chronic full study, 10 rats are sufficient for that at a biochemical level according to norms and we have measured such a number of parameters! 在我们的实验中，性激素干扰的参数以及其它参数对于解释一年之后的严重后果是充分的。我们采用的OPLS-DA统计方法是最适宜的。关于肿瘤和动物死亡，时间效果以及每只动物的平均肿瘤数量都必须被纳入分析。在风险研究中出现的每一个迹象，都必须被充分重视。孟山都公司的研究用了同样的大鼠品系，每组仅10只衡量20个参数，就得出同一种NK603转基因玉米“安全”的结论，而且他们的实验只做了3个月 (Hammond et al., 2004) The disturbance of sexual hormones or other parameters are sufficient in themselves in our case to interpret a serious effect after one year. The OPLS-DA statistical method we published is one of the best adapted. For tumours and deaths, the chronology and number of tumours per animal have to be taken into account. Any sign should be regarded as important for a real risk study. Monsanto itself measured only 10 rats of the same strain per group on 20 to conclude that the same GM maize was safe after 3 months (Hammond et al., 2004). The statistical analysis should not be done with historical data first, the comparison is falsified, thus 50 rats per group is useless 统计分析不应该先做历史数据，用这个方法做比较研究是错误的，用每组50只动物做研究是无意义。 采纳历史数据会把健康风险评估变成研究造假，因为食谱中的材料已经受到化学污染(by dibenzo-p-dioxins and dibenzofurans (Schecter et al., 1996)和汞污染(Weiss et al., 2005)，镉污染，铬污染等，污染的程度足以改变动物肝脏和肺脏的基因表达，足以扰乱基因分析(Kozul et al., 2008)。以往的食料中还发现农药和增塑剂污染，污染来自箱笼或者水(Howdeshell et al., 2003)。历史数据也有来自可能食用了转基因的动物，很多地方的鼠粮中的确发现了转基因成分。这一切都与污染水平相关，我们已经在实验大鼠和对照组大鼠中检测到这些问题。 The use of historical data falsifies health risk assessments because the diet is contaminated by dibenzo-p-dioxins and dibenzofurans (Schecter et al., 1996), mercury (Weiss et al., 2005), cadmium and chromium among other heavy metals in a range of doses that altered mouse liver and lung gene expression and confounds genomic analyses (Kozul et al., 2008). They also contained pesticides or plasticizers released by cages or from water sources (Howdeshell et al., 2003). Historical data also come from rats potentially fed on GMOs, some animal pellets in the world do indicate that. All that corresponds to the contamination levels for which we have detected some effects in our treated rats versus appropriate controls. 在历史数据中，2年SD雌性大鼠罹患乳腺纤维瘤的为13%~62%(Giknis, 2004)，但在我们的实验中对照组的发病率要低得多，这才是真正的对照，而我们的实验鼠发病率比对照组高很多，这使得我们的研究结果有显著性。动物的死亡率也是这样。 2-year historical data mammary fibroadenoma rate from Charles River SD females ranged from 13 to 62% (Giknis, 2004). We obtain a lot less in our controls, the real comparators, a lot more in treated rats. This makes our results significant, like for deaths. Double standards 双重标准 遵循同一个逻辑把塞拉利尼的实验和孟山都公司的实验做一对一的比较，如果前者被认为不足以显示危害，那么后者也不能认为证明了安全。 A factual comparative analysis of the rat feeding trial by the Séralini’s group and the Monsanto trials clearly reveals that if the Séralini experiments are considered to be insufficient to demonstrate harm, logically, it must be the same for those carried out by Monsanto to prove safety. 以往的研究发现凡是显示转基因农作物有负面效果的，都会被监管者从实验到统计方法做严格的重审，凡是声称转基因农作物安全的研究，都被照单接受。只要是没有报告负面效果的研究，都被接受为“安全”的证明，无论他们的研究方法有何种不足(被认为无关紧要)。 Basically, all previous studies finding adverse effects of GE crops have been treated by regulators with the attitude: only those studies showing adverse effects receive a rigorous evaluation of their experimental and statistical methods, while those that claim proof of safety are taken at face value. All studies that reported no adverse effects were accepted as proof of safety regardless of these manifest (but deemed irrelevant) deficiencies of their methods. 来自(Snell et al., 2012) 的一份文献概览研究可以说明这个倾向。如作者在摘要中这样说，“在这里的24项研究的结果都不建议存在任何健康危害问题…”即所有被审阅的研究都被按“票面价值”被接受和通过了。然而在文章中却指出，研究报告的作者们留下了无数缺陷，同他们指责塞拉利尼论文的问题类似，或者更严重。例如24篇中16篇(67%)文章没有交代对照组饲料是否与实验用的饲料属于同基因品种(他们的解释只是“没有采用”)。许多篇文章连讨论所用的方法都没有介绍。此外还有其他被指出的缺陷。 The review by (Snell et al., 2012) illustrates this issue. In the abstract, the authors state Results from all the 24 studies do not suggest any health hazards – taking all those studies at face value. Yet in their review, the authors find numerous weaknesses of similar or greater severity raised for the Séralini group's paper. For example, of the 24 studies they evaluated 16 (67% of all studies) did not mention using the isogenic line as control (interpreted as having not used them), many did not describe the methods in any detail, and according to the reviewers had other deficiencies too. 基于完全相同的原因，FCT应该把Hammond 等人关于耐受农达转基因玉米的那些论文全都撤回。那些论文貌似都是真正的科学讨论，发表它们只是为了给孟山都提供权威证据。 FCT should retract the Hammond et al. paper on Roundup tolerant maize for all these reasons, published for Monsanto’s authorization, or consider that each of these papers is part of the scientific debate. References 参考文献 Gamez, R., Noa, M., Mas, R., Mendoza, N., Pardo, B., Menendez, R., Perez, Y., Gonzalez, R.M., Gutierrez, A., Marrero, G., Goicochea, E., Garcia, H., Curveco, D., 2007. Long-term carcinogenicity of D-003, a mixture of high molecular weight acids from sugarcane wax, in Sprague Dawley rats: a 24 months study. Food Chem Toxicol 45, 2352-2358. Giknis, M.L.A.a.C., C.B., 2004. Charles River Laboratories. Compilation of spontaneous neoplastic lesions and survival in Crl:CD (SD) rats from control groups. Hack, R., Ebert, E., Leist, K.H., 1995. Chronic toxicity and carcinogenicity studies with the insecticide endosulfan in rats and mice. Food Chem Toxicol 33, 941-950. Hammond, B., Dudek, R., Lemen, J., Nemeth, M., 2004. Results of a 13 week safety assurance study with rats fed grain from glyphosate tolerant corn. Food Chem Toxicol 42, 1003-1014. Hammond, B., Lemen, J., Dudek, R., Ward, D., Jiang, C., Nemeth, M., Burns, J., 2006a. Results of a 90-day safety assurance study with rats fed grain from corn rootworm-protected corn. Food Chem Toxicol 44, 147-160. Hammond, B.G., Dudek, R., Lemen, J.K., Nemeth, M.A., 2006b. Results of a 90-day safety assurance study with rats fed grain from corn borer-protected corn. Food Chem Toxicol 44, 1092-1099. Howdeshell, K.L., Peterman, P.H., Judy, B.M., Taylor, J.A., Orazio, C.E., Ruhlen, R.L., Vom Saal, F.S., Welshons, W.V., 2003. Bisphenol A is released from used polycarbonate animal cages into water at room temperature. Environ Health Perspect 111, 1180-1187. King-Herbert, A.P., Sills, R.C., Bucher, J.R., 2010. Commentary: update on animal models for NTP studies. Toxicol Pathol 38, 180-181. Klimisch, H.J., Deckardt, K., Gembardt, C., Hildebrand, B., Kuttler, K., Roe, F.J., 1997. Long-term inhalation toxicity of N-vinylpyrrolidone-2 vapours. Studies in rats. Food Chem Toxicol 35, 1041-1060. Kozul, C.D., Nomikos, A.P., Hampton, T.H., Warnke, L.A., Gosse, J.A., Davey, J.C., Thorpe, J.E., Jackson, B.P., Ihnat, M.A., Hamilton, J.W., 2008. Laboratory diet profoundly alters gene expression and confounds genomic analysis in mouse liver and lung. Chem Biol Interact 173, 129-140. Minardi, F., Belpoggi, F., Soffritti, M., Ciliberti, A., Lauriola, M., Cattin, E., Maltoni, C., 2002. Results of long-term carcinogenicity bioassay on vinyl acetate monomer in Sprague-Dawley rats. Ann N Y Acad Sci 982, 106-122. Séralini, G.E., Clair, E., Mesnage, R. Gress, S., Defarge, N. Malatesta, M. Hennequin, D. Spiroux de Vendômois, J. (2012) Long term toxicity of a Roundup herbicide and a Roundup-tolerant genetically modified maize. Food and Chem. Tox. 50:4221-4231 Séralini, G.E., Mesnage, R., Defarge, N., Gress, S., Hennequin, D., Clair, E., Malatesta, M., Spiroux de Vendômois, J. (2013) Answers to critics: why there is a long term toxicity due to NK603 Roundup-tolerant genetically modified maize and to a Roundup herbicide. Food and Chem. Tox. 53:461-468 Schecter, A.J., Olson, J., Papke, O., 1996. Exposure of laboratory animals to polychlorinated dibenzodioxins and polychlorinated dibenzofurans from commerical rodent chow. Chemosphere 32, 501-508. Snell, C., Bernheim, A., Berge, J.B., Kuntz, M., Pascal, G., Paris, A., Ricroch, A.E., 2012. Assessment of the health impact of GM plant diets in long-term and multigenerational animal feeding trials: a literature review. Food Chem Toxicol 50, 1134-1148. Voss, C., Zerban, H., Bannasch, P., Berger, M.R., 2005. Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes of Sprague-Dawley rats. Toxicology 206, 359-371. Weiss, B., Stern, S., Cernichiari, E., Gelein, R., 2005. Methylmercury contamination of laboratory animal diets. Environ Health Perspect 113, 1120-1122.
在既往印象中，中国人撒谎、造假司空见惯，因为不用为此付出太多代价，甚至有人自诩：“不说假话办不成大事”！ 外国人信用造假，可能连身家性命都要赔上，还要连累家人，可谓“赔了夫人又折兵”，实在划不来！ 不知学术论文造假风险较小，还是论文造假的利益可观，如今外国人也纷纷以身试法，丢掉了个人赖以取信于人的客观和求真，陷入诚信危机的怪圈。 也许因为高水平论文等于更高级别的职位晋升、更大数额的经费支持、更显赫的名誉和地位，让任何人都抵挡不住诱惑吧！ 难怪诺贝尔奖仅凭一纸论文的高引用率进行预测不靠谱，也难怪有识之士不赞成以SCI论文论英雄，原来这些白纸黑字的玩意也能被铤而走险者玩弄于股掌之间。 像韩国如此注重诚信的民族，对待黄禹锡案仍然掺杂着很重的人情成分。因造假而服刑的黄禹锡，刑满释放后还是一条“好汉”，居然可以重启他的干细胞研究。 中国人学术造假的代价对于韩国人来说简直就是“小巫见大巫”，毫发无损！个别单位还会集体护短，甚至痛骂揭短者“不爱学校”，上面来查也是理直气壮地打报告称“查无实据”！ 不单单学术界如此不堪，当官做行政的又何尝不是犯事后尽可享受豁免，只不过“挪挪窝”而已，换一个地方照样做官，改一个职位仍然能称王称霸。 制度设计缺陷，加之惩处轻微或不惩处，让造假的代价可以忽略不计，大概是中国长期反腐不力的根本原因之一。 近闻哈佛大学125名学生涉嫌作弊，大概因为少不更事，“初生牛犊不怕虎”嘛，或者美国人把学生集体抄袭太当一回事，在中国这样的事老师见多了，根本不值一提。 纽约时报中文版今天发表一篇文章，谈到了学术造假遭遇撤稿这一世界性丑闻，有兴趣者可以读一读。 http://cn.nytimes.com/article/education/2012/10/16/c16fraud/ 学术论文为何频频撤稿？ CARL ZIMMER 报道 2012年10月16日 去年《自然》杂志(Nature)报道称，学术论文撤稿数在近十年激增十倍之多，每年撤销的科研论文超过300篇。 部分研究表明，实验差错是大多数论文撤稿的原因，然而在本周发表的一篇文章对论文撤稿进行了更深入的分析，对于这种善意的假设提出了质疑。 这篇研究报道刊登于《美国国家科学院院刊》( Proceedings of the National Academy of Sciences )。两名科学家和一位医学信息顾问选取2047篇生物医学和生命科学领域的撤稿论文，并对撤稿原因进行深入分析。结果他们发现，在所有能辨明原因的撤稿论文中，有四分之三的论文撤稿源自学术不端。 “我们发现问题比想象中严重得多，”文章作者之一、阿图罗·卡萨德沃尔博士(Dr. Arturo Casadevall)如是说。卡萨德沃尔博士来自纽约市布朗克斯区的阿尔伯特·爱因斯坦医学院(Albert Einstein College of Medicine)。 文章另一位作者是来自华盛顿大学(University of Washington)的费里克·C·方博士(Dr. Ferric C. Fang)。两位专家对当下的科研文化早有批评。在他们看来，撤稿率上升反映出科研机制的不正常——科学家在不正当的激励之下容易犯下草率错误，甚至冒险发布错误数据。 “我们意识到需要更多披露撤稿原因的有力数据，”方博士表示。 他们与医学信息顾问R·格兰特·斯蒂恩博士(R. Grant Steen)合作，在美国国家医学图书馆(National Library of Medicine)维护的PubMed数据库中搜索2012年5月前发布的撤稿通知。斯蒂恩博士来自北卡罗来纳大学教堂山分校(Chapel Hill, N.C.)，之前发表过文章分析近十年的撤稿事件。 “我们大概是强迫症发作，所以才会开始逐篇分析撤稿论文，”方博士说。 他们分析学术期刊引用的撤稿论文原因，同时也会全方位查找问题根源。 举例来说，博里斯·切斯基(Boris Cheskis)曾在任惠氏制药公司(Wyeth Research)资深科学家时，分别于2002年和2007年，与同事联合发表两篇有关雌激素信号转导机制的文章。他们随后要求撤回两篇文章，理由是文中部分数据“不可靠”。2010年，美国卫生和公众服务部(Department of Health and Human Services)下属机构——科研诚信办公室(Office of Research Integrity)判定切斯基博士伪造实验数据，存在学术不端行为。 切斯基博士最终与政府达成和解。他既不接受，也不否认上述指控，但是他同意不加入美国公共卫生署的任何顾问团，并且愿意在两年内在参加所有公共卫生署资助的研究时接受监督。 两篇文章的撤销报告并未指出存在欺骗行为。我们也无法联系切斯基博士本人对此作出评论。 方博士和同事深入研究科研诚信办公室的其他报告，同时查看相关新闻和“ Retraction Watch ”博客的跟踪报道（此博客专门监视论文撤稿的情况，调查学术不端的行为——译注）。经过他们的深入研究，他们把总计158篇论文的撤稿原因重新归类，列为“学术不端”文章。 “我们从未见过如此高水平的分析，”伊万·奥兰斯基博士(Dr. Ivan Oransky)表示。“它证实了我们的猜想。”奥兰斯基是“ Retraction Watch ”博客的作者，也是路透社健康版块的执行编辑。 奥兰斯基博士预测论文撤稿率将在未来持续增长。学术欺骗行为层出不穷，令他和搭档亚当·马库斯(Adam Marcus)疲于应付。 今年七月，日本麻醉科学会公布了麻醉学专家藤井善隆(Yoshitaka Fujii)在172篇论文中伪造数据的消息，其中大部分论文还未被正式撤销。“他们将着手调查这些伪造论文，”奥兰斯基说道。 埃默里大学(Emory University)卫生政策系教授本杰明·G·德鲁斯博士(Benjamin G. Druss)说，他认为论文中数据合理，随后又补充它们“有待查证”。他指出PubMed数据库中的论文撤稿率仅为万分之一，相比之下，该数据库中共有112908篇论文已经刊出修正版。 卡萨德沃尔对此持有异议。“这让我益发确信，我们的科研领域存在问题。”他强调道。 卡萨德沃尔继续说，就算存在欺骗行为的论文只是少数，撤稿率的攀升体现出科研领域赢家至上的文化。能否在重要期刊上发表文章，这将决定你是掌管实验室，还是面临失业。“于是某些人开始造假，”他告诉我们。 卡萨德沃尔继而指出，更好的监测技术，比如剽窃测试软件，也许有助于遏制学术不端行为，但是改变文化才是科学界需要做的头等大事。 “只要这种不恰当的奖励体制存在，问题就不会消失。”卡萨德沃尔博士表示。 本文最初发表于2012年10月1日。 翻译：李卓
Table S2. Investigators with Ten or More Retracted Articles* Author No. of Retractions Reason for Retraction Boldt, J 80 fraud Mori, N 36 fraud Herrmann, F 21 fraud Reuben, SS 18 fraud Slutsky, RA 18 fraud Matsuyama, W 17 fraud Schn, JH 17 fraud Darsee, JR 14 fraud Goldstein, G 14 error Pease, LR 14 fraud Bulfone-Paus, S 13 fraud Wang, Z 12 fraud Soman, VR 11 fraud Chiranjeevi, P 10 fraud Potti, A 10 fraud Sudb, J 10 fraud Thomas, JM 10 fraud *when multiple individuals from a single research group have been authors on retracted articles, the individual from the group on the greatest number of articles is listed .
虽然目前脱落酸（ABA）受体的争议已经结束（ http://f1000.com/reports/b/2/15/#bib-001 ），但是可能错误鉴定ABA受体的两篇Nature和一篇Science文章中，只有一篇Nature（ The RNA-binding protein FCA is an abscisic acid receptor ）被撤销了，另一篇nature（ The Mg-chelatase H subunit is an abscisic acid receptor ）的通讯作者是现任清华大学的张大鹏教授，他们认为在拟南芥中叶绿素合成途径的Mg螯合酶H亚基是脱落酸受体，然而别人报道大麦中的同源蛋白无此功能。那篇Science的通讯作者是NIBS的马力耕研究员。以下详细讨论这篇Science文章该不该撤销。 2007年，马力耕研究员在science上横空出世地发表了一篇鉴定植物激素脱落酸的受体的文章（A G Protein–Coupled Receptor Is a Plasma Membrane Receptor for the Plant Hormone Abscisic Acid）。该文指出拟南芥GCR2蛋白可能是一种新的G蛋白偶联受体（GPCR），并且是脱落酸受体。这篇文章一出来，立即引来大量人士围观，许多人唏嘘不已。说实话，当时在植物里还没有真真切切地鉴定出任何一个GPCR，马力耕等人却用预测软件推测GCR2是一个七次跨膜的GPCR，又用一系列实验表明GCR2可能是脱落酸受体。 之后，多人联合针对马力耕的文章发表了技术评论（Comment on "A G Protein–Coupled Receptor Is a Plasma Membrane Receptor for the Plant Hormone Abscisic Acid"），他们通过预测软件发现GCR2不太可能是膜蛋白，更别说是七次跨膜的GPCR，而更可能是细菌羊毛硫氨酸合成酶的同源蛋白。而且一些亲和力实验也不到位（比如用被撤销的nature文章中鉴定的ABA受体FCA做阳性对照），解释的不清楚。然而，马力耕等人根据自己补充的实验结果也进行了辩护（Response to Comment on "A G Protein–Coupled Receptor Is a Plasma Membrane Receptor for the Plant Hormone Abscisic Acid"），说现有的预测软件无法做到非常准确的预测，那么就不能否认GCR2可能是一种GPCR。事情似乎到此就为止了。 然而，某些人对科学问题就是要弄得清清楚楚，明明白白。（我们是实验室的老师说我就是个科学洁癖，呵呵。）据查，GCR2的结构已经被解析了，虽然还不知道结构长啥样，但是我可以预见：结构肯定表明GCR2不是个膜蛋白，而是一个可溶蛋白。为什么呢？马力耕的那篇文章竟然用大肠杆菌就成功表达了GCR2，我所看到的表达GPCR的文献中绝大多数都是用酵母或者昆虫细胞才能正确表达一个GPCR。另外，做GPCR的结构是非常困难的，只有某几个实验室目前做出来了。而GCR2很轻易就被某人做出来了，而且那人不是专门做GPCR的，也没有和做GPCR的人合作，于是不难猜测GCR2是个可溶蛋白。 如果GCR2是个可溶蛋白，那么马力耕的那一系列实验就很难站得住脚了，该不该撤销呢？中国学者有过主动撤销CNS的先例吗？ 其实，说到这里，又不得不提Science杂志上曾经非常热门的一篇文章：砷可以替代磷来维持某细菌GFAJ-1的生长。这个概念非常惊世骇俗，因为大家都知道砷是有毒的，一个生物机体竟然能用砷来维持生命，多么神奇，这颠覆了以前的构成生命活动的基本元素的理论。Science杂志将这篇文章于2010年12月在线后搁置了许久，最终予以发表。然而，就在前不久，science上两篇文章同时指出GFAJ-1细菌并没有把砷整合到自己的DNA中去，它仍然需要磷，不可或缺。原来，之前的science文章中培养细菌的条件并没有完全除去磷，而这种细菌有个特点就是能在极低的磷浓度下吸收磷并将其整合到自己的DNA中，虽然砷大量存在，但是并没有替代磷。也就是说这种细菌只是一种耐砷细菌而已。那么之前的那篇Science文章该被撤销吗？
Anil Potti博士是一位受人尊重、而且在美国具有注册临床肿瘤研究者的资格。他1977-1987年在印度康德拉巴德（Secunderabad, India）上中学，高中毕业时也是他们班的佼佼者，随后进入小花卉初级学院（Little Flower Junior College），在此也研修一些大专本科课程，主要是生物、物理和化学方面的。1989年,他作为6位候选人之一，与来自印度各地的其他5位获胜者进入到著名的韦诺尔（Vellore）基督教医学院接受医学和外科学士学位(M.B.B.S)的培训，并获得国优奖学金（National Merit Scholarship）的资助，以优异成绩从医学院毕业。1996年,他进入内科医生的医院实习期，实习就在美国北达科他大学的法戈医学院（University of North Dakota School of Medicine in Fargo），后来Anil Potti在此任总住院医师（Chief Resident），继而成为一名教员。2003年，以Anil Potti个人的经历，使其进入杜克大学（ Duke University）从事血液学和肿瘤学的研究,为期3年。在顺利完成了严格的培训计划之后,使他有资格获得血液学及医疗肿瘤学方面的认证。2006年,他完成了血液学/肿瘤学训练之后，由杜克大学聘任在杜克大学医学系当教员。 Anil Potti博士是医学肿瘤学方面的专科医生，而且在美国北达科他大学（University of North Dakota） 医学和健康科学学院医学系已经担任助理教授，而在杜克大学医学系（Department of Medicine at Duke University）担任副教授。对于其作为一名临床医生和教育工作者，Anil Potti博士已经获得多项著名奖项，如2010年约瑟夫·格林菲尔德辅导奖（ Joseph Greenfield Mentoring Award in 2010）,α-欧米茄-α(Alpha Omega Alpha),本年度医学学生优秀教师奖（Outstanding Teacher of the Year Award – Medical students）、Leonard B.Tow医学人文精神奖（Leonard B.Tow Humanism in Medicine Award）,内科住院医生优秀教师奖（Outstanding Teacher Award – Internal Medicine Residents）,Robert Silber 研究奖（Robert Silber Research Prize）,2008年美国临床肿瘤学会（ASCO）授予IDEA奖（国际发展与教育奖）（ASCO IDEA Mentor in 2008），还有Lisa Stafford 临床研究奖（Lisa Stafford Clinical Research Prize ）等。他同时也是一位多个社团的活跃分子，如美国的Alpha-Omega-Alpha优秀学生联合会(Alpha-Omega-Alpha (AOA) Honor Society),美国临床肿瘤学协会(American Society of Clinical Oncology)和美国癌症研究协会(American Association of Cancer Research)等。教育简历如下： 近来，Anil Potti博士以及合作者已经有6篇论文撤稿，但是这是否就是最后一篇，谁也无法给出一个肯定的回答，不过有人猜测近期可能还会出现新的，总数将接近一打( Potti retraction tally grows to six with a withdrawal in PLoS ONE, and will likely end up near adozen )。相关报道请浏览： An array of errors（ http://www.economist.com/node/21528593 ） http://retractionwatch.wordpress.com/category/by-author/anil-potti-retractions/ Anil Potti and his former Duke colleagues have retracted a sixth paper, this one in PLoS ONE . According to the retraction notice for “ An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer ,” the withdrawal was prompted by the retraction of a Nature Medicine paper that formed the basis of the PLoS ONE study’s approach: The chemotherapy sensitivity predictions as reported in this PLoS One article were based on an approach as described by Potti et al. in Nature Medicine (1). Reexamination of the validation datasets used for the Nature Medicine study has revealed the presence of errors in the labeling of clinical response in some datasets (2). Re-analysis of the predictive accuracy with correctly labeled data has shown that in two instances the reported signatures do not predict the response of the validation samples to chemotherapy (2). The authors of the Nature Medicine paper have therefore decided to retract that paper (2). Since the PLoS One article is based on the approach reported in the Nature Medicine article, we have decided to retract the PLoS One article. We apologize to readers for any inconvenience caused by the publication of our article in PLoS One. The PLoS ONE paper has been cited 29 times, according to Thomson Scientific’s Web of Knowledge. As we reported in January when the Nature Medicine paper was retracted, that paper was cited more than 250 times. The PLoS ONE retraction means we are likely halfway through all of the paper withdrawals, according to a report in The Cancer Letter of an August 22, 2011Institute of Medicine meeting: Robert Califf, director of the Duke Translational Medicine Institute and vice chancellor for clinical research, said that the university has nearly completed an internal investigation of Potti’s published research. “There were about 40 that had original data that were generated at Duke,” Califf said. “We had an institutional need to understand the veracity of the manuscripts that had the institution’s name on it.” “About a third of the manuscripts are being fully retracted,” Califf said. “About a third are having a portion retracted with other components remaining intact, and about a third seem to be ok.” “In those retractions and partial retractions, there is a clear correlation between the need to withdraw the data and the extent to which the data originated from Dr. Potti,” Califf said. “It looks like they’re fundamentally not reproducible.” No timeframe was given for these retractions. There’s plenty more in The Cancer Letter’s current issue , including details on the lawsuits filed against Duke, Potti, and his colleagues by a number of former clinical trial participants. The Economist also covers the Potti story this week, and Darrel Ince has a piece on it in the journal Significance .
撤稿情况发生的几率 有逐年上升之势 ，有人以 Medline 数据库为例进行统计分析结果显示，自 20 世纪 50 年代以来，截止 2007 年 10 月 21 日 ，MEDLINE累计收录已经发表的论文数量超过 1700 万篇，其中撤稿 871 篇。首次撤稿出现在 20 世纪 70 年代，但是之后的撤稿比例有上升态势。 来自 Thomson Reuters 科技信息公司的数据显示出同样的发展势态， 2001 年到 2010 年十年之间撤稿增加了 14 倍多，由 2001 年的 22 篇跃增到 2010 年的 339 篇， 2011 年的前 6 个月撤稿又有 210 启。 Infection and Immunity 主编和 mBio 主编联合撰文指出，撤稿率的高低与其杂志的影响因子（ IF ）之间有出其意料的正相关性， IF 越高的期刊，往往撤稿率越高。但是令人奇怪的是 SCI 刊源的《 Acta Crystallographica Section E 》， 2007 年曾经上升为国人 SCI 的贡献状元， IF 并不高（ 0.41 ），但是撤稿特高！ 2006-2010 年之间撤稿超过百篇。井冈山大学成为撤稿最多的中心区，除了个别人受到处理之外，似乎看不到撤稿后的其他处理结果。《 Acta Crystallographica Section E 》的指标变化如下： Acta Crystallographica Section E 的变化 However, the greatest number of retraction notices – 105 between 2006 and 2010 – were published by the crystallography journal Acta Crystallographica Section E , which has an impact factor of just 0.41. All the retracted papers relate to a large-scale fraud, detected in 2010, by two researchers at Jinggangshan University, in China, who were subsequently fired. 《晶体学报 E 辑》的特 点、 《 晶体学报 E 辑》十年成就了中国 1.2 万篇 SCI 论文 、 井冈山大学论文造假始末 已经有博文介绍。《临床微生物杂志》（ Journal of Clinical Microbiology ）近期因为撤稿备受关注，2011年上半年 中国人民解放军空军总医院 Tianzheng Deng 等人因抄袭，论文撤稿之后，巴西有人也是在Journal of Clinical Microbiology杂志上发表的论文，因为抄袭了 4 年前已经在该刊发表的论文而被撤稿，但是这篇抄袭论文的再次发表，其中疑点多多，值得编辑同仁浏览，了解撤稿责任的背后故事，从中汲取经验教训。请看附件 should-journals.pdf
据Retraction Watch网站2011年8月26日的报道，原在东伦敦大学（University of East London）执教的 Jatinder Ahluwalia ,因为2003年在《 Journal of Neurochemistry 》杂志上发表的论文涉嫌学术不端： Ahluwalia, J., Yaqoob, M., Urban, L., Bevan, S. and Nagy, I. (2003), Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. Journal of Neurochemistry , 84:585–591. doi:10.1046/j.1471-4159.2003.01550.x 而且这篇论文也是 Jatinder Ahluwalia 在英国伦敦帝国理工学院（Imperial College London）获得其博士学位论文中的一部分。作者在撤稿原因中的陈述如下： The authors wish to draw attention that in spite of several proof readings, regrettably, the unit for the amount of anandamide released from cultured primary sensory neurons was incorrectly entered into the manuscript therefore, it was incorrectly published in Ahluwalia et al. (2003) . Further, the authors of this manuscript wish to provide a more-informative legend for Fig. 2. The correct unit for the amount of anandamide released by cultured primary sensory neurons should be pmol/ml instead of pmol/μl throughout the manuscript. 资深作者 Istvan Nagy 也认为与 Jatinder Ahluwalia 合作的论文的确存在问题，在给 Journal of Neurochemistry 的信件（见附件）中这样写道： In 2003, we reported in the Journal of Neurochemistry (Ahluwalia et al., Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. J. Neurochem., 84, 585: 591; 2003) that application of capsaicin (10nM or 100nM) or KCl (50mM) to adult rat cultured primary sensory neurons results in increased anandamide content of the superfusate of the cells. In one of our recent studies, we repeated a part of the experiment we described in that Journal of Neurochemistry paper. While we found that application of capsaicin or KCl indeed results in increased anandamide content of the superfusate, regretfully, I have to inform you that our current data indicate that the concentration of anandamide in the superfusate we reported in the Journal of Neurochemistry paper must be incorrect. Based on our current data, we can estimate that the superfusate of 500 cultured primary sensory neurons, after incubating the cells in 100nM capsaicin for 5 minutes, could contain ~ 7 fmol/ml anandamide, in average. However, in the paper we reportedthat 250l superfusate of 500 cultured primary sensory neurons, following 3 minutes incubation in 100nM capsaicin contained 2.07pmol/ml anandamide, in average. Based on our current data, we can also estimate that 5 minutes incubation of 500 cultured primary sensory neurons in 100nM capsaicin or 50nM KCl results, respectively, in ~47fmol/ml and ~68fmol/ml anandamide in the cells and superfusate together, in average. Our current data are obtained from two independent experiments, and measurements were done in two laboratories using different machines and conditions (i.e. extraction, solvents, etc). Therefore, I think that our current data indicate the correct range of anandamide that 500 cultured primary sensory neurons could produce following capsaicin or KCl application. A possible reason for the incorrect measurements, in our previous experiments, could be that instead of anandamide alone, we measured anandamide and other lipid compounds of very similar molecular mass together, because, due to the lack of internal standard and the use of single quad mass spectrometry, we could not differentiate between molecules of very similar molecular mass. Therefore, it appears that the conclusion of the Journal of Neurochemistry paper is based on data with a large artefactual component. Jatinder Ahluwalia2004年在《自然》杂志上发表的一篇论文于2010年11月被撤销,10多年前曾因论文数据捏造被剑桥大学开除。最终Jatinder Ahluwalia在帝国理工学院（Imperial College）获得博士学位后，在东伦敦大学（University of East London）执教，现在因为又有一篇论文被发现存在学术不端行为而离开了东伦敦大学。伦敦帝国理工学院针对Jatinder Ahluwalia的第二篇撤稿论文展开了对其学位 的有效性问题进行调查， 最终结果值得关注。 资深作者 Istvan Nagy 的信件： nagy letter.pdf
首先说明，这篇博文的题目是风马牛相集的结果。 本来，《 Cell 》撤稿与刘实无关，因为所撤之稿非刘实所写。 但《 Cell 》撤稿却又与刘实相集，因为它是刘实狂言的 CNS 生命科学论文至少三分之一是错的而应撤稿之刘论的具体体现之一。 《 Cell 》的最新一篇撤稿是： Cell, Volume 143, Issue 3 , 485, 29 October 2010 doi:10.1016/j.cell.2010.10.011 Retraction Notice to: Assembly of Endogenous oskar mRNA Particles for Motor-Dependent Transport in the Drosophila Oocyte Alvar Trucco , Imre Gaspar and Anne Ephrussi (Cell 139 , 983 998; November 25, 2009) In this paper, we used cryoimmuno-electron microscopy and live-cell imaging to investigate the sequential assembly of oskar mRNA into an mRNP competent for transport from the Drosophila nurse cells to the oocyte posterior pole. We have recently identified instances in all of the figures where the cryoimmuno-EM data were inappropriately manipulated by the first author. The manipulations do not affect the live-cell imaging data. We are in the process of reanalyzing the raw experimental cryoimmuno-EM data but can already state that the published conclusions are not fully consistent with the raw data. We are therefore retracting the paper. We sincerely apologize for any inconvenience that this might have caused. 而刘实在双规前几天还发表了 《细胞》撤稿，一大群作者的成就感大减 一文。调侃《 Cell 》把另一篇几十名作者合写的一篇论文给撤了，并说：这一撤稿，好多人的成就就被打了水漂。 所以，现在倒念起刘实来，我还真被他的英明折服，更为他的勇敢感动。 下面是我从刘实的求真网站上找到的一篇刘实投给《 Cell 》而被拒稿、但后来发表在高人所编的真顶尖（锐）杂志的文章。按他的文章所指，《 Cell 》撤稿的力度还远远不够。而这篇文章所列的还是刘实 2008 年前的投稿。好像他后来还给《 Cell 》投过一些也被拒稿。但他的文章现在倒念起来还都是对的（在我看来）。 A Summary of Cell s Rejections on Shi V. Lius Submissions Title Submitted Rejected Published* Searching for the Deep Root and Fundamental Mechanism of Biotic Aging 20050311 20050318 LB 5:89-91, 2005 HTM , PDF Cellular Senescence: What Does It Really Mean? 20051004 20051016 LB 5:308-310, 2005 HTM , PDF Piggyback on a Nobel Prize or Show Its True Spirit 20060109 20060203 LB 6:12-15, 2006 HTM , PDF Stop Playing the Cell Differentiation Tune for Caulobacter 20060405 20060407 LB 6: 31-32, 2006 HTM , PDF Cell Division versus Cell Reproduction 20060816 20060817 LB 6:62-64, 2006 HTM , PDF Revisit Semi-Conservative DNA Replication and Immortal DNA Strand Hypothesis 20060824 20060825 LB 6:54-61, 2006 HTM , PDF Why we keep losing excellence in young scientists? 20060820 20060825 LB 6:65-66, 2006 HTM , PDF Are Stem Cells Really Immortal Cells? 20060909 20061002 LB 6:71-75, 2006 HTM , PDF Sorry, I Am Not Your Grandfather 20061117 20061118 Pioneer 1: 5-7, 2006 HTM , PDF Stem Cells Self-Renewal or Cell Biologists Self-Cheating? 20061219 20061223 LB 6:106-109, 2006 HTM , PDF What Is a Stem Cell? 20070129 20070130 LB 7:12-17, 2007 HTM , PDF Lius Message Blocked by Top Journals 20070314 20070315 Sci. Ethics 2: 5-6, 2007 HTM , PDF Respecting Published Answers for Important Questions on Epigenetics 20070320 20070411 Top Watch 2: 19-20,2007 HTM , PDF No Real Evidence for Round Trip in Spermatogenesis 20070423 No Reply! LB 7:26-28, 2007 HTM , PDF Immortal Strand Does Not Exist but Nonrandom Strand Segregation Should Be Universal 20070722 20070803 LB 7:26-28, 2007 HTM , PDF An alternative view on nonrandom DNA segregation and cell life 20080810 No Reply Unpublished Induction of pluripotency: where is the evidence? 20081125 No Reply Top Watch 2:94, 2007 HTM , PDF iPS cells are man-made cancer cells 20080121 No Reply LB 8: 16-18, 2008 HTM , PDF Evidence for Selection of Pre-existing Stem Cells Rather than Induction of iPS Cells 20080501 No Reply LB 8: 52-54, 2008 HTM , PDF * LB = Logical Biology .This and other journals can be read at http://im1.biz 原文链接在： HTM , PDF
看了袁贤讯写的 现在写文章越来越麻烦 一文，深有同感！现在不仅国内有些刊物是这样，国外的有些刊物也是如此。原来本应由编辑干的活，现在都要求作者干了，让人无所适从！不同刊物对版面的要求五花八门，即使作者对着它的Sample issue格式写，也很难达到出版要求！于是，一封信来，一封信去，一些宝贵的时间就浪费在这种琐事上面了！ 大家可能要问，以前Editor能干的事，现在为什么不能干了？其实，并不是他不能干，而是他去干别的事情去了！什么事情呢？越权！就是超越Editor的权力当起了Reviewer！ 我曾经给国外一本杂志投稿，经三位reviewers评阅后，Executive editor来信告诉我同意录用，但必须在格式和文字上进行重大修改（注意：不是内容哦），并强调让论文写作公司修改。以下是他的来信原文： I am pleased to confirm that we can accept your paper for publication but before we can proceed further major revisions of it are needed. May I respectfully remind you that this is a rapid publication journal and, as such, no proofs of your paper will be issued to you before it is published. It is therefore imperative that what we send to the printers is correct in all details. You have been asked previously to advise your paper in accordance with the advice that is given in our Instructions to Authors as well as our Guidance Notes. It is therefore disappointing to record that you have not followed this advice. You would find the use of our Checklist, which is also available online via our website, to be of help to you. In addition you should also consult some recently published papers in this Journal to see the style that is preferred. Overall, the quality of the writing in your paper remains very poor, it would benefit it considerably if you could seek the help of a professional paper writing agency to ensure a much higher standard of presentation. Of particular concern are the following points. However, these are not necessarily complete and you must therefore carefully check your final manuscript against the advice we give in our Instructions to Authors. 于是，我根据他的建议，对照Instructions to Authors、Guidance Notes和Checklist，将文章从头至尾认真地修改了几遍，直到自己觉得满意后才寄回去。 令人没有想到的是，从第二封信起，Editor不提格式和文字的问题了，反而当起了Reviewer，一遍又一遍地指出我的研究结果不明确，要修改；我的分析数据不完整，要补充！前前后后的通信不下五个来回，我都忍气吞声地尽量按他的要求修改或说明。我觉得，如果经过Author与Editor之间的互动交流，可以真正提高一篇论文的质量，多改几回也未尝不是件好事！ 可是，事与愿违，他在后面的多次来信中对我的研究结果变本加厉地挑错，而且对我的文章已经越来越不满意了！请问这个Editor，你为什么弃三位Reviewers的评阅意见而不顾呢？你的权力应该是在格式和文字方面把关吧？就因为我们没让专门的写作公司修改就说我们的英语烂？对此，我很有意见，经与同事商量，决定主动撤稿，并对他的越权行为表达不满！ 下面就是我写的撤稿信原文： We determine to retract our manuscript for publication in your journal because you always surpass your right as an editor other than a reviewer. We have fully revised the article based on reviewers' suggestions, and also modified its style obeying the instruction to authors. Unfortunately, you indicate new challenges against it this time. Actually you always misunderstand our work and often suggest some unacceptable opinions. I want you know every research work is not complete at all, and the academic value of an article is the real importance but not grammar and words. Although we are not native English speakers, we have published about 10 papers in English journals. We wish you change your behavior as an editor and never mislead other authors. Thank you for your serious reply letters! 后来，这个Editor回了信，但现在已经找不到，大意是作为Author当然有撤稿的自由，但他还是会等到修回期限再做决定！此后，我们没有关注他的决定，也不打算再向这本杂志投稿！
标签: 撤稿
